{
    "A. Nattermann": {
        "Company Name": "A. Nattermann",
        "Year": "1906-",
        "Description": "A. Nattermann & Cie. GmbH is a German pharmaceutical company headquartered in Cologne-Bocklemund (North Rhine-Westphalia), Nattermannallee 1."
    },
    "AAH": {
        "Company Name": "AAH",
        "Year": "1970-",
        "Description": ""
    },
    "Abbott": {
        "Company Name": "Abbott",
        "Year": "1888-",
        "Description": ""
    },
    "AbbVie": {
        "Company Name": "AbbVie",
        "Year": "2013-",
        "Description": "42deg20'12''N 87deg50'04''W / 42.33679degN 87.83432degW / 42.33679; -87.83432 (Headquarters Site)"
    },
    "Abiomed": {
        "Company Name": "Abiomed",
        "Year": "1981-",
        "Description": "Abiomed, Inc. is a medical device technology company that operates as a stand-alone business within Johnson & Johnson's MedTech Segment.[2] Abiomed develops and manufactures temporary external and implantable mechanical circulatory support devices. The company is headquartered in Danvers, Massachusetts with additional offices in Woburn, Baltimore, Berlin, Aachen, and Tokyo."
    },
    "Abivax": {
        "Company Name": "Abivax",
        "Year": "2013-",
        "Description": "Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases."
    },
    "Acadia": {
        "Company Name": "Acadia",
        "Year": "1993-",
        "Description": "Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.[2]"
    },
    "Acceleron": {
        "Company Name": "Acceleron",
        "Year": "2003-",
        "Description": "Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-b) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels."
    },
    "ACG Group": {
        "Company Name": "ACG Group",
        "Year": "1961-",
        "Description": ""
    },
    "ACI Limited": {
        "Company Name": "ACI Limited",
        "Year": "1973-",
        "Description": ""
    },
    "ACME Laboratories": {
        "Company Name": "ACME Laboratories",
        "Year": "1954-",
        "Description": "The ACME Laboratories Ltd. is a pharmaceutical company based in Bangladesh. It is part of the ACME Group of Companies.[1][2][3][4] Mizanur Rahman Sinha is the managing director and largest shareholder of the company and Nagina Afzal Sinha is the chairperson.[5]"
    },
    "Acorda": {
        "Company Name": "Acorda",
        "Year": "1995-",
        "Description": "Acorda Therapeutics, Inc. is an American biotechnology company based in Pearl River, New York. The company develops therapies that improve neurological function in people with Parkinson's disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine) in the United States."
    },
    "ACT": {
        "Company Name": "ACT",
        "Year": "2008-",
        "Description": "ACT Biotech Inc is a San Francisco-based, privately held biopharmaceutical company focused on the development and commercialization of targeted cancer drugs.[1][2] It was founded in 2008.[3]"
    },
    "Acura": {
        "Company Name": "Acura",
        "Year": "1935-",
        "Description": "Acura Pharmaceuticals Inc. is a pharmaceutical company focused on the development and commercialization of deterrents to medication abuse and misuse.[3] As of 2012[update], the company had several opioid products under development, which would use \"Aversion Technology\".[4]  As of 2014[update], it was a publicly traded company, listed on NASDAQ under the symbol \"ACUR\"."
    },
    "Adcock Ingram": {
        "Company Name": "Adcock Ingram",
        "Year": "1890-",
        "Description": ""
    },
    "Advanced Accelerator Applications": {
        "Company Name": "Advanced Accelerator Applications",
        "Year": "2002-",
        "Description": "Advanced Accelerator Applications (AAA or Adacap) is a France-based pharmaceutical group, specialized in the field of nuclear medicine.[1] \nThe group operates in all three segments of nuclear medicine (PET, SPECT and therapy) to diagnose and treat serious conditions in the fields of oncology, neurology, cardiology, infectious and inflammatory diseases.[2]"
    },
    "Advanz": {
        "Company Name": "Advanz",
        "Year": "1963-",
        "Description": "Advanz Pharma Corp. is a British multinational pharmaceutical company headquartered in London. It changed its name from Concordia Healthcare Corp. in November 2018.[3] The company focuses on a number of therapy areas including endocrinology, ophthalmology, urology, anti-infectives, pain management, central nervous system disorders, oncology, haematology, cardiology and intensive care medicine. The company also focuses on acquiring legacy pharmaceutical compounds which are usually off-patent.[4] The operational headquarters is in London, UK, operations centre in Mumbai, India and regional hubs in Europe, Australia and Canada."
    },
    "Advaxis": {
        "Company Name": "Advaxis",
        "Year": "2006-",
        "Description": "Advaxis Inc. is an American company devoted to the discovery, development and commercialization of immunotherapies based on a technology platform which uses engineered Listeria monocytogenes (aka Lm).[1]: 1   The company is headquartered in Princeton, New Jersey and was incorporated in Delaware in 2006.[1]: 1"
    },
    "Aerie": {
        "Company Name": "Aerie",
        "Year": "2005-",
        "Description": "Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candidates are once-daily therapies for lowering intraocular pressure with mechanisms to treat patients with glaucoma or ocular hypertension.[1][2][3]"
    },
    "Agios": {
        "Company Name": "Agios",
        "Year": "2008-",
        "Description": "Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias.[3] The company was founded in 2008 (or 2007)[4] by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts.[2][5] The company tendered an initial public offering in July 2013.[6]: Table 1"
    },
    "Ajanta": {
        "Company Name": "Ajanta",
        "Year": "1973-",
        "Description": ""
    },
    "Akbarieh": {
        "Company Name": "Akbarieh",
        "Year": "1890-",
        "Description": "Akbarieh (Persian: khbryh), headquarters in Tehran, Iran, is one of the oldest suppliers of pharmaceuticals and fine chemicals and importers to Iran.[1][2] Established in 1890, the company is still operated by the Akbarieh family. Akbarieh customers are health professionals, and manufacturers of pharmaceuticals, food, cosmetic and feed industries.[3]"
    },
    "Alcon": {
        "Company Name": "Alcon",
        "Year": "2019-",
        "Description": "Alcon Inc. (<See Tfd>German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people.[2]"
    },
    "Alembic": {
        "Company Name": "Alembic",
        "Year": "1907-",
        "Description": ""
    },
    "Alexion": {
        "Company Name": "Alexion",
        "Year": "1992-",
        "Description": "Alexion Pharmaceuticals, Inc., an independent subsidiary of AstraZeneca, is an American pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases."
    },
    "Algeta": {
        "Company Name": "Algeta",
        "Year": "1997-",
        "Description": ""
    },
    "Alimera": {
        "Company Name": "Alimera",
        "Year": "2003-",
        "Description": "Alimera Sciences, Inc. is a biopharmaceutical sales company based in Alpharetta, Georgia that specializes in the commercialization and sales of prescription ophthalmic pharmaceuticals. The company's main selling focus is on diseases affecting the back of the eye, or retina.[2] The company is the licensee for Iluvien, a fluocinolone acetonide intravitreal implant."
    },
    "ALK-Abell\u00f3": {
        "Company Name": "ALK-Abell\u00f3",
        "Year": "1923-",
        "Description": "ALK-Abello A/S (Nasdaq Copenhagen: ALK B), also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy (AIT) products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products  (also known as 'allergy vaccines')[2] with 67% of its revenue coming from sales in Europe.[3]"
    },
    "Alkaloid": {
        "Company Name": "Alkaloid",
        "Year": "1936-",
        "Description": "Alkaloid AD Skopje (Macedonian: Alkaloid AD Skopje[1]) is a pharmaceutical company in North Macedonia which for eight decades, has been operating in the field of manufacturing drugs, cosmetic and chemical products and processing botanical raw materials."
    },
    "Alkem": {
        "Company Name": "Alkem",
        "Year": "1973-",
        "Description": ""
    },
    "Alkermes": {
        "Company Name": "Alkermes",
        "Year": "1987-",
        "Description": "Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall.[3]  In September 2011 Alkermes, Inc. merged with Elan Drug Technologies (EDT), the former drug formulation and manufacturing division of Elan Corporation, plc.[4] The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio.[1]"
    },
    "Almirall": {
        "Company Name": "Almirall",
        "Year": "1943-",
        "Description": ""
    },
    "Alnylam": {
        "Company Name": "Alnylam",
        "Year": "2002-",
        "Description": "Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics[3] for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.[4] In 2016, Forbes included the company on its \"100 Most Innovative Growth Companies\" list.[5]"
    },
    "Alphapharm": {
        "Company Name": "Alphapharm",
        "Year": "1982-",
        "Description": ""
    },
    "Altana": {
        "Company Name": "Altana",
        "Year": " ????-2006",
        "Description": ""
    },
    "Alvogen": {
        "Company Name": "Alvogen",
        "Year": "2009-",
        "Description": "Alvogen is an Icelandic pharmaceutical company founded in 2009. In 2014, a controlling stake in the company was acquired by CVC Capital Partners and Temasek Holdings. Alvogen has about 350 different medical and non-medical products, and both produces its own products and markets the products of brand name pharmaceutical companies."
    },
    "Alzheon": {
        "Company Name": "Alzheon",
        "Year": "2013-",
        "Description": "Alzheon is an American clinical-stage biopharmaceutical company based in Framingham, Massachusetts.[1] The company is developing medicines for patients with Alzheimer's disease and other neurological and psychiatric disorders.[2]"
    },
    "AMAG": {
        "Company Name": "AMAG",
        "Year": "1981-",
        "Description": "AMAG Pharmaceuticals, Inc. is an American pharmaceutical company developing products that treat iron deficiency anemia (IDA) in adult patients.  The company was a publicly traded company listed on NASDAQ under the symbol \"AMAG\" until November 2020 when it was acquired by Covis Pharma.[2]"
    },
    "Ameridose": {
        "Company Name": "Ameridose",
        "Year": "2006-",
        "Description": "Ameridose, LLC. is a medical manufacturer based in Westborough, Massachusetts. The company was founded, along with its sister company New England Compounding Center, by brothers-in-law Greg Conigliaro and Barry Cadden.[5] The owners of Ameridose are Carla R. Conigliaro, Barry J. Cadden, Lisa M. Conigliaro and Gregory A. Conigliaro.[6]"
    },
    "Amgen": {
        "Company Name": "Amgen",
        "Year": "1980-",
        "Description": "Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.[3][4] One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total.[5]"
    },
    "Amneal": {
        "Company Name": "Amneal",
        "Year": "2002-",
        "Description": ""
    },
    "Amphastar": {
        "Company Name": "Amphastar",
        "Year": "2004-",
        "Description": "Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company.[4] It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products.[5]"
    },
    "Amrutanjan Healthcare": {
        "Company Name": "Amrutanjan Healthcare",
        "Year": "1893-",
        "Description": ""
    },
    "Angelini": {
        "Company Name": "Angelini",
        "Year": "1919-",
        "Description": "Angelini is a large-sized private international group. Founded in Italy in the early twentieth century, the Angelini group has offices in 21 countries. Owned by Angelini family and currently led by Sergio Marullo di Condojanni and Thea Paola Angelini, the industrial group employs approximately 5800 people.[3]"
    },
    "Annexin": {
        "Company Name": "Annexin",
        "Year": "????-",
        "Description": "Annexin Pharmaceuticals is a Swedish privately held biotech company[1][2] developing new therapeutic approaches for inflammatory cardiovascular diseases. The concept for the therapy is based on the anti-inflammatory properties of Annexin A5, a body own protective protein that acts simultaneously against several key pathogenic mechanisms of cardiovascular diseases. The company is currently focusing on treatment of peripheral artery disease (PAD)."
    },
    "Anthera": {
        "Company Name": "Anthera",
        "Year": "2004-",
        "Description": "Anthera Pharmaceuticals, Inc. is an American biopharmaceutical company focused on developing and commercializing products to treat serious conditions associated with cystic fibrosis, inflammation and autoimmune diseases. Liprotamase (Sollpura), Anthera's leading drug candidate which is being developed for exocrine pancreatic insufficiency (EPI) is currently in Phase 3 clinical trials, and A-623 (Blisibimod) for the treatment of IgA nephropathy[1][2] is currently in Phase 2 clinical trial."
    },
    "Antibiotice Ia\u0219i": {
        "Company Name": "Antibiotice Ia\u0219i",
        "Year": "1955-",
        "Description": "Antibiotice Iasi is a public pharmaceutical company which is one of the largest drug producing company in Romania. It is 53.02%-owned by the Romanian Ministry of Health.[3] Its research center and production facilities are based in Valea Lupului, a commune near Iasi."
    },
    "Aplia": {
        "Company Name": "Aplia",
        "Year": "2009-",
        "Description": "Innate Immunotherapeutics (INNM) was a biopharmaceutical company, previously known as Virionyx, with headquarters in Sydney, Australia and a branch in Auckland, New Zealand. Their focus in 2009 was the \"development of a new generation of immune response modifier for potential use in the treatment of a range of infectious diseases, certain cancers, and as a novel cellular and humoral adjuvant, \"[2] and developed a  proprietary multiple sclerosis drug, MIS416.[3] In April 2009 the firm changed its name to Innate Immunotherapeutics to reflect their focus on the development of MIS416, and moved their headquarters from Auckland, New Zealand to Sydney, Australia.[2] On June 22, 2017, Innate Immunotherapeutics announced that the MIS416 clinical trials undertaken to evaluate its efficacy in managing secondary progressive multiple sclerosis (SPMS),[4][5][6][7] had \"failed to show any clinically meaningful benefit or statistical significance.\"[8] These findings resulted in the stocks crashing on the Australian Securities Exchange (ASX).[8]"
    },
    "Apotex": {
        "Company Name": "Apotex",
        "Year": "1974-",
        "Description": "Apotex Inc. is a Canadian pharmaceutical corporation.[4] Founded in 1974 by Barry Sherman, the company is the largest producer of generic drugs in Canada, with annual sales exceeding CA$2.5 billion.[5] By 2023, Apotex employed close to 8,000 people as Canada's largest drug manufacturer, with over 300 products selling in over 115 countries.[2][6][7] Apotex manufactures and distributes generic medications for a range of diseases and health conditions that include cancer, diabetes, high cholesterol, glaucoma, infections and blood pressure."
    },
    "Apricus": {
        "Company Name": "Apricus",
        "Year": "1987-",
        "Description": "Apricus Biosciences, Inc. is a San Diego-based biopharmaceutical company advancing innovative medicines in urology and rheumatology."
    },
    "Arab Pharmaceutical Manufacturing": {
        "Company Name": "Arab Pharmaceutical Manufacturing",
        "Year": "1962-",
        "Description": "The Arab Pharmaceutical Manufacturing Company (APM) is a pharmaceuticals and healthcare company based in Jordan.  Its headquarters are located in Amman.  APM was founded in 1962 and it operates two main production facilities, in Al Salalem and Buhayra.  APM produces dozens of products, its \"Products Range\" page is located here.[1]"
    },
    "Arbutus": {
        "Company Name": "Arbutus",
        "Year": "2007-",
        "Description": "Arbutus Biopharma Corporation is a publicly traded Canadian (NASDAQ: ABUS) biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.[1]"
    },
    "Arena": {
        "Company Name": "Arena",
        "Year": "1997-",
        "Description": "Arena Pharmaceuticals, Inc. is an American biopharmaceutical company founded in 1997 and headquartered in San Diego, California.[3] The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. The company's most advanced investigational clinical programs are ralinepag (formerly APD811) in testing for pulmonary arterial hypertension (PAH), etrasimod (formerly APD334) in evaluation for inflammatory indications and APD371 for the treatment of pain associated with Crohn's disease.[4] In 2016, the company downsized and shifted its focus to developing new drugs currently being tested in clinical trials.[5][6] In December 2021, Pfizer announced that it had agreed to acquire Arena for $6.7 billion in cash.[7][8] In March 2022, it was announced the acquisition by Pfizer had been concluded.[9]"
    },
    "Array": {
        "Company Name": "Array",
        "Year": "1998-",
        "Description": "Array BioPharma is an American clinical stage, pharmaceutical company that focuses on oncology medication headquartered in Boulder, Colorado. The company is currently a subsidiary of Pfizer after being acquired for $11 billion in 2019."
    },
    "Arrowhead": {
        "Company Name": "Arrowhead",
        "Year": "2004-",
        "Description": "Javier San Martin, M.D., Chief Medical Officer\nKen Myszkowski, MBA, CPA, chief financial officer"
    },
    "AryoGen": {
        "Company Name": "AryoGen",
        "Year": "2009-",
        "Description": "AryoGen Pharmed (Persian: arywjn frmd) is an Iranian biopharmaceutical company specializing in manufacturing Therapeutic Monoclonal antibodies and some other recombinant proteins.[1][2][3]"
    },
    "Aspen Pharmacare": {
        "Company Name": "Aspen Pharmacare",
        "Year": "1850-",
        "Description": ""
    },
    "Assertio": {
        "Company Name": "Assertio",
        "Year": "1995-",
        "Description": "Assertio Therapeutics, Inc. (formerly Depomed, Inc.) is an American specialty pharmaceutical company.[3] It mainly markets products for treatment in neurology, pain and diseases of the central nervous system.[4] Depomed was founded in 1995 and is headquartered in Newark, California.[5] It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc.[6] As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.[7]"
    },
    "Astellas": {
        "Company Name": "Astellas",
        "Year": "2005-",
        "Description": "Astellas Pharma Inc. (asuterasuZhi Yao Zhu Shi Hui She , Asuterasu Seiyaku Kabushiki-gaisha) is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. (Shan Zhi Nei Zhi Yao Zhu Shi Hui She , Yamanouchi Seiyaku Kabushiki-gaisha) and Fujisawa Pharmaceutical Co., Ltd. (Teng Ze Yao Pin Gong Ye Zhu Shi Hui She , Fujisawa Yakuhin Kogyo Kabushiki-gaisha)."
    },
    "Astex": {
        "Company Name": "Astex",
        "Year": "1999-",
        "Description": ""
    },
    "AstraZeneca": {
        "Company Name": "AstraZeneca",
        "Year": "1999-",
        "Description": ""
    },
    "aTyr": {
        "Company Name": "aTyr",
        "Year": "2005-",
        "Description": "aTyr Pharma is a public biotherapeutics company (Nasdaq: LIFE)[1] that is focused on researching the extracellular functionality and signaling pathways of tRNA synthetases."
    },
    "Aurobindo": {
        "Company Name": "Aurobindo",
        "Year": "1986-",
        "Description": ""
    },
    "Avax": {
        "Company Name": "Avax",
        "Year": "2006-",
        "Description": "Avax Technologies, Inc. is a Philadelphia-based biotechnology company whose most advanced product candidate is MVax for melanoma. MVax is a cancer vaccine that received a Special Protocol Assessment agreement with the FDA in October 2006, and subsequently began a Phase III registration clinical trial in November 2007. In previous studies, MVax demonstrated a 5-year overall survival rate (OS)of 44% and response rate of 35% (13% CR, 22% PR).[1]"
    },
    "Avella": {
        "Company Name": "Avella",
        "Year": "1996-",
        "Description": "Avella Specialty Pharmacy, formerly known as The Apothecary Shops, is an American specialty pharmacy company.[1][2][3][4][5][6][7] Avella is headquartered in Phoenix, Arizona, and has facilities in eight states.[2][5][8] Dr. John D. Musil is the company's founder.[3][4][9] Rebecca Shanahan is the CEO.[10]"
    },
    "Aventis": {
        "Company Name": "Aventis",
        "Year": "1956-",
        "Description": ""
    },
    "B. Braun": {
        "Company Name": "B. Braun",
        "Year": "1839-",
        "Description": ""
    },
    "Barkat": {
        "Company Name": "Barkat",
        "Year": "2010-",
        "Description": "Barkat Pharmaceutical Group (Persian: grwh drwyy brkht, Gruh-e Darvii-ye Berekat) is an Iranian Pharmaceutical public company, which was founded in 2010, named Tadbir innovation pharmaceutical company.[1] The company provides services through cooperation between science-based institutions and scientists based on medicine around the world.[2] It  supplies 14 percent of all the country's essential drugs through its 25 subsidiaries.[3][4][5] The company produces 700 kinds of products[6] in the pharmaceutical sector and offers it internally.[7]"
    },
    "Bausch & Lomb": {
        "Company Name": "Bausch & Lomb",
        "Year": "1853-",
        "Description": ""
    },
    "Bausch Health": {
        "Company Name": "Bausch Health",
        "Year": "1959-",
        "Description": "Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc.) is an American-Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health and neurology. Bausch Health owns Bausch & Lomb, a supplier of eye health products. Bausch Health's business model is primarily focused on acquiring small pharmaceutical companies and then sharply increasing the prices of the drugs these companies sell.[2]"
    },
    "Bavarian Nordic": {
        "Company Name": "Bavarian Nordic",
        "Year": "1994-",
        "Description": ""
    },
    "Baxter": {
        "Company Name": "Baxter",
        "Year": "1931-",
        "Description": ""
    },
    "Bayer": {
        "Company Name": "Bayer",
        "Year": "1863-",
        "Description": ""
    },
    "BCM": {
        "Company Name": "BCM",
        "Year": "1991-",
        "Description": ""
    },
    "Beacon": {
        "Company Name": "Beacon",
        "Year": "2006-",
        "Description": ""
    },
    "Beam": {
        "Company Name": "Beam",
        "Year": "2017-",
        "Description": "Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR and  prime editing, whereby single nucleotides in a DNA sequence can be modified without cutting the DNA, theoretically reducing the likelihood of off-target effects compared to previous CRISPR-based methods[vague].[2][3]"
    },
    "Behestan Darou": {
        "Company Name": "Behestan Darou",
        "Year": "2001-",
        "Description": "Behestan Darou (Persian: bhstn drw) is a private joint stock pharmaceutical company based in Tehran, Iran. Founded in 2001, the company is currently one of the largest importers of finished pharmaceutical products in terms of sales and number of products imported.[1][2] Formed subsequent to the Ministry of Health decision to privatize the Iranian pharmaceutical sector, the company imports and markets more than 300 generic and patented pharmaceuticals from a number of international pharmaceutical manufacturers.\nBehestan Darou is a subsidiary of Behphar holding.[3]\nBehestan Darou's operation currently involves registration, importation and marketing of prescription and consumer healthcare products.[4]"
    },
    "BeiGene": {
        "Company Name": "BeiGene",
        "Year": "2010-",
        "Description": ""
    },
    "Bengal Chemicals and Pharmaceuticals": {
        "Company Name": "Bengal Chemicals and Pharmaceuticals",
        "Year": "1901-",
        "Description": ""
    },
    "Benitec": {
        "Company Name": "Benitec",
        "Year": "1997-",
        "Description": ""
    },
    "Berlin Chemie": {
        "Company Name": "Berlin Chemie",
        "Year": "1890-",
        "Description": "Berlin-Chemie AG is a German pharmaceutical company based in Berlin, Germany. It is part of the Menarini Group."
    },
    "Besins Healthcare": {
        "Company Name": "Besins Healthcare",
        "Year": "1885-",
        "Description": "Besins Healthcare is a privately held, fifth-generation family-owned multinational pharmaceutical company headquartered in Monaco.  Founded in 1885 in Paris, Besins Healthcare focuses on transdermal delivery technology treatments and has products available in 100 countries."
    },
    "Beximco": {
        "Company Name": "Beximco",
        "Year": "1980-",
        "Description": "Beximco Pharmaceuticals Ltd, also known as Beximco Pharma (stylised as BEXIMCO PHARMA) is a Bangladeshi multinational pharmaceutical company.[3] It is a part of Bangladesh Export Import Company Limited (BEXIMCO).[4]"
    },
    "Bharat Biotech": {
        "Company Name": "Bharat Biotech",
        "Year": "1996-",
        "Description": "17deg39'55''N 78deg36'17''E / 17.6652degN 78.6047degE / 17.6652; 78.6047"
    },
    "Bial": {
        "Company Name": "Bial",
        "Year": "1924-",
        "Description": "Bial (Portela e C.a, S.A.) is a pharmaceutical company headquartered in Sao Mamede do Coronado, in Trofa, Porto district, Portugal. It was founded in 1924, being among the largest companies of its kind in Portugal. Its products are sold in pharmacies in more than 58 countries in 4 continents: Europe, America, Africa and Asia."
    },
    "Biocon": {
        "Company Name": "Biocon",
        "Year": "1978-",
        "Description": ""
    },
    "BioCryst": {
        "Company Name": "BioCryst",
        "Year": "1986-",
        "Description": ""
    },
    "Bioderma": {
        "Company Name": "Bioderma",
        "Year": "1977-",
        "Description": "Bioderma Laboratories is a privately owned French pharmaceutical company that specialises in medication for dermatological and hair/scalp conditions, as well as for Pediatry and cell regeneration.[4] It was founded in 1977, in Aix en Provence, where its headquarters still reside. However, in 2001, the company opened its first specialised biometrology lab for skincare research and development in Lyon. \nIts primary business sector is Dermatology, with products such as ABCDerm, Atoderm, Cicabio, Crealine, Hydrabio, Matriciane, Matricium, Sebium, White Objective, secure (skin care), Node (hair care) and Photoderm (sun care).[citation needed]"
    },
    "Bio Farma": {
        "Company Name": "Bio Farma",
        "Year": "1890-",
        "Description": "PT Bio Farma (Persero) is an Indonesian state-owned enterprise based in Bandung, West Java and the only local vaccine manufacturer in Indonesia,[2]  which produces vaccines and sera to support immunization in Indonesia and other countries.[3] Bio Farma vaccine produced vaccines against measles, polio, hepatitis B, and pentavalent vaccine.[2] Bio Farma has supplied vaccines to multiple countries through UNICEF, PAHO and other organizations.[4] Since 2020, it also serves as the holding company for listed state-owned enterprises Kimia Farma and Indofarma.[5]"
    },
    "Biogen": {
        "Company Name": "Biogen",
        "Year": "1978-",
        "Description": "Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Sweden, and Switzerland.[2]"
    },
    "Bioinvent": {
        "Company Name": "Bioinvent",
        "Year": "1983-",
        "Description": "BioInvent International is a Swedish clinical-stage biotech company that discovers and develops novel and first-in-class immunomodulatory antibodies for cancer therapy. The company's validated, proprietary F.I.R.S.T(tm) technology platform simultaneously identifies both targets and the antibodies that bind to them, generatingnew drug candidates to fuel the Company's own broad clinical development pipeline or for additional licensing and partnering. Currently, the company has five clinical programs for hematological cancer and solid tumor treatment.[1] Furthermore, the company has a fully integrated, proprietary, state-of-the art manufacturing facility unit. Martin Welschof has been CEO since 2018.[2][3][4][5][6][7] The company is a partner of The Leukemia & Lymphoma Society's Therapy Acceleration Program, an initiative that develops blood cancer treatment.[8]"
    },
    "BioLineRx": {
        "Company Name": "BioLineRx",
        "Year": "2003-",
        "Description": "BioLineRx Ltd. (Hebrew: byvlyyn Ar Aks), or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange."
    },
    "BioMarin": {
        "Company Name": "BioMarin",
        "Year": "1997-",
        "Description": "BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I (MPS I), by manufacturing laronidase (Aldurazyme, commercialized by Genzyme Corporation).  BioMarin was also the first company to provide therapeutics for phenylketonuria (PKU).[5][6]"
    },
    "bioM\u00e9rieux": {
        "Company Name": "bioM\u00e9rieux",
        "Year": "1963-",
        "Description": "bioMerieux SA is a French multinational biotechnology company founded and headquartered in Marcy-l'Etoile, France, close to Lyon.  bioMerieux is present in 44 countries and serves more than 160 countries through a large network of distributors.[1]"
    },
    "BiondVax": {
        "Company Name": "BiondVax",
        "Year": "2003-",
        "Description": "BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases."
    },
    "Bioverativ": {
        "Company Name": "Bioverativ",
        "Year": "2016-",
        "Description": "Bioverativ Inc. is an American multinational biotechnology company that specializes in the discovery, development, and delivery of therapies for the treatment of haemophilia.[3] Bioverativ competes with Baxalta (acquired by Shire Plc in 2016[4]), Pfizer and Novo Nordisk.[2] The company traded on the NASDAQ exchange under the ticker symbol BIVV until Sanofi completed its acquisition on March 8, 2018."
    },
    "Biovista": {
        "Company Name": "Biovista",
        "Year": "2005-",
        "Description": "Biovista Inc. is a private drug development services company based in Charlottesville, Virginia, US.  Biovista's core business activities include drug repositioning and drug de-risking as well as disease cohort analysis, adverse event prediction and clinical hold analysis services.  Biovista is also applying its technology platform to develop its own drug repositioning programs in the areas of central nervous system (CNS), diabetes/obesity, eye disorders, and oncology.[citation needed]"
    },
    "Bliss": {
        "Company Name": "Bliss",
        "Year": "1984-",
        "Description": ""
    },
    "Bluepharma": {
        "Company Name": "Bluepharma",
        "Year": "1990-",
        "Description": "Bluepharma (full name Bluepharma -- Industria Farmaceutica, SA) is a pharmaceutical company of Portuguese ownership, which is located in Coimbra, Portugal. Bluepharma became FDA approved since 2009 for the development of solid pharmaceutical forms, \"becoming the first Portuguese pharmaceutical company to export to the US market.\"[1]"
    },
    "Boehringer Ingelheim": {
        "Company Name": "Boehringer Ingelheim",
        "Year": "1885-",
        "Description": "C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861-1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one. Headquartered in Ingelheim, it operates globally with 146 affiliates and more than 47,700 employees. Unlike most large pharmaceutical companies which are listed, the company is private and fully owned by the Boehringer, Liebrecht and von Baumbach families.[3] The company's key areas of interest are: respiratory diseases, metabolism, immunology, oncology and diseases of the central nervous system. Boehringer Ingelheim is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). The corporate logo of Boehringer Ingelheim depicts a stylized rendition of the central section of the imperial palace of Charlemagne.[4]"
    },
    "Bosnalijek": {
        "Company Name": "Bosnalijek",
        "Year": "1951-",
        "Description": ""
    },
    "Bracco": {
        "Company Name": "Bracco",
        "Year": "1927-",
        "Description": "The Bracco Group is an Italian multinational active in the healthcare sector with more than 3,300 employees worldwide,[2] which operates in a variety of business areas.[2]"
    },
    "Bristol-Myers Squibb": {
        "Company Name": "Bristol-Myers Squibb",
        "Year": "1887-",
        "Description": ""
    },
    "BTG": {
        "Company Name": "BTG",
        "Year": "1991-",
        "Description": "BTG Limited is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer and other disorders. The current name was adopted when the British Technology Group changed its name on 27 May 1998.[2] BTG was a constituent of the FTSE 250 Index until it was acquired by Boston Scientific in August 2019."
    },
    "Cadila": {
        "Company Name": "Cadila",
        "Year": "1952-",
        "Description": ""
    },
    "Camurus": {
        "Company Name": "Camurus",
        "Year": "1991-",
        "Description": "Camurus AB (publ) is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap."
    },
    "Canadian Plasma Resources": {
        "Company Name": "Canadian Plasma Resources",
        "Year": "2012-",
        "Description": "Canadian Plasma Resources (CPR) is a private, for-profit bio-pharmaceutical company and a licensed blood establishment based in Saskatoon, Saskatchewan, Canada. It was founded in 2012 and specializes in the collection of source plasma for further manufacturing and contract-manufacturing of plasma-based bio-pharmaceuticals with operations in Saskatoon (Saskatchewan), Moncton (New Brunswick), Calgary, Edmonton (Alberta), Winnipeg (Manitoba) and administrative office in Oakville, Ontario. CPR is one of the only four establishments in Canada that are licensed to collect plasma. The others are Canadian Blood Services (CBS), Hema-Quebec and Cangene, now owned by ProMetic Life Sciences Inc."
    },
    "CanSinoBIO": {
        "Company Name": "CanSinoBIO",
        "Year": "2009-",
        "Description": "39deg04'26''N 117deg32'35''E / 39.0739degN 117.5430degE / 39.0739; 117.5430"
    },
    "Capsugel": {
        "Company Name": "Capsugel",
        "Year": "1931-",
        "Description": "Capsugel is a company that manufactures and sells two-piece hard gelatin drug capsules.[3]: 703  Capsugel also sells equipment for filling empty and liquid capsules, as well as equipment for sealing liquid capsules."
    },
    "Cassava Sciences": {
        "Company Name": "Cassava Sciences",
        "Year": "1998-",
        "Description": ""
    },
    "Catalent": {
        "Company Name": "Catalent",
        "Year": "2007-",
        "Description": ""
    },
    "Catalyst": {
        "Company Name": "Catalyst",
        "Year": "2002-",
        "Description": ""
    },
    "Cathay Drug": {
        "Company Name": "Cathay Drug",
        "Year": "1952-",
        "Description": "The Cathay Drug Company, Inc. (CDCI) is a Philippine pharmaceutical company based in Makati."
    },
    "Cederroth": {
        "Company Name": "Cederroth",
        "Year": "1895-",
        "Description": "Cederroth AB is a Swedish pharmaceuticals company which manufactures and markets personal care, healthcare, wound care, household and first aid products. Founded in 1895 in Gavle, by Christian Cederroth, it is based in Upplands Vasby."
    },
    "Cel-Sci": {
        "Company Name": "Cel-Sci",
        "Year": "1983-",
        "Description": "Cel-Sci Corporation (NYSE American: CVM), is a biotechnology company that tests drugs for the treatment of cancer, autoimmune and infectious diseases through the research and development of immunotherapy products."
    },
    "Celesio": {
        "Company Name": "Celesio",
        "Year": "1835-",
        "Description": ""
    },
    "Celgene": {
        "Company Name": "Celgene",
        "Year": "1986-",
        "Description": "Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS).[2]"
    },
    "Celltrion": {
        "Company Name": "Celltrion",
        "Year": "2002-",
        "Description": "Celltrion, Inc. (Korean: jusighoesa selteurion) is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.[2] Celltrion's founder, Seo Jung-jin, is the richest person in South Korea.[3]"
    },
    "Cencora": {
        "Company Name": "Cencora",
        "Year": "2001-",
        "Description": ""
    },
    "Century": {
        "Company Name": "Century",
        "Year": "1966-",
        "Description": ""
    },
    "Ceragenix": {
        "Company Name": "Ceragenix",
        "Year": "????-",
        "Description": "Ceragenix Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Denver, Colorado that develops prescription therapies based on a platform of proprietary surface active technologies--skin Barrier Repair Technology (BRT) and Cerageninis, a new class of broad spectrum anti-infectives.[1] The company discovers, develops and commercializes anti-infective drugs based on its proprietary class of compounds, Ceragenins. Active against a range of gram positive and gram negative bacteria, these agents are being developed as anti-infective medical device coatings and as therapeutics for antibiotic-resistant organisms."
    },
    "Cerevel": {
        "Company Name": "Cerevel",
        "Year": "2018-",
        "Description": "Cerevel Therapeutics Holdings, Inc. is an American biotechnology and pharmaceuticals company based in Cambridge, Massachusetts, focused on the development of novel therapies for mental and neurological illnesses.[1]"
    },
    "CFR": {
        "Company Name": "CFR",
        "Year": "1922-",
        "Description": "CFR Pharmaceuticals, now owned by Abbott Laboratories, is a Chilean pharmaceutical company engaged in the development, production, and sale of pharmaceutical drugs in 15 Latin American countries such as Argentina, Bolivia, Chile, Colombia, Costa Rica, Ecuador, Paraguay, Peru, Venezuela and others and in Vietnam in Asia. The company is one of the largest Pharmaceutical companies in Latin America."
    },
    "Cheplapharm Arzneimittel": {
        "Company Name": "Cheplapharm Arzneimittel",
        "Year": "1998-",
        "Description": "Cheplapharm Arzneimittel GmbH, headquartered in Greifswald, is a German pharmaceutical company that markets branded drugs, medical products, supplements and cosmetics."
    },
    "Chemidex": {
        "Company Name": "Chemidex",
        "Year": "1981-",
        "Description": "Chemidex Pharma was a British pharmaceutical manufacturer, owned by Navin Engineer and his wife Varsha Engineer, and based in Egham."
    },
    "Cheng Fong": {
        "Company Name": "Cheng Fong",
        "Year": "2016-",
        "Description": "Cheng Fong Chemical Co. Ltd is a Chinese active pharmaceutical ingredient (API) company that exports to the United States of America.[1] In September 2016, the US FDA issued a warning letter \"following a five-day inspection in April 2016 that found the company failed to appropriately maintain its facilities and investigate reports of foreign particles in finished batches.\"[2] According to the FDA, Cheng Fong officials told investigators \"that the rooms had never been cleaned.\".[1]"
    },
    "Chiesi": {
        "Company Name": "Chiesi",
        "Year": "1935-",
        "Description": "Chiesi Farmaceutici S.p.A. is an Italian family controlled[1][2] global pharmaceutical company based in Parma, Emilia-Romagna. Chiesi has 31 affiliates[3] in the world, nearly 6,500 total employees[4] and provides medicines to patients in 100 nations. Chiesi currently has revenues of 3 billion euros.[4] According to 2020 official data from the European Patent Office (EPO), Chiesi Group, with 42 patents filed, is confirmed as the first Italian Pharmaceutical Company and third among Italian Companies across all sectors for filing the highest number of patents.[5]"
    },
    "Chong Kun Dang": {
        "Company Name": "Chong Kun Dang",
        "Year": "1941-",
        "Description": "Chong Kun Dang (Korean: jonggeundang) is a South Korean multinational pharmaceutical company headquartered in Seoul. Founded as Goongbon Pharmacy under Japanese rule in 1941, it was renamed in 1946 and has since become one of the largest pharmaceutical manufacturers in the country."
    },
    "Chugai": {
        "Company Name": "Chugai",
        "Year": "1943-",
        "Description": ""
    },
    "CinnaGen": {
        "Company Name": "CinnaGen",
        "Year": "1994-",
        "Description": "CinnaGen is an Iran based biotechnology company that was founded in 1994 by Hamid Mobtaker.[specify] As of 2016, it manufactured biosimilar drugs, laboratory diagnostic reagents for in vitro use, and recombinant proteins, and exported to other countries in the Middle East and to countries in the Commonwealth of Independent States.[1]: 70"
    },
    "Cipla": {
        "Company Name": "Cipla",
        "Year": "1935-",
        "Description": ""
    },
    "Civica Rx": {
        "Company Name": "Civica Rx",
        "Year": "2018-",
        "Description": "Civica Rx is a nonprofit generic drug company founded in 2018 by leading U.S. health systems and philanthropies[1] for the purpose of preventing and mitigating drug shortages in the United States, and the price hikes that can accompany them.[2]"
    },
    "Clovis Oncology": {
        "Company Name": "Clovis Oncology",
        "Year": "2009-",
        "Description": ""
    },
    "Coco": {
        "Company Name": "Coco",
        "Year": "2013-",
        "Description": ""
    },
    "Combe": {
        "Company Name": "Combe",
        "Year": "1949-",
        "Description": "Combe Incorporated, based in White Plains, New York, is an American personal-care company founded in 1949 by Ivan Combe. Combe products are sold in 64 countries on six continents. Ivan Combe primarily promoted the brand names instead of the company name. Combe owns the brands Just for Men, Sea-Bond, Vagisil, and Grecian Formula.[1]"
    },
    "Compugen": {
        "Company Name": "Compugen",
        "Year": "1993-",
        "Description": "Compugen Ltd. (Hebrew: kvmpyvg'n) is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big companies such as Novartis AG, Abbot Laboratories and Pfizer Inc.[2] Subsequently, Compugen made a decision to become a drug development company with its own internal pipeline, and in 2010, decided to a focus on oncology and immunology.[3] OncoMed Pharmaceuticals and Five Prime Therapeutics are among Compugen's competitors.[4]"
    },
    "Concord": {
        "Company Name": "Concord",
        "Year": "2000-",
        "Description": ""
    },
    "Cobel Darou": {
        "Company Name": "Cobel Darou",
        "Year": "2001-",
        "Description": "Cobel Darou (Persian: khwbl drw) headquartered in Tehran, Iran, is one of the biggest pharmaceutical companies[1][2] in Iran. Cobel Darou engages in the research, registration, importing and marketing of pharmaceutical products for sale principally in the prescription market. Cobel Darou covers the most major therapeutic areas: cardiovascular, oncology, diabetes, central nervous system,[3][4] internal medicine and vaccines."
    },
    "Corcept": {
        "Company Name": "Corcept",
        "Year": "1998-",
        "Description": "Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders.[1] Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects.[2] Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.[3]"
    },
    "Creative biomart": {
        "Company Name": "Creative biomart",
        "Year": "????-",
        "Description": "Creative Biomart is a New York-based, privately held biotechnology company focused on the development and commercialization of recombinant proteins and protein production.[1][2]"
    },
    "Crookes Healthcare": {
        "Company Name": "Crookes Healthcare",
        "Year": "1918-",
        "Description": ""
    },
    "CSL": {
        "Company Name": "CSL",
        "Year": "1916-",
        "Description": ""
    },
    "CSL Behring": {
        "Company Name": "CSL Behring",
        "Year": "1904-",
        "Description": "CSL Behring is a biopharmaceutical company, manufacturing plasma-derived and recombinant therapeutic products.[2] The company is a combination of Behringwerke, founded in 1904 in Marburg, Germany by Emil von Behring, and the Commonwealth Serum Laboratories (CSL), established in Australia in 1916 to provide vaccines to the people of Australia, as well as other companies acquired since 2004."
    },
    "CSPC": {
        "Company Name": "CSPC",
        "Year": "1992-",
        "Description": "CSPC Pharmaceutical Group (simplified Chinese: Shi Yao Ji Tuan You Xian Gong Si ; traditional Chinese: Shi Yao Ji Tuan You Xian Gong Si ; pinyin: Shiyao jituan youxian  gongsi) (China Pharma, SEHK: 1093, Hang Seng Index component) researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province."
    },
    "CSPC Zhongrun": {
        "Company Name": "CSPC Zhongrun",
        "Year": "1989-",
        "Description": "Hebei Zhongrun Pharmaceutical Co., Ltd (CSPC Zhongrun) (simplified Chinese: Shi Yao Ji Tuan He Bei Zhong Run Zhi Yao You Xian Gong Si ; traditional Chinese: Shi Yao Ji Tuan He Bei Zhong Run Zhi Yao You Xian Gong Si ; pinyin: Shiyao jituan hebei zhongrun zhiyao youxian  gongsi) is one of China's largest producers of bulk antibiotic active pharmaceutical ingredients. CSPC Zhongrun produces both penicillin and cephalosporin series API."
    },
    "CureVac": {
        "Company Name": "CureVac",
        "Year": "2000-",
        "Description": ""
    },
    "Cyclacel": {
        "Company Name": "Cyclacel",
        "Year": "1997-",
        "Description": ""
    },
    "Cytokinetics": {
        "Company Name": "Cytokinetics",
        "Year": "1997-",
        "Description": "Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function."
    },
    "CytRx": {
        "Company Name": "CytRx",
        "Year": "1985-",
        "Description": "CytRx Corp. is a biopharmaceutical research and development oncology company based in Los Angeles, California."
    },
    "Daewoong": {
        "Company Name": "Daewoong",
        "Year": "1945-",
        "Description": "Daewoong Pharmaceutical Co., Ltd. (Korean: jusighoesa daeungjeyag) is a pharmaceutical company headquartered in Seoul, South Korea.[1] Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products, including prescription and over-the-counter healthcare products."
    },
    "Daiichi Sankyo": {
        "Company Name": "Daiichi Sankyo",
        "Year": "2005-",
        "Description": "Daiichi Sankyo Company, Limited (Japanese: Di Yi San Gong Zhu Shi Hui She , Hepburn: Daiichi Sankyo Kabushiki-gaisha) is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022.[3] The company owns the American pharmaceutical company American Regent."
    },
    "Danco": {
        "Company Name": "Danco",
        "Year": "2000-",
        "Description": "Danco Laboratories is a pharmaceutical distributor located in midtown Manhattan which distributes the abortifacient drug mifepristone under the brand name Mifeprex. Mifeprex is the only drug distributed by Danco, although the company plans to expand to other drugs in the future."
    },
    "Darou Pakhsh": {
        "Company Name": "Darou Pakhsh",
        "Year": "1956-",
        "Description": "Karkhanjat Darupakhsh Company is the largest pharmaceutical company in Iran, 74% of whose shares belong to Social Security Investment Company (Shasta)."
    },
    "Dawa": {
        "Company Name": "Dawa",
        "Year": "1994-",
        "Description": "Dawa Life Sciences is a Kenyan life sciences company with core competencies in healthcare. It was founded by Dr. Raju Mohindra and Dr. Ajay Patel in 1994.[3] Dawa Life Sciences provides better medication for humans and animals (Pharmaceuticals and Animal Health). The company is based in Kenya and is structured to offer a wide range of products and support throughout the region and beyond.[4]"
    },
    "Debiopharm": {
        "Company Name": "Debiopharm",
        "Year": "1979-",
        "Description": "Debiopharm  is a privately-held Swiss biopharmaceutical company mainly active in development and clinical testing of drug candidates.[1] It was founded in 1979 by Rolland-Yves Mauvernay."
    },
    "Dechra": {
        "Company Name": "Dechra",
        "Year": "1997-",
        "Description": ""
    },
    "Delix": {
        "Company Name": "Delix",
        "Year": "2019-",
        "Description": "Delix Therapeutics is an American biotech company based in Boston, Massachusetts.[1] The company develops novel neuroplasticity-promoting therapeutics for central nervous system (CNS) diseases such as depression and post-traumatic stress disorder (PTSD).[2] It was co-founded in 2019 by David E. Olson and Nick Haft.[3]"
    },
    "Dentsply Sirona": {
        "Company Name": "Dentsply Sirona",
        "Year": "1899-",
        "Description": "Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries.[4] The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.[5]"
    },
    "Dermapharm": {
        "Company Name": "Dermapharm",
        "Year": "1991-",
        "Description": "Dermapharm Holding SE or Dermapharm AG, based in Grunwald, is a publicly listed German pharmaceutical company specializing in the manufacture and distribution of dermatological and allergological preparations."
    },
    "Deurali-Janta": {
        "Company Name": "Deurali-Janta",
        "Year": "1988-",
        "Description": "Deurali-Janta Pharmaceuticals Private Limited (DJPL) is a Nepalese pharmaceutical company, based in Kathmandu.[1]"
    },
    "Diffusion": {
        "Company Name": "Diffusion",
        "Year": "2001-",
        "Description": ""
    },
    "Dishman Carbogen Amcis": {
        "Company Name": "Dishman Carbogen Amcis",
        "Year": "1983-",
        "Description": ""
    },
    "Divi's Laboratories": {
        "Company Name": "Divi's Laboratories",
        "Year": "1990-",
        "Description": ""
    },
    "Douglas": {
        "Company Name": "Douglas",
        "Year": "1967-",
        "Description": "Douglas Pharmaceuticals Ltd is a New Zealand-based manufacturer of pharmaceutical products. Founded in 1967 by West Auckland chemist Graeme Douglas,[2] the company started out distributing prescription medicines, before manufacturing and later successfully researching and developing its own products for export."
    },
    "Dr. Reddy's Laboratories": {
        "Company Name": "Dr. Reddy's Laboratories",
        "Year": "1984-",
        "Description": ""
    },
    "Editas Medicine": {
        "Company Name": "Editas Medicine",
        "Year": "2013-",
        "Description": "Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology.[2][3] Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.[4][5][6]"
    },
    "Eisai": {
        "Company Name": "Eisai",
        "Year": "1944-",
        "Description": ""
    },
    "Elder": {
        "Company Name": "Elder",
        "Year": "1989-",
        "Description": ""
    },
    "Eli Lilly and Company": {
        "Company Name": "Eli Lilly and Company",
        "Year": "1876-",
        "Description": ""
    },
    "Emcure": {
        "Company Name": "Emcure",
        "Year": "1983-",
        "Description": ""
    },
    "Emergent": {
        "Company Name": "Emergent",
        "Year": "1998-",
        "Description": ""
    },
    "EMS": {
        "Company Name": "EMS",
        "Year": "1950-",
        "Description": "EMS is the biggest domestic pharmaceutical company in Brazil.[1] Founded in the mid-1950s, the company has six industrial plants based in Sao Bernardo do Campo, Hortolandia and Jaguariuna, in the state of Sao Paulo, Manaus, Brasilia and Belgrade in Serbia."
    },
    "Endo": {
        "Company Name": "Endo",
        "Year": "1997-",
        "Description": "Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations, and customers are almost exclusively U.S.-based, in 2013 Endo executed a corporate tax inversion to Ireland to avoid U.S. corporate taxes on their U.S. drug sales, and to avail of Ireland's corporate tax system.[2][3][4]"
    },
    "Endocyte": {
        "Company Name": "Endocyte",
        "Year": "1996-",
        "Description": "Endocyte is a biopharmaceutical company established in 1996 and headquartered in West Lafayette, Indiana,[1] a resident of the Purdue Research Park.[2]  In 2011 the company completed successfully an initial public offering (IPO).[3] As of 2013[update], the company had 93 employees.[1]  The original president and CEO, Ron Ellis,[1] was succeeded by Mike Sherman, who held a CFO position at the company before this change in June 2016. In 2018 the company was acquired by Novartis.[4]"
    },
    "Epitopoietic Research Corporation": {
        "Company Name": "Epitopoietic Research Corporation",
        "Year": "2006-",
        "Description": "Epitopoietic Research Corporation (ERC) is a Belgian Pharmaceutical company that is specialized in the development of ERC1671 (Gliovac, Sitooiganap (EU)), a treatment for Glioblastoma multiforme, which is the most aggressive form of brain cancer. In 2019 ERC provided treatment under the US Federal Right-to-try law.[1][2][3][4][5][6]"
    },
    "Eskayef": {
        "Company Name": "Eskayef",
        "Year": "1990-",
        "Description": "Eskayef Pharmaceuticals Ltd., also known as SK+F, is a pharmaceutical company in Bangladesh. It belongs to the Transcom Group.[1][2] Simeen Rahman is the Managing Director and CEO of the company.[2][3]"
    },
    "Esperion": {
        "Company Name": "Esperion",
        "Year": "2008-",
        "Description": "Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan."
    },
    "Esteve": {
        "Company Name": "Esteve",
        "Year": "1920-",
        "Description": "Esteve is a Spanish international pharmaceutical company headquartered in Barcelona. Since its founding in 1929, Esteve has extended its commercial activity to more than 100 countries around the world."
    },
    "Excision BioTherapeutics": {
        "Company Name": "Excision BioTherapeutics",
        "Year": "2015-",
        "Description": "David Rowe"
    },
    "Exelgyn": {
        "Company Name": "Exelgyn",
        "Year": "1997-",
        "Description": "Exelgyn is a French pharmaceutical company which makes  and distributes the medical abortion drugs mifepristone (marketed as Mifegyne) and misoprostol."
    },
    "Fabre-Kramer": {
        "Company Name": "Fabre-Kramer",
        "Year": "1992-",
        "Description": "Fabre-Kramer Pharmaceuticals is a pharmaceutical company that specializes in the development of psychotropic drugs. Products in their current development pipeline include gepirone and FKB01MD for major depression, gepirone and FKW00GA for social anxiety disorder,[1] gepirone for hypoactive sexual desire disorder, FKF02SC for schizophrenia, and FKK01PD for Parkinson's disease.[2]"
    },
    "Fareva": {
        "Company Name": "Fareva",
        "Year": "1985-",
        "Description": ""
    },
    "Faron": {
        "Company Name": "Faron",
        "Year": "2003-",
        "Description": "Faron Pharmaceuticals is a Finnish drug discovery and development company based in Turku, Finland."
    },
    "Fermentek": {
        "Company Name": "Fermentek",
        "Year": "1995-",
        "Description": "Fermentek Ltd. is a biotechnological company in the Atarot industrial zone of Jerusalem, Israel. It specializes in the research, development and manufacture of biologically active, natural products isolated from microorganisms as well as from other natural sources such as plants and algae."
    },
    "Ferring": {
        "Company Name": "Ferring",
        "Year": "1950-",
        "Description": "Ferring Pharmaceuticals is a Swiss multinational biopharmaceutical company specialising in areas such as reproductive health, maternal health, gastroenterology and urology.[1] Ferring has been developing treatments for mothers and babies for over 50 years.[2]"
    },
    "FLAVORx": {
        "Company Name": "FLAVORx",
        "Year": "1995-",
        "Description": ""
    },
    "Flexion": {
        "Company Name": "Flexion",
        "Year": "2007-",
        "Description": "Flexion Therapeutics, Inc. is an American biopharmaceutical company based in Burlington, Massachusetts that is focused on  the discovery, development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), the most common form of arthritis.[1][2][3]"
    },
    "Fortress": {
        "Company Name": "Fortress",
        "Year": "2006-",
        "Description": "Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.[1][2][3]"
    },
    "Fortune Pharmacal": {
        "Company Name": "Fortune Pharmacal",
        "Year": "1954-",
        "Description": "Fortune Pharmacal (Chinese: Xing Fu Yi Yao ) is a Hong Kong pharmaceutical company founded in 1954. The company's products, which are manufactured in Hong Kong, are marketed in Hong Kong, China, Canada, and the United States."
    },
    "Fosun": {
        "Company Name": "Fosun",
        "Year": "1994-",
        "Description": ""
    },
    "Fresenius": {
        "Company Name": "Fresenius",
        "Year": "1912-",
        "Description": "Fresenius is a German surname. Notable people with the surname include:"
    },
    "Fulhold": {
        "Company Name": "Fulhold",
        "Year": "2014-",
        "Description": "Fulhold Pharma Limited (formerly Fulhold Pharma plc)[1] is a British pharmaceutical company. It produces the patented CarboHydrate Derived Fulvic Acid (CHD-FA) and formulations containing this product."
    },
    "G.D. Searle": {
        "Company Name": "G.D. Searle",
        "Year": "1888-",
        "Description": "G.D. Searle, LLC is a wholly owned subsidiary of Pfizer.[1] It is currently a trademark company and subsidiary of Pfizer, operating in more than 43 countries. It also operates as a distribution trademark for various pharmaceuticals that were developed by G. D. Searle & Company (often referred to as Searle). Searle is most notable for having developed the first female birth control pill,[2] and the artificial sweetener NutraSweet. Searle also developed the drug Lomotil, an antidiarrheal medication. One notable alumnus of Searle is Donald Rumsfeld, the Secretary of Defense for George W. Bush in the 2000s. Prior to its 1985 merger with Monsanto, Searle was a company mainly focusing on life sciences, specifically pharmaceuticals, agriculture, and animal health."
    },
    "Galapagos NV": {
        "Company Name": "Galapagos NV",
        "Year": "1999-",
        "Description": "Galapagos NV (formerly known as Galapagos Genomics) is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb."
    },
    "Galderma": {
        "Company Name": "Galderma",
        "Year": "1981-",
        "Description": ""
    },
    "Galenika": {
        "Company Name": "Galenika",
        "Year": "1945-",
        "Description": "Galenika a.d. (Serbian Cyrillic: Galenika a.d.) is a Serbian pharmaceutical company with headquarters in Zemun, Belgrade."
    },
    "Gedeon Richter": {
        "Company Name": "Gedeon Richter",
        "Year": "1901-",
        "Description": "Gedeon Richter Plc. is a European multinational pharmaceutical and biotechnology company headquartered in Budapest. It is the largest pharmaceutical company in Central and Eastern Europe, with an expanding direct presence in Western Europe, China, Northern America and Latin America. Richter has the largest R&D unit in Central and Eastern Europe and operations in over 100 countries.[3][4][5][6][7][8]"
    },
    "Genentech": {
        "Company Name": "Genentech",
        "Year": "1976-",
        "Description": ""
    },
    "General": {
        "Company Name": "General",
        "Year": "1984-",
        "Description": "General Pharmaceuticals Limited is a pharmaceutical company based in Dhaka, Bangladesh since 1987."
    },
    "Genmab": {
        "Company Name": "Genmab",
        "Year": "1999-",
        "Description": "Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schonharting, at the time managing director of BankInvest Biomedical venture fund.[7]  The company is based in Copenhagen, Denmark - internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, USA, and Genmab K.K. in Tokyo, Japan. Genmab is a dual-listed company with shares traded on both the Copenhagen Stock Exchange in Denmark[8] and the NASDAQ Global Select Market in the US.[9]"
    },
    "Genset": {
        "Company Name": "Genset",
        "Year": "1989-",
        "Description": "Genset, a biotechnology company, was established in 1989 in Paris, France with Pascal Brandys as its first president.[1]"
    },
    "Giaconda": {
        "Company Name": "Giaconda",
        "Year": "2004-",
        "Description": ""
    },
    "Gilead": {
        "Company Name": "Gilead",
        "Year": "1987-",
        "Description": ""
    },
    "Glatt group": {
        "Company Name": "Glatt group",
        "Year": "1954-",
        "Description": ""
    },
    "GlaxoSmithKline": {
        "Company Name": "GlaxoSmithKline",
        "Year": "1924-",
        "Description": ""
    },
    "GlaxoSmithKline Pakistan": {
        "Company Name": "GlaxoSmithKline Pakistan",
        "Year": "2001-",
        "Description": ""
    },
    "Glenmark": {
        "Company Name": "Glenmark",
        "Year": "1977-",
        "Description": ""
    },
    "Granules India": {
        "Company Name": "Granules India",
        "Year": "1984-",
        "Description": ""
    },
    "Green Cross": {
        "Company Name": "Green Cross",
        "Year": "1950-1998",
        "Description": "Green Cross Corporation (Zhu Shi Hui She midoriShi Zi ; Kabushiki Gaisha Midori Juji) was one of the premier pharmaceutical companies in Japan. The company merged into Yoshitomi Pharmaceutical Industries, Ltd. (Ji Fu Zhi Yao Zhu Shi Hui She ) on April 1, 1998, and renamed to Welfide Corporation (ueruhuaidoZhu Shi Hui She ) on April 1, 2000. And finally Welfide Corporation and Mitsubishi-Tokyo Pharmaceutical Inc. (San Ling Dong Jing Zhi Yao Zhu Shi Hui She ) were merged to form Mitsubishi Pharma Corporation (San Ling ueruhua-maZhu Shi Hui She ) on October 1, 2001."
    },
    "Grifols": {
        "Company Name": "Grifols",
        "Year": "1940-",
        "Description": "Grifols, S.A. (Catalan: ['grifuls]) is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma-based products, a field in which it is the European leader and largest worldwide,[3][4] the company also supplies devices, instruments, and reagents for clinical testing laboratories."
    },
    "Grindeks": {
        "Company Name": "Grindeks",
        "Year": "1946-",
        "Description": ""
    },
    "Gr\u00fcnenthal": {
        "Company Name": "Gr\u00fcnenthal",
        "Year": "1946-",
        "Description": ""
    },
    "GSK": {
        "Company Name": "GSK",
        "Year": "2000-",
        "Description": ""
    },
    "GTx": {
        "Company Name": "GTx",
        "Year": "1997-",
        "Description": "GTx, Inc. was a pharmaceutical company that is working on drugs in the selective estrogen receptor modulator (SERM) and selective androgen receptor modulator (SARM) classes. Its drugs in development included enobosarm (ostarine) and GTx-758."
    },
    "Guangzhou": {
        "Company Name": "Guangzhou",
        "Year": "1951-",
        "Description": "Guangzhou Pharmaceuticals Corporation (Yan Zhou Yi Yao Ji Tuan ) is a pharmaceutical wholesaling and distribution company headquartered in Guangzhou, China, and a 50:50 joint venture between Walgreens Boots Alliance and Guangzhou Pharmaceutical Holdings Limited. It is the third-largest pharmaceutical wholesaler in China measured by revenues.[1]"
    },
    "GW": {
        "Company Name": "GW",
        "Year": "1998-",
        "Description": ""
    },
    "HAL Allergy Group": {
        "Company Name": "HAL Allergy Group",
        "Year": "1959-",
        "Description": "HAL Allergy Group is a pharmaceutical company that develops, produces and sells products for allergy diagnostic and allergen immunotherapy (AIT). The research facilities and headquarters are located at the Leiden Bio Science Park, Netherlands.[1]"
    },
    "Hanhong": {
        "Company Name": "Hanhong",
        "Year": "2012-",
        "Description": "Hanhong Pharmaceutical Technology Co.[1] is a Chinese drug manufacturer.[2] The company, its owner Du Changgen and some of its employees are indicted by the United States Justice Department for crimes relating to fentanyl, xylazine and methamphetamine production, distribution of synthetic opioids, and sales resulting from precursor chemicals. The indictments accuses Hanhong of exporting large quantities of fentanyl precursors and non-opioid additives like xylazine, to drug traffickers in Mexico (including to the Sinaloa Cartel) and the United States. Its owner Du Changgen is the head of the Du Transnational Criminal Organization, which is listed on the United States Attorney General's Consolidated Priority Organization Target (CPOT) list, which according to the DEA is a list of the leaders of the most prolific drug trafficking and money laundering organizations, having the greatest impact on the United States illicit drug supply.[3]"
    },
    "Hanmi": {
        "Company Name": "Hanmi",
        "Year": "1973-",
        "Description": "Hanmi Pharm Co., Ltd. (Korean: hanmiyagpum jusighoesa; Hanja: Han Mei Yao Pin  Zhu Shi Hui She ) is a South Korean pharmaceutical company that is headquartered in Seoul.[1]"
    },
    "Hansoh": {
        "Company Name": "Hansoh",
        "Year": "1995-",
        "Description": "Hansoh Pharmaceutical Group Company Limited (simplified Chinese: Han Sen Zhi Yao Ji Tuan You Xian Gong Si ; traditional Chinese: Han Sen Zhi Yao Ji Tuan You Xian Gong Si ; pinyin: Hansen Zhiyao Jituan Youxian Gongsi) is a pharmaceutical company that manufactures and sells various types of medicine in mainland China.[1] It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair.[2] Zhong and her family own 66% of the company.[3] It is the largest psychotropic drug producer in China.[4]"
    },
    "Harbin": {
        "Company Name": "Harbin",
        "Year": "1988-",
        "Description": "Harbin Pharmaceutical Group Co., Ltd. (shortened to HPGC or Hayao) is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products.[2][3][4] HPGC medication offerings include traditional Chinese medicine (TCM) and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.[5]"
    },
    "Harrow Health": {
        "Company Name": "Harrow Health",
        "Year": "2012-",
        "Description": ""
    },
    "Hebei Yuxing Bio-Engineering Co. Ltd": {
        "Company Name": "Hebei Yuxing Bio-Engineering Co. Ltd",
        "Year": "????-",
        "Description": "Hebei Yuxing Bio-Engineering Co. Ltd is a Chinese active pharmaceutical ingredient (API) company that exports to the United States of America.[1] Recently, the US FDA issued a warning letter due to \"evidence that the company was keeping incomplete documentation and did not adequately investigate instances of microbial contamination.\"[2]"
    },
    "Help Remedies": {
        "Company Name": "Help Remedies",
        "Year": "2008-",
        "Description": "Help Remedies, Inc. is an American pharmaceutical company, founded by Richard Fine and Nathan Frank in 2008,[1] based in New York City that sells an assortment of single-ingredient over-the-counter medications.[2]  The company has been noted for its unique product packaging and design ethic.[3][4][5][6][7] All products are packaged in a flat, white, textured box that opens like a tin."
    },
    "Himispherx": {
        "Company Name": "Himispherx",
        "Year": "1990-",
        "Description": "AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders.[2] Founded in 1990, the company has twenty-three employees.[3]"
    },
    "Herron": {
        "Company Name": "Herron",
        "Year": "????-",
        "Description": ""
    },
    "Hetero Drugs": {
        "Company Name": "Hetero Drugs",
        "Year": "1993-",
        "Description": ""
    },
    "Hikma": {
        "Company Name": "Hikma",
        "Year": "1978-",
        "Description": ""
    },
    "Hindustan Antibiotics": {
        "Company Name": "Hindustan Antibiotics",
        "Year": "1954-",
        "Description": ""
    },
    "Hisamitsu": {
        "Company Name": "Hisamitsu",
        "Year": "1847-",
        "Description": ""
    },
    "Hospira": {
        "Company Name": "Hospira",
        "Year": "2004-2015",
        "Description": "Hospira was an American global pharmaceutical and medical device company with headquarters in Lake Forest, Illinois. It had approximately 19,000 employees.[1] Before its acquisition by Pfizer, Hospira was the world's largest producer of generic injectable pharmaceuticals,[2] manufacturing generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems. Hospira's products are used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.[3]  It was formerly the hospital products division of Abbott Laboratories. On September 3, 2015, Hospira was acquired by Pfizer, who subsequently sold off the medical devices portion of Hospira to ICU Medical."
    },
    "Hovid": {
        "Company Name": "Hovid",
        "Year": "1980-",
        "Description": "Hovid Berhad (Chinese: He Ren Ke You Xian Gong Si ; MYX: 7213) is a Malaysian health care provider and pharmaceutical company. It was founded in the early 1940s. The company's headquarters are located in Ipoh, the capital city of Perak state, Malaysia.[1] It was formerly known as Ho Yan Hor Sdn Bhd (Chinese: He Ren Ke Si Ren You Xian Gong Si )."
    },
    "Hovione": {
        "Company Name": "Hovione",
        "Year": "1959-",
        "Description": "Hovione is a Contract Development and Manufacturing Organization (CDMO) with services for drug substance, drug product intermediate and drug product. The company has four FDA inspected sites in the United States, Portugal, Ireland and China development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione is also present in the inhalation area, and provides a complete range of services, from active pharmaceutical ingredients (APIs), formulation development and devices. Hovione was the first Chemical/ Pharmaceutical Company to become a Certified B Corporation (certification), is a member of Rx-360[1] and EFCG.[2]"
    },
    "Huadong Medicine": {
        "Company Name": "Huadong Medicine",
        "Year": "1993-",
        "Description": "HD Medicine, or Huadong Medicine Co., Ltd., is a Hangzhou-based pharmaceutical company registered on the Shenzhen Stock Exchange since January 27, 2000. It has a listed share capital of 380,000,000 renminbi and a market capitalization of 126,323,040 renminbi as of July 2005[update]. It is the largest pharmaceutical company in Zhejiang and the leading immunosuppressant manufacturer in China.[1]"
    },
    "Hypera": {
        "Company Name": "Hypera",
        "Year": "2001-",
        "Description": "Hypera Pharma is a Brazilian multinational pharmaceutical \ncompany and is the Brazilian largest pharmaceutical company by market capitalization.[citation needed] Headquartered in Sao Paulo, its business include pharmaceuticals, consumer healthcare and cosmetics products, and biotechnology products."
    },
    "IFM": {
        "Company Name": "IFM",
        "Year": "2015-",
        "Description": "IFM Therapeutics is a pharmaceutical company focused on developing biological treatments for autoimmune diseases."
    },
    "Immuron": {
        "Company Name": "Immuron",
        "Year": "2005-",
        "Description": ""
    },
    "Incepta": {
        "Company Name": "Incepta",
        "Year": "1999-",
        "Description": ""
    },
    "Incyte": {
        "Company Name": "Incyte",
        "Year": "2002-",
        "Description": "Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware,[2] and Morges, Switzerland.[3]\nThe company was created in 2002 through the merger of Incyte Pharmaceuticals, founded in Palo Alto, California in 1991[4] and Incyte Genomics, Inc. of Delaware.[5] The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.[6]"
    },
    "Indian Drugs and Pharmaceuticals": {
        "Company Name": "Indian Drugs and Pharmaceuticals",
        "Year": "1961-",
        "Description": ""
    },
    "Intarcia": {
        "Company Name": "Intarcia",
        "Year": "1995-",
        "Description": "Intarcia Therapeutics is an American biopharmaceutical company based in Boston, MA and incorporated under the laws of Delaware.[1][2]  It was founded in 1995 under the name \"BioMedicines\" and changed to its present name in 2004.[1] In 2013, Intarcia relocated its headquarters to Boston, keeping its manufacturing facility in Hayward, CA. In addition to Boston and Hayward, Intarcia also has a location in Research Triangle Park, North Carolina, where it discovers and develops peptides for its drug delivery system.[3]"
    },
    "Intas": {
        "Company Name": "Intas",
        "Year": "1984-",
        "Description": ""
    },
    "Intellia Therapeutics": {
        "Company Name": "Intellia Therapeutics",
        "Year": "2014-",
        "Description": "Intellia Therapeutics, Inc. is an American clinical-stage  biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. The company's in vivo programs use intravenously administered CRISPR as the therapy, in which the company's proprietary delivery technology enables highly precise editing of disease-causing genes directly within specific target tissues. Intellia's ex vivo programs use CRISPR to create the therapy by using engineered human cells to treat cancer and autoimmune diseases.[2]"
    },
    "Ionis": {
        "Company Name": "Ionis",
        "Year": "1989-",
        "Description": "Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics. The company has three commercially approved medicines: Spinraza (Nusinersen), Tegsedi (Inotersen), and Waylivra (Volanesorsen), and has four drugs in pivotal studies: tominersen for Huntington's disease (together with Roche), tofersen for SOD1-ALS, AKCEA-APO(a)-LRx for cardiovascular disease, and AKCEA-TTR-LRx for all forms of TTR amyloidosis.[4]"
    },
    "Ipca": {
        "Company Name": "Ipca",
        "Year": "1949-",
        "Description": ""
    },
    "Ipsen": {
        "Company Name": "Ipsen",
        "Year": "1929-",
        "Description": ""
    },
    "ITH": {
        "Company Name": "ITH",
        "Year": "2008-",
        "Description": "ITH Pharma is a specialist British compounding pharmaceutical company, founded in 2008 by two pharmacists."
    },
    "Jaber Ebne Hayyan": {
        "Company Name": "Jaber Ebne Hayyan",
        "Year": "1960-",
        "Description": "Jaber Ebne Hayyan Pharmaceutical Company (Persian: shrkht drwszy jbr bn Hyn) engages in manufacture and sale of injection and oral antibiotics, ointments, inhalers, nasal sprays & pearls (soft gel capsules). The company was formerly known as Squibb Iran and changed its name in 1979. Jaber Ebne Hayyan Pharmaceutical Company was founded in 1960 and is based in Tehran, Iran. The company is public joint stock and member of Tehran Stock Exchange with the registered capital of 378,000,000,000 rials.[citation needed]"
    },
    "Janssen": {
        "Company Name": "Janssen",
        "Year": "1953-",
        "Description": ""
    },
    "Jazz": {
        "Company Name": "Jazz",
        "Year": "2003-",
        "Description": "Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States.[2] One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem (sodium oxybate), the sodium salt of the naturally occurring neurotransmitter g-Hydroxybutyric acid (GHB). In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales.[1] In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness (EDS) in narcolepsy as well as obstructive sleep apnea (OSA). In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals.[3]"
    },
    "Jenapharm": {
        "Company Name": "Jenapharm",
        "Year": "1950-2001",
        "Description": "Jenapharm is a pharmaceutical company from Jena, Germany. Founded in 1950 in East Germany, the company focused from the beginning on the production and development of steroids. Because of the economic circumstances of the Eastern Bloc, the company initially used a unique process of steroid synthesis starting from hog bile, however, this method was abandoned a decade later in favor of total synthesis. Initially the company produced a wide range of generic steroids, including corticosteroids, but later on it focused on anabolic steroids, estrogens and progestins.[2]"
    },
    "Jiangsu Hengrui": {
        "Company Name": "Jiangsu Hengrui",
        "Year": "1970-",
        "Description": ""
    },
    "Jilin Aodong Medicine": {
        "Company Name": "Jilin Aodong Medicine",
        "Year": "1993-",
        "Description": "Jilin Aodong Medicine Industry Group Company Limited (SZSE: 000623; Chinese: Ji Lin Ao Dong Yao Ye Ji Tuan Gu Fen You Xian Gong Si ) is a state-owned enterprise in Dunhua, Jilin, China. It involves in the manufacture and sale of Chinese patent drugs and pharmaceutical packaging products, and the collection of traffic tolls and the road engineering construction business.[1] It was established in 1993 and listed on the Shenzhen Stock Exchange in 1996."
    },
    "JN-International Medical Corporation": {
        "Company Name": "JN-International Medical Corporation",
        "Year": "1998-",
        "Description": "JN-International Medical Corporation (JNIMC) is a U.S.-based biopharmaceutical corporation which since 1998 has been focused on developing vaccines and diagnostics for infectious disease for developing countries. This private corporation (formerly known as Jeeri Neotech International, Inc) was founded in 1998 by Dr. Jeeri R. Reddy with the help of Dr. Kelly F. Lechtenberg in a small rural town, Oakland, Nebraska. From there it grew and expanded until in the year 2000 the corporation moved to Omaha, Nebraska."
    },
    "Johnson & Johnson": {
        "Company Name": "Johnson & Johnson",
        "Year": "1886-",
        "Description": ""
    },
    "Jointown": {
        "Company Name": "Jointown",
        "Year": "1999-",
        "Description": "Liu Zhaonian (Co-Founder)\nLiu Shulin (Co-Founder)"
    },
    "Jones": {
        "Company Name": "Jones",
        "Year": "1981-",
        "Description": "Jones Pharma is a specialty pharmaceuticals manufacturer and marketer based in St. Louis, Missouri. The company was founded on March 16, 1981, by Dennis M. Jones and Judith Pearce Jones under the name Jones Medical Industries. The company completed its initial public offering in 1986, trading under the ticker symbol JMED on the NASDAQ. The primary therapeutic compounds marketed by the company include Thrombin-JMI[1] and Levoxyl.[2] On May 30, 2000, the company became a wholly owned subsidiary of King Pharmaceuticals (NYSE:KG), based in Bristol, Tennessee. The market value of the company on its closing trade was $3.6 billion.[3][4]  Parent company King Pharmaceuticals was acquired by Pfizer in 2010.[5][6]"
    },
    "Julphar": {
        "Company Name": "Julphar",
        "Year": "1980-",
        "Description": ""
    },
    "Kadmon": {
        "Company Name": "Kadmon",
        "Year": "2009-",
        "Description": "Kadmon Corporation (originally Kadmon Pharmaceuticals) is a biopharmaceutical company based in New York City.  It also has operations in Warrendale, PA and Brighton, MA. The company was founded in 2009 by Samuel D. Waksal,[2][3] founder and former CEO of ImClone Systems, a company now fully merged into Eli Lilly.  Waksal had served a federal prison sentence stemming from his fiduciary role as CEO in the 2001 ImClone stock trading case. When released in 2009 he was barred from serving as an officer for any publicly traded company but Kadmon was privately financed.[4][5]"
    },
    "Kalbe Farma": {
        "Company Name": "Kalbe Farma",
        "Year": "1966-",
        "Description": "PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966.[1] The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.\nThe Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, distribution arm that reaches over 1 million outlets. Notably, the company produces misoprostol (sold under the brand name of Invitec), a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient (abortion-inducing substance).[2]"
    },
    "Kamada": {
        "Company Name": "Kamada",
        "Year": "1990-",
        "Description": "Kamada Ltd. is a biopharmaceutical company specializing in the development, manufacture and marketing of proteins as  pharmaceuticals. The company's headquarters and laboratories are located in the park of Kiryat Weizmann Institute of Science in Rehovot. The production facility is located in Kibbutz Beit Kama."
    },
    "Kangmei": {
        "Company Name": "Kangmei",
        "Year": "????-",
        "Description": "Kangmei Pharmaceutical Co., Ltd (Chinese: Yan Dong Kang Mei Yao Ye Gu Fen You Xian Gong Si ; pinyin: Guangdong Kangmei Yaoye Gufen Youxian Gongsi; abbreviated Kang Mei Yao Ye ; Kangmei Yaoye) is a large pharmaceutical company based in Guangdong with headquarters in Puning and Shenzhen.[1][2] Kangmei Pharmaceutical produces medication and medical equipment, with a focus on traditional Chinese medicine.[3][4] It is traded on the Shanghai Stock Exchange[1] and had a market capitalization of more than 47 billion RMB in 2019.[1]"
    },
    "KannaLife": {
        "Company Name": "KannaLife",
        "Year": "2010-",
        "Description": "Kannalife Sciences Inc. , a subsidiary of Neuropathix, Inc., is a bio-pharmaceutical and phyto-medical company based in Doylestown, Pennsylvania founded by Dean Petkanas and Thoma Kikis.[1] Kannalife was formed in 2010 and is involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants.[2]"
    },
    "Kentam Products Limited": {
        "Company Name": "Kentam Products Limited",
        "Year": "????-",
        "Description": "Kentam Product Limited is a Malawian pharmaceutical, and chemical manufacturing company that operates primarily in Luwinga (Northern Region) and is expanding internationally.[1] Kentam's high demand products in Malawi are Kilpain (paracetamol), Ketaprin (aspirin), and Bufen (ibuprofen).[2] These are high demand products in the Malawian market. Kentam serves mainly the private sector.[3]"
    },
    "Kerala State Drugs and Pharmaceuticals Limited": {
        "Company Name": "Kerala State Drugs and Pharmaceuticals Limited",
        "Year": "1974-",
        "Description": ""
    },
    "Kimia Farma": {
        "Company Name": "Kimia Farma",
        "Year": "1971-",
        "Description": "PT Kimia Farma Tbk is an Indonesian pharmaceutical producer and distributor in Indonesia. It is based in Jakarta.[1]"
    },
    "Kinetic Concepts": {
        "Company Name": "Kinetic Concepts",
        "Year": "2008-",
        "Description": ""
    },
    "Kissei": {
        "Company Name": "Kissei",
        "Year": "1946-",
        "Description": "Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:[1]"
    },
    "Kite": {
        "Company Name": "Kite",
        "Year": "2009-",
        "Description": "Kite Pharma, Inc. is an American biotechnology company that develops cancer immunotherapy products with a primary focus on genetically engineered autologous CAR T cell therapy - a cell-based therapy which relies on chimeric antigen receptors and T cells. Founded in 2009, and based in Santa Monica, California, it was acquired by Gilead Sciences in 2017."
    },
    "Knight": {
        "Company Name": "Knight",
        "Year": "1995-",
        "Description": "Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange (symbol GUD), with a market capitalization of $1.02 billion as of August 2019.[1]"
    },
    "Kunming": {
        "Company Name": "Kunming",
        "Year": "2007-",
        "Description": "Kunming Pharmaceutical Corp. is a company that is involved in the manufacture and sale of natural drugs, as well as the wholesale and retail of other drugs. It is the largest pharmaceutical enterprise in Yunnan."
    },
    "Kyowa Kirin": {
        "Company Name": "Kyowa Kirin",
        "Year": "1949-",
        "Description": "Kyowa Kirin Co., Ltd. (Xie He kirinZhu Shi Hui She , Kyowa Kirin Kabushiki Kaisha) is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and is among the 40 largest in the world by revenue. The company is headquartered in Chiyoda-ku, Tokyo and is a  member of the Nikkei 225 stock index.[4][5]"
    },
    "Laboratoires Expanscience": {
        "Company Name": "Laboratoires Expanscience",
        "Year": "1950-",
        "Description": "Laboratoires Expanscience was created in 1950 by Paul Berthome and a pharmacist[1] and is a pharmaceutical laboratory specializing in dermocosmetics, rheumatology, dermatology and the marketing of active cosmetic ingredients. It owns a well known brand Mustela."
    },
    "Laboratoires Pierre Fabre": {
        "Company Name": "Laboratoires Pierre Fabre",
        "Year": "1951-",
        "Description": "Laboratoires Pierre Fabre is a French multinational pharmaceutical and cosmetics company. The company had a consolidated turnover of 1.978 billion euros in 2012 (including 54% international).[2] It is headquartered in the city of Castres, Midi-Pyrenees, France.[2]"
    },
    "Laboratoires Servier": {
        "Company Name": "Laboratoires Servier",
        "Year": "1954-",
        "Description": "Servier Laboratories (French: Laboratoires Servier, often abbreviated to Servier) is an international pharmaceutical company governed by a non-profit foundation, with its headquarters in France (Suresnes).[3]"
    },
    "Laurus Labs": {
        "Company Name": "Laurus Labs",
        "Year": "2005-",
        "Description": ""
    },
    "Lavipharm": {
        "Company Name": "Lavipharm",
        "Year": "1911-",
        "Description": "Lavipharm S.A. is the largest integrated Greek pharmaceutical company that develops, manufactures, markets and distributes pharmaceutical, cosmetic, veterinary and consumer health products in Greece and internationally (France, Cyprus and the United States). It was founded in 1911."
    },
    "Lawley": {
        "Company Name": "Lawley",
        "Year": "1995-",
        "Description": ""
    },
    "Leadiant": {
        "Company Name": "Leadiant",
        "Year": "1957-",
        "Description": "Leadiant Biosciences, formerly known as Sigma-Tau Industrie Farmaceutiche Riunite, was founded in 1957[1] by research chemist Claudio Cavazza."
    },
    "Leo": {
        "Company Name": "Leo",
        "Year": "1908-",
        "Description": "LEO Pharma A/S is a multinational Danish pharmaceutical company, founded in 1908, with a presence in about 100 countries. Its headquarters are in Ballerup, near Copenhagen[1] The company is 100% integrated into a private foundation owned by the LEO Foundation.[2] LEO Pharma develops and markets products for dermatology, bone remodeling thrombosis and coagulation.[3] In 1945, it was the first producer of penicillin outside the US and UK."
    },
    "Lexicon": {
        "Company Name": "Lexicon",
        "Year": "1995-",
        "Description": "Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company developing treatments for human disease. The company was founded in 1995 in The Woodlands, Texas under the name Lexicon Genetics, Incorporated by co-founders Professor Allan Bradley, FRS and Professor Bradley's postdoctoral fellow Arthur T Sands.[2] The company has used its patented mouse gene knockout technology and extensive in vivo screening capabilities to study nearly 5,000 genes in its Genome5000 program and has identified over 100 potential therapeutic targets. Lexicon has advanced multiple drug candidates into human clinical trials and has a broad and diverse pipeline of drug targets behind its clinical programs.  Lexicon is pursuing drug targets in five therapeutic areas including oncology, gastroenterology, immunology, metabolism, and ophthalmology."
    },
    "LIFSE": {
        "Company Name": "LIFSE",
        "Year": "1947-",
        "Description": "Laboratorio Industrial Farmaceutico Sociedad del Estado or LIFSE (English: Pharmaceutical Industrial Laboratory, State Society) is a state-owned enterprise that is producing and distributing pharmacy."
    },
    "Ligand": {
        "Company Name": "Ligand",
        "Year": "1987-",
        "Description": "Ligand Pharmaceuticals Incorporated is a biopharmaceutical company located in San Diego, California.[4] Founded in 1987 as Progenix Inc., the company went public in 1992. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to the acquisition of existing drugs and forming partnerships to develop them further.[citation needed]"
    },
    "Lijun": {
        "Company Name": "Lijun",
        "Year": "2005-",
        "Description": "Lijun International Pharmaceutical (Holding) Co., Limited (simplified Chinese: Li Jun Guo Ji Yi Yao (Kong Gu )You Xian Gong Si ; traditional Chinese: Li Jun Guo Ji Yi Yao (Kong Gu )You Xian Gong Si ) (SEHK: 2005) is a Wanchai, Hong Kong-based investment holding company with two pharmaceutical business segments:"
    },
    "Liminal": {
        "Company Name": "Liminal",
        "Year": "1988-",
        "Description": "Liminal BioSciences Inc.,[1] formerly known as Prometic Life Sciences Inc.,[2] is a Canadian biopharmaceutical company."
    },
    "Lion": {
        "Company Name": "Lion",
        "Year": "1918-",
        "Description": "Lion Corporation (raionZhu Shi Hui She , Raion Kabushiki Gaisha) is a Japanese multinational manufacturer of detergent, soap, medications, and oral hygiene products and other toiletries. The company also has a chemical engineering research division which works on developing new products.[1]"
    },
    "Locus": {
        "Company Name": "Locus",
        "Year": "2015-",
        "Description": ""
    },
    "Loghman": {
        "Company Name": "Loghman",
        "Year": "1968-",
        "Description": "Loghman Pharmaceutical & Hygienic Co. (Persian: shrkht drwyy w bhdshty lqmn, Shirkat-e Darvii-ye va Behedashiti-ye Laqman) is an Iranian pharmaceuticals company. The company engages in the discovery, development, manufacture, and marketing of drugs in Iran.[1]"
    },
    "Lundbeck": {
        "Company Name": "Lundbeck",
        "Year": "1915-",
        "Description": "H. Lundbeck A/S (commonly known simply as Lundbeck) is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company's products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine.[2]"
    },
    "Lundbeck Seattle": {
        "Company Name": "Lundbeck Seattle",
        "Year": "2004-",
        "Description": "Lundbeck Seattle Biopharmaceuticals is a pharmaceutical development company based in Bothell, Washington. Formerly known as Alder Biopharmaceuticals, it specializes in therapeutic monoclonal antibodies."
    },
    "Lupin Limited": {
        "Company Name": "Lupin Limited",
        "Year": "1968-",
        "Description": ""
    },
    "Mallinckrodt": {
        "Company Name": "Mallinckrodt",
        "Year": "1867-",
        "Description": "Mallinckrodt Pharmaceuticals plc is an American-Irish domiciled manufacturer of specialty pharmaceuticals (namely, adrenocorticotropic hormone), generic drugs and imaging agents.[2] In 2017, it generated 90% of its sales from the U.S. healthcare system.  While Mallinckrodt is headquartered in Ireland for tax purposes, its operational headquarters are in the U.S.[3]  Mallinckrodt's 2013 tax inversion to Ireland drew controversy when it was shown Acthar was Medicaid's most expensive drug.[4]"
    },
    "MannKind Corporation": {
        "Company Name": "MannKind Corporation",
        "Year": "1991-",
        "Description": ""
    },
    "Mankind": {
        "Company Name": "Mankind",
        "Year": "1991-",
        "Description": ""
    },
    "Mapp": {
        "Company Name": "Mapp",
        "Year": "2003-",
        "Description": "Mapp Biopharmaceutical is an American pharmaceutical company founded in 2003 by Larry Zeitlin and Kevin Whaley.[2] Mapp Biopharmaceutical is based in San Diego, California. It is responsible for the research and development of  ZMapp, a drug which is still[when?] under development and comprises three humanized monoclonal antibodies used as a treatment for Ebola virus disease.[3][4] The drug was first tested in humans during the 2014 West Africa Ebola virus outbreak."
    },
    "Martin Dow": {
        "Company Name": "Martin Dow",
        "Year": "1995-",
        "Description": ""
    },
    "McGuff": {
        "Company Name": "McGuff",
        "Year": "1979-",
        "Description": "The McGuff Companies consist of three entities: a wholesale distributor of medical supplies, a pharmaceutical manufacturing facility which produces sterile injectables for national and international distribution, and a 503B outsourcing facility (in development). The McGuff Companies have been featured in the International Journal of Pharmaceutical Compounding (IJPC).[1][2]"
    },
    "McNeil Consumer Healthcare": {
        "Company Name": "McNeil Consumer Healthcare",
        "Year": "1879-",
        "Description": "McNeil Consumer Healthcare is an American medicals products company belonging to Kenvue consumer health group. It primarily sells fast-moving consumer goods such as over-the-counter drugs."
    },
    "Medac": {
        "Company Name": "Medac",
        "Year": "1970-",
        "Description": "Medac GmbH (stylized as medac) is a German, worldwide operating pharmaceutical company based in Wedel near Hamburg and Tornesch, which is privately owned."
    },
    "Medherant": {
        "Company Name": "Medherant",
        "Year": "2015-",
        "Description": ""
    },
    "Medivir": {
        "Company Name": "Medivir",
        "Year": "1988-",
        "Description": "Medivir is a Swedish biotech company.[1] Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies. \nMedivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.[2]\nMedivir is listed on the Nasdaq Stockholm Mid Cap List."
    },
    "Medochemie": {
        "Company Name": "Medochemie",
        "Year": "1976-",
        "Description": ""
    },
    "Meiji Seika": {
        "Company Name": "Meiji Seika",
        "Year": "1916-",
        "Description": "Meiji Seika Pharma Co., Ltd. (Meiji SeikahuarumaZhu Shi Hui She , Meiji Seika Faruma Kabushiki gaisha), formerly Meiji Seika Kaisha, Ltd. (Ming Zhi Zhi Guo Zhu Shi Hui She , Meiji Seika Kabushiki-gaisha) is a Japanese pharmaceutical company. It is currently a subsidiary of Meiji Holdings[1] and a Japanese leader in the area of infectious disease with 18% market share. It markets treatments for depression, obsessive-compulsive disorder, vaccines and allergy drugs. Meiji Pharma is doing research in generic anticancer drugs and biosimilars with partner organisations.[2]"
    },
    "Melinta": {
        "Company Name": "Melinta",
        "Year": "2000-",
        "Description": "Melinta Therapeutics, founded in 2000 as Rib-X Pharmaceuticals, is an American publicly traded biopharmaceutical firm that focuses on the design and development of novel broad-spectrum antibiotics for the treatment of antibiotic-resistant infections in hospital settings. The company is located in Parsippany, New Jersey.[1]"
    },
    "Melior Discovery": {
        "Company Name": "Melior Discovery",
        "Year": "2005-",
        "Description": "Melior Discovery, Inc. is a private biopharmaceutical company based in Exton, Pennsylvania, USA."
    },
    "Menarini": {
        "Company Name": "Menarini",
        "Year": "1886-",
        "Description": "The Menarini Group is an Italian pharmaceutical company. Its headquarters is in Florence, Tuscany, and it has three divisions: Menarini Ricerche, Menarini Biotech, and Menarini Diagnostics. It develops pharmacological solutions for cardiovascular diseases, oncology, pain/inflammation, asthma and anti-infectives. Menarini's research activities are carried out through Menarini Ricerche, which deals with all R&D activities, from the creation of new projects to drug registration. Its Menarini Biotech follows the creation of a biotechnological drug from the very early stages of research, through to the pilot scale and up to industrial production. The Group's Menarini Diagnostics division is a healthcare company with a worldwide network of affiliates partners and distributors focused on diabetes, haematology, clinical chemistry, urinalysis, and immunology. In 2020, the company had 17,650 employees worldwide.[6]"
    },
    "Mentholatum": {
        "Company Name": "Mentholatum",
        "Year": "1889-",
        "Description": ""
    },
    "Merck & Co.": {
        "Company Name": "Merck & Co.",
        "Year": "1891-",
        "Description": "Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of which it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. It is one of the largest pharmaceutical companies in the world, generally ranking in the global top five by revenue.[5][6]"
    },
    "Merck Group": {
        "Company Name": "Merck Group",
        "Year": "1668-",
        "Description": ""
    },
    "Meridian Medical Technologies": {
        "Company Name": "Meridian Medical Technologies",
        "Year": "1968-",
        "Description": "Meridian Medical Technologies, LLC is an American company which specialized primarily in developing and manufacturing antidotes for chemical weapons."
    },
    "Merrimack": {
        "Company Name": "Merrimack",
        "Year": "2000-",
        "Description": "Merrimack Pharmaceuticals, Inc. is a pharmaceutical company based in Cambridge, Massachusetts, United States. They specialize in developing drugs for the treatment of cancer."
    },
    "Merz": {
        "Company Name": "Merz",
        "Year": "1908-",
        "Description": "Merz Pharma GmbH & Co. KGaA (also Merz Pharma KGaA or Merz) is an internationally active family-owned company, headquartered in Frankfurt am Main, Germany. Merz is the parent company of independent businesses in the fields of aesthetic medicine, therapeutic medicine (including for neurological movement disorders), and wellness and beauty products with its brands Tetesept[1] and Merz Spezial.[2]"
    },
    "Microgen": {
        "Company Name": "Microgen",
        "Year": "2003-",
        "Description": "Microgen (<See Tfd>Russian: Mikrogen) is Russia's largest producer of immunobiological products,[4][5][6] one of the three largest pharmaceutical companies in Russia.[7][8]"
    },
    "MindMed": {
        "Company Name": "MindMed",
        "Year": "2019-",
        "Description": "Mind Medicine (MindMed) Inc., doing business as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.[2][3][4][5]"
    },
    "Mitsubishi Tanabe": {
        "Company Name": "Mitsubishi Tanabe",
        "Year": "2007-",
        "Description": "Mitsubishi Tanabe Pharma Corporation is a Japanese pharmaceuticals company from Osaka,[1] a subsidiary of Mitsubishi Chemical Holdings Corporation. Mitsubishi Pharma Corporation (San Ling ueruhua-maZhu Shi Hui She , Mitsubishi Werufama Kabushiki-gaisha) was formed in 2001 from the merger of Mitsubishi-Tokyo Pharmaceuticals and Welfide Corporation. On October 1, 2007, Tanabe Seiyaku Co., Ltd. merged with Mitsubishi Pharma to form Mitsubishi Tanabe Pharma.[2]"
    },
    "Mochida": {
        "Company Name": "Mochida",
        "Year": "1945-",
        "Description": "Mochida Pharmaceutical Co., Ltd (Chi Tian Zhi Yao Zhu Shi Hui She , mochida seiyaku kabushiki gaisha) is a Japanese pharmaceutical company.[1]"
    },
    "Moderna": {
        "Company Name": "Moderna",
        "Year": "2010-",
        "Description": ""
    },
    "Molecular Partners": {
        "Company Name": "Molecular Partners",
        "Year": "2004-",
        "Description": "Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zurich, Switzerland.[2] The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins,[3] with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development.[1]"
    },
    "Mundipharma": {
        "Company Name": "Mundipharma",
        "Year": "1952-",
        "Description": ""
    },
    "Mustang": {
        "Company Name": "Mustang",
        "Year": "2015-",
        "Description": "Mustang Bio (Nasdaq: MBIO) is a clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S.[1][2][3] Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency (X-SCID).[4][5][6]"
    },
    "Myrexis": {
        "Company Name": "Myrexis",
        "Year": "1999-",
        "Description": "Myrexis is a biopharmaceutical company based in Salt Lake City, Utah, USA. It focused on drug development in several areas of medicine, in particular cancer therapy and auto-immune diseases. It was founded in 1999 as a spin-off from Myriad Genetics[1] and was originally known as Myriad Pharmaceuticals. Richard B. Brewer was its CEO from May 2012 until his death in August 2012.[2][3]"
    },
    "Myriad Genetics": {
        "Company Name": "Myriad Genetics",
        "Year": "1991-",
        "Description": ""
    },
    "Naari": {
        "Company Name": "Naari",
        "Year": "2007-",
        "Description": ""
    },
    "Nanjing Ange": {
        "Company Name": "Nanjing Ange",
        "Year": "2003-",
        "Description": "Nanjing Ange Pharmaceutical Co., Ltd. (simplified Chinese: Nan Jing An Ge Yi Yao Hua Gong You Xian Gong Si ; traditional Chinese: Nan Jing An Ge Yi Yao Hua Gong You Xian Gong Si ; pinyin: Nanjing ange yiyao huagong youxian gongsi) is a pharmaceutical company in Nanjing, in the People's Republic of China, specializing in the development of \"New Drugs\" (the drugs that previously have not been marketed in China, i.e., New Chemical Entities for China's FDA) as well as the research, development, production and trade of chemical APIs and pharmaceutical intermediates.[1]"
    },
    "Napp": {
        "Company Name": "Napp",
        "Year": "1923-",
        "Description": ""
    },
    "Natco": {
        "Company Name": "Natco",
        "Year": "1981-",
        "Description": ""
    },
    "NatiVita": {
        "Company Name": "NatiVita",
        "Year": "2012-",
        "Description": "NatiVita is an international research and manufacturing pharmaceutical company, it is situated in Beshankovichy urban settlement, Vitebsk region, Belarus. NatiVita is the first company in Belarus, that started developing and producing biopharmaceutical medicines based on monoclonal antibodies using target cell therapy for specific genetic diseases such as Breast cancer, Lung cancer, Myeloma.[1] \nThe company was established in 2012 with support of AB ZiaValda[2] (Lithuania), <<UniPharma>> (Slovakia), <<NatcoPharma Ltd>> (India)"
    },
    "Nector": {
        "Company Name": "Nector",
        "Year": "1995-",
        "Description": ""
    },
    "NeilMed": {
        "Company Name": "NeilMed",
        "Year": "1999-",
        "Description": "NeilMed Pharmaceuticals Inc. is a USA based pharmaceutical, medical devices' manufacturer & supplier company based in Santa Rosa, California.[1] It manufactures and supplies nasal saline over-the-counter products, including the patented Sinus Rinse Kit, a nasal irrigation system used worldwide.[2][3][4][5]"
    },
    "Neimeth": {
        "Company Name": "Neimeth",
        "Year": "1997-",
        "Description": "NEIMETH International Pharmaceuticals PLC is a publicly listed pharmaceutical company founded in 1997 and headquartered in Lagos. It was established by a former managing director of Pfizer Products of Nigeria to acquire some of the trading assets of Pfizer International in Nigeria.[1]"
    },
    "Nektar": {
        "Company Name": "Nektar",
        "Year": "1990-",
        "Description": "Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California.[2] The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances.[3] It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc.[2] The company developed the world's first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough.[4]"
    },
    "Neurolixis": {
        "Company Name": "Neurolixis",
        "Year": "2011-",
        "Description": "Neurolixis is a biopharmaceutical company focused on novel drugs for the treatment of human central nervous system diseases."
    },
    "Neuropathix": {
        "Company Name": "Neuropathix",
        "Year": "2016-",
        "Description": "Neuropathix, Inc. is a biopharmaceutical company based in Doylestown, Pennsylvania focused on the research and development of pain management and neuroprotective therapeutics.[1]"
    },
    "New England Compounding Center": {
        "Company Name": "New England Compounding Center",
        "Year": "1998-",
        "Description": "New England Compounding Center (NECC) is a compounding pharmacy founded in 1998, along with its sister companies Ameridose, Medical Sales Management Inc, and Alaunus Pharmaceutical LLC. Based in Framingham, Massachusetts, the New England Compounding Center was founded by brothers-in-law Greg Conigliaro and Barry Cadden. The owners are Carla R. Conigliaro, Barry J. Cadden, Lisa M. Conigliaro and Gregory A. Conigliaro\n[5]"
    },
    "NicOx": {
        "Company Name": "NicOx",
        "Year": "1996-",
        "Description": "Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health.[1] Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.[2][3]"
    },
    "Nippon Kayaku": {
        "Company Name": "Nippon Kayaku",
        "Year": "1916-",
        "Description": "Nippon Kayaku (Ri Ben Hua Yao Zhu Shi Hui She , Nihon Kayaku Kabushiki-gaisha) (Japan Pharmaceuticals) is a Japanese company that was founded in 1916 as the first industrial explosives manufacturer in Japan under the company name Nippon Kayaku Seizo Co., Ltd.. Its main business areas are functional chemicals, pharmaceuticals, safety systems and agrochemicals.[3]\nIt has 8 plants and 4 laboratories in Japan.[4] It also has subsidiaries in different countries around the world.[5] It is listed on the Nikkei 225.[6]"
    },
    "Nippon Soda": {
        "Company Name": "Nippon Soda",
        "Year": "1920-",
        "Description": ""
    },
    "North China": {
        "Company Name": "North China",
        "Year": "1953-",
        "Description": "North China Pharmaceutical Group Corp. (NCPC), (simplified Chinese: Hua Bei Zhi Yao Ji Tuan You Xian Ze Ren Gong Si ; traditional Chinese: Hua Bei Zhi Yao Ji Tuan You Xian Ze Ren Gong Si ; pinyin: Huabei zhiyao jituan youxian zeren gongsi) is a pharmaceutical manufacturer in China. NCPC was one of the key construction projects during China's First Five-Year Plan. After five years of construction since the foundation date in June 1953, the first successful pharmaceutical production, started in June 1958. Being one of the antibiotic producers both in technology and production scale at that time, NCPC created a history of commercial production of antibiotics in China. It has 45 years of development experience. NCPC has been taking the lead in the Chinese pharmaceutical industry in key economic indexes, ranked as one of the Top500 Enterprises and the best profit-makers in China. By the end of 2002, the total assets of the company were valued at US$2 billion, with 18,500 employees. In 2002, NCPC claimed a domestic sales revenue of US$700 million and export sales of US$100 million.[1]"
    },
    "Northwest Biotherapeutics": {
        "Company Name": "Northwest Biotherapeutics",
        "Year": "1998-",
        "Description": "Northwest Biotherapeutics, Inc. is a development-stage[1] American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton.[2]"
    },
    "Norwich Pharma Services": {
        "Company Name": "Norwich Pharma Services",
        "Year": "1887-",
        "Description": "Norwich Pharma Services, previously known as Norwich Eaton Pharmaceuticals, Norwich Pharmacal, and Norwich Pharmaceuticals, is a manufacturer, packager, and distributor of prescription drugs and over-the-counter products. Laboratory support services include stability evaluation, microbiological testing, analytical testing and method development. The company was formed in 1887.[1][2][3][4][5][6]"
    },
    "NovaBay": {
        "Company Name": "NovaBay",
        "Year": "2000-",
        "Description": "NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on developing novel, fast-acting, synthetic anti-infectives compounds. These compounds are designed to mimic the body's defense system against infection. The company is currently focused on products for the eye care market. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis.[1]\nand  NeutroPhase, used in treatment of Necrotizing Fasciitis[2][3]"
    },
    "Novartis": {
        "Company Name": "Novartis",
        "Year": "1996-",
        "Description": ""
    },
    "Novartis Gene Therapies": {
        "Company Name": "Novartis Gene Therapies",
        "Year": "2012-",
        "Description": "Novartis Gene Therapies, until 2020 known as AveXis, is a biotechnology company that develops treatments for rare neurological genetic disorders. It was founded in Dallas, Texas, United States in 2012 by John Carbona after reorganizing a company called BioLife Cell Bank founded by David Genecov and John Harkey.[1][2] Work done at Nationwide Children's Hospital in the laboratory of Brian Kaspar was licensed to AveXis in October 2013. Unusual for the time, Nationwide Children's Hospital, in addition to upfront and milestone payments, also took an equity position in AveXis.[3] Kaspar became paid consultant pari passu with the license agreement in 2013.[4] The company was built specifically around a discovery of a novel method of treating spinal muscular atrophy using gene therapy.[5] AveXis was acquired by Novartis in 2018 for USD 8.7 billion.[6][7][8][9][10][11][12]"
    },
    "Novavax": {
        "Company Name": "Novavax",
        "Year": "1987-",
        "Description": "39deg08'14''N 77deg13'36''W / 39.1371degN 77.2267degW / 39.1371; -77.2267"
    },
    "Novo Nordisk": {
        "Company Name": "Novo Nordisk",
        "Year": "1923-",
        "Description": ""
    },
    "NovoBiotic": {
        "Company Name": "NovoBiotic",
        "Year": "2003-",
        "Description": "NovoBiotic Pharmaceuticals is a privately held, early-stage biotechnology company focused on the discovery and development of new drugs from natural sources."
    },
    "Noxxon": {
        "Company Name": "Noxxon",
        "Year": "1997-",
        "Description": "TME Pharma, formerly NOXXON Pharma, is a biotechnology company founded in 1997 in Berlin, Germany which specialises on cancer treatment by targeting the tumor microenvironment. TME Pharma N.V. is listed on Euronext Growth, Paris (ALTME)and is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller (vfa)."
    },
    "Ocean Biomedical": {
        "Company Name": "Ocean Biomedical",
        "Year": "2019-",
        "Description": ""
    },
    "Octapharma": {
        "Company Name": "Octapharma",
        "Year": "1983-",
        "Description": "Octapharma AG, founded in 1983, is a family-owned pharmaceutical company based in Switzerland. It bills itself as \"one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines.\"[citation needed]"
    },
    "Olainfarm": {
        "Company Name": "Olainfarm",
        "Year": "1972-",
        "Description": ""
    },
    "Oncolytics": {
        "Company Name": "Oncolytics",
        "Year": "1998-",
        "Description": "Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.[1]"
    },
    "Ono": {
        "Company Name": "Ono",
        "Year": "1717-",
        "Description": ""
    },
    "Onyx": {
        "Company Name": "Onyx",
        "Year": "1992-",
        "Description": ""
    },
    "Oramed": {
        "Company Name": "Oramed",
        "Year": "2006-",
        "Description": ""
    },
    "Orchid": {
        "Company Name": "Orchid",
        "Year": "1992-",
        "Description": "Orchid Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992, by  Kailasam Raghavendra Rao, an alumnus of IIM Ahmedabad (PGP '79) . As of 2007, it was among the top fortune 500 Indian companies by market capitalization.[1]"
    },
    "Orexigen": {
        "Company Name": "Orexigen",
        "Year": "2002-",
        "Description": "Orexigen Therapeutics, Inc. is a public American pharmaceutical company focused on development of treatments for obesity.[1] The company is based in La Jolla, California and was established by Eckard Weber in 2002.[1]  As a public company, Orexigen is traded on the NASDAQ exchange under the stock symbol OREX.[1]"
    },
    "Orexo": {
        "Company Name": "Orexo",
        "Year": "1995-",
        "Description": "Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners."
    },
    "Organon & Co.": {
        "Company Name": "Organon & Co.",
        "Year": "2020-",
        "Description": "Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey.[4] Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States.[5]"
    },
    "Orifarm": {
        "Company Name": "Orifarm",
        "Year": "1994-",
        "Description": "Orifarm (founded 1994) is a Danish pharmaceutical company[1][2] based in Odense.[3][4][5]"
    },
    "Orion": {
        "Company Name": "Orion",
        "Year": "1917-",
        "Description": ""
    },
    "Ortho-McNeil": {
        "Company Name": "Ortho-McNeil",
        "Year": "1993-",
        "Description": "Ortho-McNeil Pharmaceutical (now operating under Janssen Pharmaceuticals) was a pharmaceutical company based in Raritan, New Jersey, that was formed from the merger of Ortho Pharmaceutical and McNeil Pharmaceutical in 1993.[1] Both of these pharmaceutical companies were pioneers and leaders in areas such as pain management, acid reflux disease, and infectious diseases.[2]"
    },
    "Otis Clapp": {
        "Company Name": "Otis Clapp",
        "Year": "1840-",
        "Description": "Otis Clapp & Son (today branded simply as \"Otis Clapp\") is an American pharmaceutical manufacturer which has been owned by Medique since 2008. Prior to its acquisition by Medique, was an independent company for a 168 year history, making it one of the United States' longest-operating pharmaceutical manufacturers."
    },
    "Otsuka": {
        "Company Name": "Otsuka",
        "Year": "1964-",
        "Description": "Otsuka Pharmaceutical Co., Ltd. (Da Zhong Zhi Yao Zhu Shi Hui She , Otsuka Seiyaku Kabushiki-gaisha) (TYO: 4578), abbreviated OPC, is a pharmaceutical company headquartered in Tokyo, Osaka and Naruto, Japan. The company was established August 10, 1964."
    },
    "Ovation": {
        "Company Name": "Ovation",
        "Year": "2000-",
        "Description": "Ovation Pharmaceuticals is an American manufacturer and distributor of pharmaceuticals products. It was founded in 2000 by Jeffrey Aronin and is headquartered in Deerfield, Illinois. A major office is also located near Lebanon, New Jersey. Ovation is a privately held corporation based on a business model of acquiring mature but under-promoted pharmaceuticals, as well as pharmaceutical candidates which are far along the development and FDA certification processes. Since 2009, the company has been wholly owned by the Danish pharmaceutical company Lundbeck."
    },
    "Oxford Biomedica": {
        "Company Name": "Oxford Biomedica",
        "Year": "1995-",
        "Description": ""
    },
    "Oystershell NV": {
        "Company Name": "Oystershell NV",
        "Year": "1979-",
        "Description": "Oystershell NV is a Belgian pharmaceutical laboratory based in Merelbeke for over-the-counter products.[1][2]"
    },
    "PainCeptor": {
        "Company Name": "PainCeptor",
        "Year": "2004-",
        "Description": "PainCeptor Pharma is a private Canadian company focused on the development of drugs that act outside the central nervous system on nociceptors to treat pain.[3]  The company was established in 2004 through the merger of two academic spinout firms: Antalium from McGill University and NeuroCeptor from Queens University.[4][5]  At its inception, the company's primary operations were in Montreal and Kingston,[5] and it established a partnership with the Danish company NeuroSearch as part of its birth.[2]"
    },
    "Panacea Biotec": {
        "Company Name": "Panacea Biotec",
        "Year": "1984-",
        "Description": ""
    },
    "PATH": {
        "Company Name": "PATH",
        "Year": "1977-",
        "Description": "PATH (formerly known as the Program for Appropriate Technology in Health) is an international, nonprofit global health organization.[2] PATH is based in Seattle with 1,600 employees in more than 70 countries around the world. Its president and CEO is Nikolaj Gilbert, who is also the Managing Director and CEO of Foundations for Appropriate Technologies in Health (FATH), PATH's Swiss subsidiary. PATH focuses on six platforms: vaccines, drugs, diagnostics, devices, system, and service innovations."
    },
    "Patheon": {
        "Company Name": "Patheon",
        "Year": "1974-",
        "Description": "Patheon is a service brand within Thermo Fisher Scientific's brand portfolio. Contract development and manufacturing organization (CDMO) services offered under the Patheon brand include small molecule API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics and commercial manufacturing and packaging. In 2017, Patheon was acquired by Thermo Fisher Scientific to form its Pharma Services business."
    },
    "Perrigo": {
        "Company Name": "Perrigo",
        "Year": "1887-",
        "Description": ""
    },
    "Pfizer": {
        "Company Name": "Pfizer",
        "Year": "1849-",
        "Description": "40deg45'01''N 73deg58'21''W / 40.75028degN 73.97250degW / 40.75028; -73.97250"
    },
    "Pfizer UK": {
        "Company Name": "Pfizer UK",
        "Year": "1952-",
        "Description": ""
    },
    "Pharmaceutical Product Development": {
        "Company Name": "Pharmaceutical Product Development",
        "Year": "1985-",
        "Description": "Pharmaceutical Product Development (PPD) is a global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory and lifecycle management services. In December 2021, PPD became a  wholly owned subsidiary of Thermo Fisher Scientific."
    },
    "Pharma Nord": {
        "Company Name": "Pharma Nord",
        "Year": "1981-",
        "Description": "Pharma Nord is an international pharmaceutical company with corporate headquarters in Vejle, Denmark and a manufacturing facility and research laboratories in Vojens, Denmark. Pharma Nord has 25 daughter companies throughout Europe, Asia, North America and the Middle East. Pharma Nord is a privately owned limited company.[1]"
    },
    "Pharmacosmos": {
        "Company Name": "Pharmacosmos",
        "Year": "1965-",
        "Description": "Pharmacosmos is a pharmaceutical company specialized in treatment of iron deficiency anemia.[1]"
    },
    "Pharmaniaga": {
        "Company Name": "Pharmaniaga",
        "Year": "1994-",
        "Description": "Pharmaniaga Berhad (Pharmaniaga) is a Malaysian pharmaceutical company. It is a subsidiary of Boustead Holdings, an affiliate of the Malaysian military."
    },
    "Pharmascience": {
        "Company Name": "Pharmascience",
        "Year": "1983-",
        "Description": "Pharmascience Inc. is a Quebec-based pharmaceutical company founded by pharmacists Morris Goodman and Ted Wise in 1983. Pharmascience Inc. is headquartered in Montreal and distributes its products to more than 50 countries.[2][3]"
    },
    "Pharmavite": {
        "Company Name": "Pharmavite",
        "Year": "1971-",
        "Description": "Pharmavite is an American vitamin and supplement company, based in West Hills, California and founded in 1971 by Barry Pressman and Henry Burdick. Its Nature Made vitamin brand was launched that same year.[2] It was acquired by Otsuka Pharmaceutical in 1989.[3][4][5]"
    },
    "Pharmstandard": {
        "Company Name": "Pharmstandard",
        "Year": "2003-",
        "Description": ""
    },
    "Phoenix Pharmahandel": {
        "Company Name": "Phoenix Pharmahandel",
        "Year": "1994-",
        "Description": "PHOENIX Pharmahandel GmbH & Co KG (PHOENIX Group), headquartered in Mannheim, Baden-Wurttemberg, is the largest pharmaceutical wholesaler in Germany, and the second largest in Europe, with about 153 distribution centers across the country delivering drugs to approximately 12,000 independent pharmacies. Its PHOENIX Documentation is an internet-based archive offering detailed information on drugs, their components, indications, and effects. The formation of holding company PHOENIX International Beteiligungs GmbH took place. The Phoenix Group is a majority owner of the pharmaceutical wholesalers Purus A.S. in the Czech Republic and Tamro in Finland. The Phoenix Group itself is mostly owned by the pharmaceutical conglomerate Merckle Group.[2]"
    },
    "Phibro Animal Health": {
        "Company Name": "Phibro Animal Health",
        "Year": "1946-",
        "Description": "Phibro Animal Health Corporation is an American animal health and mineral nutrition company. Its products include antibacterials, anticoccidials, anthelmintics, as well as animal nutrition and vaccines for livestock.[6][7]\nThe company operates through three segments Mineral Nutrition, Performance Materials, and Animal Health, from which most of its revenue is derived.[8] The company operates in the United States, Latin America, Canada, Europe, Middle East, Africa, and Asia-Pacific.[6] It is incorporated in Delaware.[9]"
    },
    "Photocure": {
        "Company Name": "Photocure",
        "Year": "1993-",
        "Description": "Photocure ASA is a Norwegian specialty pharma company that develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology. Photocure's strategy in cancer is to continue the commercialization of Hexvix for bladder cancer diagnostics, and continue the development of the cancer portfolio and out-license prior to phase III studies. This strategy is based on a strong platform of intellectual property in photodynamic therapy.[citation needed]"
    },
    "Piramal Group": {
        "Company Name": "Piramal Group",
        "Year": "1984-",
        "Description": ""
    },
    "PKU Healthcare": {
        "Company Name": "PKU Healthcare",
        "Year": "1993-",
        "Description": "PKU Healthcare Co., Ltd. formerly known as PKU International Healthcare Group Southwest Pharmaceutical Co., Ltd., is a Chinese pharmaceutical company. The major shareholder was PKU Healthcare Group, a subsidiary of PKU Founder Group. PKU Founder Group itself is a subsidiary of Peking University, in turn making the listed company a state-owned enterprise by broader definition."
    },
    "Pluri": {
        "Company Name": "Pluri",
        "Year": "2001-",
        "Description": "Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment.[2] According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.[3]"
    },
    "Portola": {
        "Company Name": "Portola",
        "Year": "2003-",
        "Description": ""
    },
    "Prasco": {
        "Company Name": "Prasco",
        "Year": "2002-",
        "Description": "Prasco is a pharmaceutical company headquartered in Cincinnati, Ohio, and founded in 2002 by E. Thomas Arington, former Chairman and CEO of Duramed Pharmaceuticals and former president of the healthcare consulting firm MarketMaster.  The company remains privately held.  It specializes in the field of authorized generics, generic drugs manufactured by the branded innovator company but marketed under a private label.  According to IMS Health, the pharmaceutical industry auditing service, Prasco is one of the fastest growing pharmaceutical companies in the industry, in terms of relative growth and prescriptions dispensed for the years 2005 and 2006.[1]  Although it does not release financial data, $150 million in sales were tracked by an independent consulting company during 2005, reportedly doubling the previous years' figures.[2]"
    },
    "Precision": {
        "Company Name": "Precision",
        "Year": "2006-",
        "Description": "Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina.[3] Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary \"ARCUS\" genome editing platform.[4]"
    },
    "Procter & Gamble": {
        "Company Name": "Procter & Gamble",
        "Year": "1837-",
        "Description": ""
    },
    "ProMetic Life Sciences": {
        "Company Name": "ProMetic Life Sciences",
        "Year": "1994-",
        "Description": "Liminal BioSciences Inc.,[1] formerly known as Prometic Life Sciences Inc.,[2] is a Canadian biopharmaceutical company."
    },
    "Promomed": {
        "Company Name": "Promomed",
        "Year": "2005-",
        "Description": "Promomed Group is a Russian pharmaceutical company specialising in elaboration, production, check studies and distribution of medicinal drugs. Its major production site, the Biokhimik Plant, is in Saransk."
    },
    "ProQR": {
        "Company Name": "ProQR",
        "Year": "2012-",
        "Description": ""
    },
    "Protalix": {
        "Company Name": "Protalix",
        "Year": "1993-",
        "Description": "Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease."
    },
    "Protein Sciences": {
        "Company Name": "Protein Sciences",
        "Year": "2013-",
        "Description": "Protein Sciences Corporation is a biotech company based in Meriden, Connecticut. The company develops and produces vaccines and biopharmaceuticals for use against influenza and other diseases. In 2017, the company was acquired by Sanofi for $750 million.[1]"
    },
    "Protek": {
        "Company Name": "Protek",
        "Year": "1990-",
        "Description": "Protek (<See Tfd>Russian: Protek) is a Russian company that includes drug manufacturing, retail, and distribution. It is one of the largest pharmaceutical companies of Russia.[2] It was founded in 1990 by Vadim Yakunin and Grigor Khachaturov.[3] In 2022, the company's revenue in Russia amounted to 257 billion rubles.[4]"
    },
    "Proteon": {
        "Company Name": "Proteon",
        "Year": "2001-",
        "Description": "Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri."
    },
    "pSivida": {
        "Company Name": "pSivida",
        "Year": "2004-",
        "Description": ""
    },
    "Puma": {
        "Company Name": "Puma",
        "Year": "2010-",
        "Description": "Puma Biotechnology is a publicly traded biopharmaceutical company (NASDAQ: PBYI) headquartered in Los Angeles, CA."
    },
    "Quantum": {
        "Company Name": "Quantum",
        "Year": "2004-",
        "Description": "Quantum Pharma Plc (LSE: QP)[3] is a manufacturer and supplier of unlicensed medicines and Special Obtain products based in Burnopfield, County Durham.[1]  As of 2014, Andrew Scaife was the company's chief executive officer (CEO),[3] who had joined the company's management team in 2009.[1]"
    },
    "Quark": {
        "Company Name": "Quark",
        "Year": "1993-",
        "Description": "Quark Pharmaceuticals is a pharmaceutical company that develops RNA interference-based treatments for chronic and acute diseases."
    },
    "R-Pharm": {
        "Company Name": "R-Pharm",
        "Year": "2001-",
        "Description": "R-Pharm (<See Tfd>Russian: R-Farm) is an international pharmaceutical company headquartered in Russia.[1][2][3][4][5][6] It reached the headlines in September 2020 following approval of its drug \"Coronavir\" as a treatment in cases of mild to moderate COVID-19 infection.[7][8] It was founded by Alexey Repik (ru) in 2001, but has had an increasingly international operations base since, with Japanese Corporation Mitsui & Co., Ltd. acquiring 10% of its shares in 2017.[9] In 2022, against the background of the introduction of personal sanctions, Alexey Repik resigned from the owners of R-Pharm, selling his share in the company to the management of R-Pharm, and resigned as chairman of the board of directors [1]."
    },
    "Ratiopharm": {
        "Company Name": "Ratiopharm",
        "Year": "1974-",
        "Description": "Ratiopharm is a German pharmaceutical company that is Europe's leading generics brand."
    },
    "Reata": {
        "Company Name": "Reata",
        "Year": "2002-",
        "Description": "Reata Pharmaceuticals, Inc. is a pharmaceutical company based in Plano, Texas. Founded in 2002, it is primarily focused on investigating experimental oral antioxidative and anti-inflammatory drugs,[2] which dually activate the antioxidative transcription factor Nrf2 and inhibit the pro-inflammatory transcription factor NF-kB.[3]"
    },
    "Recherche et Industrie Th\u00e9rapeutiques": {
        "Company Name": "Recherche et Industrie Th\u00e9rapeutiques",
        "Year": "1945-",
        "Description": ""
    },
    "Reckitt": {
        "Company Name": "Reckitt",
        "Year": "1999-",
        "Description": ""
    },
    "Recursion": {
        "Company Name": "Recursion",
        "Year": "2014-",
        "Description": "Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering.[1][2][3]"
    },
    "Regeneron": {
        "Company Name": "Regeneron",
        "Year": "1988-",
        "Description": "Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.[2]  Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap."
    },
    "Regulus": {
        "Company Name": "Regulus",
        "Year": "2007-",
        "Description": "Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals.[1]"
    },
    "Renata": {
        "Company Name": "Renata",
        "Year": "1993-",
        "Description": "Renata Limited (formerly Pfizer Laboratories (Bangladesh) Limited), also known as Renata, is one of the top ten pharmaceutical manufacturers in Bangladesh in terms of revenue.[1] Renata is engaged in the manufacture and marketing of human pharmaceutical and animal health products.[2] The company also manufactures animal therapeutics and nutrition products. As of 2024, Renata employs about 11,000 people in its head office in Mirpur, Dhaka[3] and its 14 production facilities in Mirpur, Dhaka, Rajendrapur, Gazipur and Bhaluka, Mymensingh.[4]"
    },
    "Repligen": {
        "Company Name": "Repligen",
        "Year": "1981-",
        "Description": "Repligen Corporation is an American company devoted to the development and production of materials used in the manufacture of biological drugs.2014  The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981.[1]  A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN.[2]  In February 2014, Repligen had employed 116 people, about 50% of these based in Sweden.[3]"
    },
    "Repros": {
        "Company Name": "Repros",
        "Year": "1987-",
        "Description": "Repros Therapeutics Inc. (Nasdaq: RPRX), was a US-based development stage biopharmaceutical company headquartered in The Woodlands, Texas. Founded in 1987 as Zonagen, it focused on the development of oral small molecule drugs to address major unmet medical needs in male and female health. Joseph S. Podolski[1] was the CEO of this company."
    },
    "Retrotope": {
        "Company Name": "Retrotope",
        "Year": "2006-",
        "Description": "Retrotope, Inc. is a drug development company advancing the idea that polyunsaturated fatty acids (PUFA) drugs fortified with heavy isotopes (reinforced lipids) protect living cells by making bonds within the delicate molecules inside and around cells harder to break. This makes the cells less prone to damage caused by reactive oxygen species (ROS), one of the principal causes of ageing and age-associated diseases.[2] Founded in 2006 by entrepreneurs and scientists with seed funding from private investors, Retrotope is developing a non-antioxidant approach to preventing lipid peroxidation, a detrimental factor in mitochondrial, neuronal, and retinal diseases.[3] The company employs the virtual business model[4] and works in scientific collaboration with more than 80 research groups in universities worldwide.[5]"
    },
    "Roche": {
        "Company Name": "Roche",
        "Year": "1896-",
        "Description": ""
    },
    "Rohto": {
        "Company Name": "Rohto",
        "Year": "1949-",
        "Description": "Rohto Pharmaceutical Co., Ltd. (ro-toZhi Yao Zhu Shi Hui She , Roto Seiyaku Kabushiki-gaisha) is a multinational corporation in fast-moving consumer goods and pharmaceutical corporation headquartered in Ikuno-ku, Osaka, Japan. with revenues steadily increasing from Y=95,619 million in 2006 to Y=120,292 million in 2011. Skin care contributes to 61.3% of the revenues, while Eye Care contributes to 21% of their sales."
    },
    "Romat": {
        "Company Name": "Romat",
        "Year": "1992-",
        "Description": "Romat (Russian: Romat) is a pharmaceutical company and Kazakhstan's leading pharmaceutical brand."
    },
    "RosePharma": {
        "Company Name": "RosePharma",
        "Year": "2003-",
        "Description": "Rose Pharma is a private company that was founded in 2003 as Gastrotech Pharma and is located in Copenhagen, Denmark. The company is led by CEO Leif Helth Jensen, who is, together with Michael Forer and Florian Schonharting, also member of the Board of Directors. Rose Pharma is a clinical stage biotechnology company focused on the development of novel treatments for IBS and anorexia/cachexia associated with cancer and other major pathologies."
    },
    "Rowell": {
        "Company Name": "Rowell",
        "Year": "1929-",
        "Description": "Rowell Laboratories, Inc., is a pharmaceutical manufacturing company. The company was founded in 1929, originally located in Baudette, Minnesota, and later included facilities in Marietta, Georgia, and Orlando, Florida.  Rowell Laboratories, Inc. was incorporated again in 2008 in Florida and manufactures and sells the NatureCare brand of skin care products."
    },
    "RPG": {
        "Company Name": "RPG",
        "Year": "1993-",
        "Description": ""
    },
    "Rubicon Research": {
        "Company Name": "Rubicon Research",
        "Year": "1999-",
        "Description": ""
    },
    "Ryukakusan": {
        "Company Name": "Ryukakusan",
        "Year": "1871-",
        "Description": "35deg41'44''N 139deg46'49''E / 35.6954532degN 139.7802246degE / 35.6954532; 139.7802246"
    },
    "Saidal": {
        "Company Name": "Saidal",
        "Year": "1984-",
        "Description": "Saidal Group (Arabic: mjm` Sydl, French: Groupe Saidal) is an Algerian pharmaceutical company created in 1982. Saidal Group is the largest pharmaceutical company in Algeria and one of the largest in Africa."
    },
    "Salix": {
        "Company Name": "Salix",
        "Year": "1989-2015",
        "Description": "Salix Pharmaceuticals, Inc. is an American specialty pharmaceutical company based in Bridgewater, New Jersey."
    },
    "Salubris": {
        "Company Name": "Salubris",
        "Year": "1998-",
        "Description": "Shenzhen Salubris Pharmaceuticals (Chinese: Shen Zhen Xin Li Tai Yao Ye ; pinyin: Shenzhen Xinlitai Yaoye; SZSE: 002294) is a Chinese pharmaceutical company."
    },
    "Sangamo": {
        "Company Name": "Sangamo",
        "Year": "1995-",
        "Description": ""
    },
    "Sankogan": {
        "Company Name": "Sankogan",
        "Year": "1319-",
        "Description": ""
    },
    "Sanofi": {
        "Company Name": "Sanofi",
        "Year": "2004-",
        "Description": ""
    },
    "Santen": {
        "Company Name": "Santen",
        "Year": "1890-",
        "Description": "Santen Pharmaceutical Co., Ltd. (Can Tian Zhi Yao Zhu Shi Hui She , Santen Seiyaku Kabushiki-gaisha), is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.[3]"
    },
    "Sarepta": {
        "Company Name": "Sarepta",
        "Year": "1980-",
        "Description": "Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals,[1] shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively.[2] As of 2023, the company has four approved drugs (see the Products section below)."
    },
    "Sato": {
        "Company Name": "Sato",
        "Year": "1939-",
        "Description": "49deg11'12''N 123deg06'26''W / 49.186805degN 123.107211degW / 49.186805; -123.107211"
    },
    "Seagen": {
        "Company Name": "Seagen",
        "Year": "1997-",
        "Description": ""
    },
    "SEPPIC": {
        "Company Name": "SEPPIC",
        "Year": "1943-",
        "Description": "SEPPIC designs and supplies specialty chemical products for health and wellbeing.[1] The company is based in France, with distributors and production sites around the world. It has four main areas of business: personal care, pharmaceuticals and nutrition, vaccine adjuvants and injectables, and industrial specialties.[2]"
    },
    "Serum Institute of India": {
        "Company Name": "Serum Institute of India",
        "Year": "1966-",
        "Description": ""
    },
    "Servier": {
        "Company Name": "Servier",
        "Year": "1954-",
        "Description": "Servier Laboratories (French: Laboratoires Servier, often abbreviated to Servier) is an international pharmaceutical company governed by a non-profit foundation, with its headquarters in France (Suresnes).[3]"
    },
    "Sanitas": {
        "Company Name": "Sanitas",
        "Year": "1922-",
        "Description": ""
    },
    "Shanghai": {
        "Company Name": "Shanghai",
        "Year": "1994-",
        "Description": "Shanghai Pharmaceuticals (Chinese: Shang Hai Yi Yao , also referred as Shanghai Pharma) is a Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets."
    },
    "Sheffield": {
        "Company Name": "Sheffield",
        "Year": "1880-",
        "Description": "Sheffield Pharmaceuticals is a manufacturer of over the counter pharmaceutical products to retailers in the United States.[1] It manufactures and sells products both under its own labels and privately for other companies, and is an FDA registered cGMP facility.  The company was founded in 1880 as the Sheffield Dentifrice Company by Washington Sheffield, the inventor of modern toothpaste."
    },
    "Shenzhen Kangtai": {
        "Company Name": "Shenzhen Kangtai",
        "Year": "1992-",
        "Description": "22deg32'48''N 113deg56'37''E / 22.5467degN 113.9437degE / 22.5467; 113.9437"
    },
    "Shionogi": {
        "Company Name": "Shionogi",
        "Year": "1878-",
        "Description": ""
    },
    "Sido Muncul": {
        "Company Name": "Sido Muncul",
        "Year": "1940-",
        "Description": "PT Industri Jamu dan Farmasi Sido Muncul Tbk, commonly known as Sido Muncul, is an Indonesian herbal medicine and food products company based in Semarang, Indonesia, established in 1940. It produces and markets a variety of consumer products related to herbal medication, such as the jamu Tolak Angin."
    },
    "SIGA": {
        "Company Name": "SIGA",
        "Year": "1995-",
        "Description": ""
    },
    "Sihuan": {
        "Company Name": "Sihuan",
        "Year": "2014-",
        "Description": "Sihuan Pharmaceutical is a Chinese pharmaceutical manufacturer with headquarters in Beijing and branch office in Haikou, Hainan Province.[1] The main company in the group is the holding company Sihuan Pharmaceutical Holdings Group Ltd, which is listed on the Hong Kong stock market."
    },
    "Silence": {
        "Company Name": "Silence",
        "Year": "1994-",
        "Description": ""
    },
    "Simcere": {
        "Company Name": "Simcere",
        "Year": "1995-",
        "Description": "Simcere Pharmaceutical Group or Simcere Pharmaceutical (Chinese: Xian Sheng Yao Ye , SEHK: 2096) is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The Company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration (SFDA) to manufacture and sell over 210 other products."
    },
    "Sino": {
        "Company Name": "Sino",
        "Year": "2000-",
        "Description": "Sino Biopharmaceutical Limited (SEHK: 1177|Hang Seng Index component) (simplified Chinese: Zhong Guo Sheng Wu Zhi Yao You Xian Gong Si ; traditional Chinese: Zhong Guo Sheng Wu Zhi Yao You Xian Gong Si ; pinyin: zhong guo sheng wu zhi yao you xian gong si), shortly Sino Biopharm, is a civilian-run enterprise principally engaged in the medicine products business in Mainland China."
    },
    "Sinopharm": {
        "Company Name": "Sinopharm",
        "Year": "1998-",
        "Description": "39deg58'29''N 116deg20'24''E / 39.9747degN 116.3401degE / 39.9747; 116.3401"
    },
    "Sinopharm Group": {
        "Company Name": "Sinopharm Group",
        "Year": "2003-",
        "Description": "Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51-49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical."
    },
    "Sinovac": {
        "Company Name": "Sinovac",
        "Year": "1999-",
        "Description": "40deg01'52''N 116deg18'01''E / 40.031degN 116.3003degE / 40.031; 116.3003"
    },
    "Smnith": {
        "Company Name": "Smnith",
        "Year": "1944-",
        "Description": "Smith Drug Company is a Spartanburg, South Carolina based drug wholesale company and a division of J M Smith Corporation.[1] The company was founded in 1944 with annual revenue in excess of $2.5 Billion as of 2013.[2]"
    },
    "Solopharm": {
        "Company Name": "Solopharm",
        "Year": "2010-",
        "Description": "Solopharm (Grotex OOO) - Russian pharmaceutical company, which produces liquid sterile dosage forms according to GMP standards (license No.  00023-LS).[1] \nProduct line consists of infusion and injection solutions, ophthalmic, otolaryngological, gastroenterological, rheumatological and cosmetological products."
    },
    "Solvay": {
        "Company Name": "Solvay",
        "Year": "1863-",
        "Description": "Solvay is a Belgian multinational chemical company established in 1863, with its headquarters located in Neder-Over-Heembeek, Brussels, Belgium."
    },
    "Somnogen Canada Inc": {
        "Company Name": "Somnogen Canada Inc",
        "Year": "????-",
        "Description": "Somnogen is a Canadian multinational pharmaceutical corporation with its global headquarters located in Toronto, Canada. Somnogen produces and develop a wide range of prescription and over-the-counter medications in the field of sleep medicine. Somnogen has a portfolio of products for major areas within the field of sleep/wake therapeutic segment including insomnia and excessive daytime sleepiness."
    },
    "Spark": {
        "Company Name": "Spark",
        "Year": "2013-",
        "Description": "Spark Therapeutics, Inc. is a developer of gene therapy treatments, which treat debilitating genetic diseases.[1] It was founded in 2013 and has been a subsidiary of Hoffmann-La Roche since 2020."
    },
    "Spectrum": {
        "Company Name": "Spectrum",
        "Year": "2018-",
        "Description": "Spectrum Pharmaceuticals, Inc. is an American biopharmaceutical company located in Boston, MA. It develops and markets drugs for treatments in hematology and oncology."
    },
    "Spotlight Innovation": {
        "Company Name": "Spotlight Innovation",
        "Year": "2012-",
        "Description": "Spotlight Innovation Inc. (OTCQB: STLT) [STATUS CLOSED] was an American pharmaceutical holding company.[2][3][4] The company maintained two subsidiaries: Caretta Therapeutics, Inc.[5] and Celtic Biotech Iowa, Inc.[6] Spotlight Innovation Inc. is based in Urbandale, Iowa and was publicly traded on the OTCQB marketplace under the stock ticker symbol, STLT.[3][7]"
    },
    "Square": {
        "Company Name": "Square",
        "Year": "1958-",
        "Description": "Square Pharmaceuticals Ltd. is a Bangladeshi multinational pharmaceutical company.[1] It was founded in 1958[2] by Samson H. Chowdhury along with three of his friends PK Saha, Kazi Harunur Roshid and Radhabinod Rai as a private firm. It went public in 1991 and is listed on the Dhaka Stock Exchange[3] and on the Chittagong Stock Exchange (ID of SPL: 13002)[4] Square Pharmaceutical started to export different antibiotics and medicine across the world from 1987. Now it exports its medicine to 36 countries of the world.[5]"
    },
    "Stada Arzneimittel": {
        "Company Name": "Stada Arzneimittel",
        "Year": "1895-",
        "Description": "Simone Berger (CHRO),\nMiguel Pagan Fernandez (CTO),\nBoris Dobler (CFO),"
    },
    "Stallergenes Greer": {
        "Company Name": "Stallergenes Greer",
        "Year": "2015-",
        "Description": "Stallergenes Greer International AG is a global biopharmaceutical company headquartered in Baar, Switzerland, specializing in the diagnosis and treatment of respiratory allergies through immunotherapy.[2]"
    },
    "SPC": {
        "Company Name": "SPC",
        "Year": "1971-",
        "Description": ""
    },
    "Sphere Fluidics": {
        "Company Name": "Sphere Fluidics",
        "Year": "2010-",
        "Description": ""
    },
    "STADA Arzneimittel": {
        "Company Name": "STADA Arzneimittel",
        "Year": "1895-",
        "Description": "Simone Berger (CHRO),\nMiguel Pagan Fernandez (CTO),\nBoris Dobler (CFO),"
    },
    "Stiefel": {
        "Company Name": "Stiefel",
        "Year": "1847-",
        "Description": "Stiefel Laboratories Inc. is an American dermatological pharmaceutical company, with its global headquarters in Research Triangle Park, North Carolina.[1] It makes products such as Duac and Oilatum.[2] Stiefel was acquired by GSK plc at a price of $2.9 billion.[3][4] The company was founded in 1847 by John David Stiefel, who initially created medicated soaps.[5]"
    },
    "Strides": {
        "Company Name": "Strides",
        "Year": "1990-",
        "Description": ""
    },
    "Stryker": {
        "Company Name": "Stryker",
        "Year": "1941-",
        "Description": "Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan.[2] Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties."
    },
    "Sumitomo": {
        "Company Name": "Sumitomo",
        "Year": "2005-",
        "Description": "Sumitomo Pharma Company Limited (Zhu You hua-maZhu Shi Hui She , Sumitomo Fama Kabushiki-Gaisha) is a Japanese multinational pharmaceutical company. The company is focused on oncology, psychiatry, neurology, women's health issues, urological diseases among other areas. Its headquarters are located in Chuo-ku, Osaka.[1]"
    },
    "Sun": {
        "Company Name": "Sun",
        "Year": "1983-",
        "Description": ""
    },
    "Sunovion": {
        "Company Name": "Sunovion",
        "Year": "1984-",
        "Description": ""
    },
    "Sutro": {
        "Company Name": "Sutro",
        "Year": "2003-",
        "Description": "Sutro Biopharma, Inc. is a publicly traded biotechnology company headquartered in South San Francisco, California focused on  clinical-stage drug discovery, development and manufacturing. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design. Founded in 2003 under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in 2009. William Newell,  CEO as of 2024[update], joined Sutro in January 2009.[1]"
    },
    "Swedish Orphan Biovitrum": {
        "Company Name": "Swedish Orphan Biovitrum",
        "Year": "2001-",
        "Description": "Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden."
    },
    "Synthon": {
        "Company Name": "Synthon",
        "Year": "1991-",
        "Description": "Synthon is a Dutch  multinational that produces generic human drugs."
    },
    "Taisho": {
        "Company Name": "Taisho",
        "Year": "1912-",
        "Description": ""
    },
    "Takeda": {
        "Company Name": "Takeda",
        "Year": "1781-",
        "Description": "The Takeda Pharmaceutical Company Limited[1] (Wu Tian Yao Pin Gong Ye Zhu Shi Hui She , Takeda Yakuhin Kogyo kabushiki gaisha) [takeda jakWciNG ko:gjo:] is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following its merger with Shire). The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year.[7] The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo.[8][9] In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.[10] As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.[11]"
    },
    "Taro": {
        "Company Name": "Taro",
        "Year": "1950-",
        "Description": "Taro Pharmaceutical Industries is an Israeli research-based pharmaceutical manufacturer that was publicly listed in the New York Stock Exchange before it was acquired by Sun Pharma. The company has more than 180 of its own drugs sold all over the world, reaching the markets of over 25 countries.[1] The company's products are mainly sold in the United States, Canada and Israel.[2]"
    },
    "Tasly": {
        "Company Name": "Tasly",
        "Year": "1994-",
        "Description": ""
    },
    "Teijin": {
        "Company Name": "Teijin",
        "Year": "1918-",
        "Description": "Teijin Limited (Di Ren Zhu Shi Hui She , Teijin Kabushiki-gaisha) is a Japanese chemical, pharmaceutical and information technology company. Its main fields of operation are high-performance fibers such as aramid, carbon fibers & composites, healthcare, films, resin & plastic processing, polyester fibers, products converting and IT products."
    },
    "Temmler": {
        "Company Name": "Temmler",
        "Year": "1917-",
        "Description": "Temmler Werke GmbH was founded in Detmold in 1917 by Hermann Temmler. The Temmler Group is a German pharmaceutical company, which focuses on the production, sale and contract production of pharmaceutical products.[1] In 2012, the Temmler Group was taken over by the Aenova Group and with its seven production sites is one of the largest European pharmaceutical contract manufacturers."
    },
    "Terapia Ranbaxy": {
        "Company Name": "Terapia Ranbaxy",
        "Year": "1921-",
        "Description": ""
    },
    "Teva": {
        "Company Name": "Teva",
        "Year": "1901-",
        "Description": ""
    },
    "Teva Active Pharmaceutical Ingredients": {
        "Company Name": "Teva Active Pharmaceutical Ingredients",
        "Year": "1935-",
        "Description": "Teva API is an international pharmaceutical company headquartered in Israel. Teva API is a stand-alone business unit of Teva Pharmaceutical Industries limited, the largest generic drug manufacturer in the world [1] and one of the 15 largest pharmaceutical companies worldwide.[2]"
    },
    "Teva Canada": {
        "Company Name": "Teva Canada",
        "Year": "1965-",
        "Description": "Teva Canada is one of Canada's largest generic pharmaceutical companies. The company was founded as Novopharm by Leslie Dan in 1965. After its acquisition by pharmaceutical giant Teva Pharmaceutical Industries in 2000, it was renamed Teva Novopharm. The Novopharm name was dropped in 2010, when it became Teva Canada.[1]"
    },
    "Theramex": {
        "Company Name": "Theramex",
        "Year": "2018-",
        "Description": ""
    },
    "Theraplix": {
        "Company Name": "Theraplix",
        "Year": "1931-",
        "Description": "Theraplix is a European pharmaceutical company. Founded in 1931[1] by the pharmacist Francois Albert-Buisson,[2][3] It is now a subsidiary of Sanofi.[4]"
    },
    "Thornton & Ross": {
        "Company Name": "Thornton & Ross",
        "Year": "1922-",
        "Description": ""
    },
    "Tilray": {
        "Company Name": "Tilray",
        "Year": "2013-",
        "Description": ""
    },
    "TME": {
        "Company Name": "TME",
        "Year": "1997-",
        "Description": "TME Pharma, formerly NOXXON Pharma, is a biotechnology company founded in 1997 in Berlin, Germany which specialises on cancer treatment by targeting the tumor microenvironment. TME Pharma N.V. is listed on Euronext Growth, Paris (ALTME)and is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller (vfa)."
    },
    "Tonix": {
        "Company Name": "Tonix",
        "Year": "2011-",
        "Description": "Tonix Pharmaceuticals (Tonix Pharmaceuticals Holding Corp.) is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.[1]"
    },
    "Torque": {
        "Company Name": "Torque",
        "Year": "1985-",
        "Description": ""
    },
    "Torrent": {
        "Company Name": "Torrent",
        "Year": "1959-",
        "Description": ""
    },
    "Transgene": {
        "Company Name": "Transgene",
        "Year": "1979-",
        "Description": "Transgene S.A. is a French biotechnology company founded in 1979. It is based in Illkirch-Graffenstaden, near Strasbourg, and develops and manufactures immunotherapies for the treatment of cancer."
    },
    "Troikaa": {
        "Company Name": "Troikaa",
        "Year": "1983-",
        "Description": "Troikaa Pharmaceuticals is an Indian multinational pharmaceutical company headquartered in Ahmedabad city of Gujarat, India.[1] It is a public unlisted company and is classified as company limited by shares.[2][3]"
    },
    "TTK Group": {
        "Company Name": "TTK Group",
        "Year": "1928-",
        "Description": ""
    },
    "Turing": {
        "Company Name": "Turing",
        "Year": "2015-",
        "Description": "Vyera Pharmaceuticals (formerly Turing Pharmaceuticals) is a pharmaceutical company incorporated in Zug, Switzerland, with offices in New York City. The company started to do business in the US as Vyera Pharmaceuticals in September 2017.[2][3]"
    },
    "UCB": {
        "Company Name": "UCB",
        "Year": "1928-",
        "Description": "UCB (Union Chimique Belge) is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of EUR4.178 billion in 2016[2] which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease.[2] The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system (CNS) disorders (including epilepsy), inflammatory disorders (including allergy), and oncology."
    },
    "Unichem": {
        "Company Name": "Unichem",
        "Year": "1944-",
        "Description": ""
    },
    "Unilab": {
        "Company Name": "Unilab",
        "Year": "1945-",
        "Description": ""
    },
    "Unilever": {
        "Company Name": "Unilever",
        "Year": "1929-",
        "Description": ""
    },
    "USV": {
        "Company Name": "USV",
        "Year": "1961-",
        "Description": ""
    },
    "Veloxis": {
        "Company Name": "Veloxis",
        "Year": "1999-",
        "Description": "Veloxis Pharmaceuticals A/S, formerly LifeCycle Pharma A/S,[1] develops improved versions of difficult-to-formulate drugs with its proprietary drug formulation technology, called MeltDose(r).  Veloxis is focused on building a clinical and market-stage pharmaceutical business around its late-stage transplant immunosuppression product candidate LCP-Tacro.  The company was founded in 2002 as a spin-off from H. Lundbeck A/S. Veloxis is headquartered in Horsholm, Denmark, with an office in Cary, North Carolina.[2]"
    },
    "Veranova": {
        "Company Name": "Veranova",
        "Year": "1815-",
        "Description": "Veranova, L.P. (formally Johnson Matthey Health) is an American multinational contract development and manufacturing organization (CDMO) based in Wayne, PA, with operations in North America and Europe.[1]"
    },
    "Vernalis Research": {
        "Company Name": "Vernalis Research",
        "Year": "2018-",
        "Description": ""
    },
    "Vertex": {
        "Company Name": "Vertex",
        "Year": "1989-",
        "Description": ""
    },
    "Vianex": {
        "Company Name": "Vianex",
        "Year": "1971-",
        "Description": "Vianex S.A. (Greek: Bianex A.E.) is a Greek pharmaceutical company, founded in 1971 by the Giannakopoulos' family that has been involved with the pharmaceutical industry since 1924.[6]"
    },
    "Viatris": {
        "Company Name": "Viatris",
        "Year": "2020-",
        "Description": ""
    },
    "ViiV Healthcare": {
        "Company Name": "ViiV Healthcare",
        "Year": "2009-",
        "Description": ""
    },
    "ViroMed": {
        "Company Name": "ViroMed",
        "Year": "1996-",
        "Description": ""
    },
    "Vivimed Labs": {
        "Company Name": "Vivimed Labs",
        "Year": "1988-",
        "Description": ""
    },
    "Weifa": {
        "Company Name": "Weifa",
        "Year": "1940-",
        "Description": "Weifa[1] is a Norwegian pharmaceutical company headquartered in Oslo with production facilities in Kragero."
    },
    "Wilson Therapeutics": {
        "Company Name": "Wilson Therapeutics",
        "Year": "2012-",
        "Description": "Wilson Therapeutics is a biopharmaceutical company, based in Stockholm, Sweden, that develops novel therapies for rare diseases. The company is listed in the Mid-Cap segment on Nasdaq Stockholm with the stock ticker WTX."
    },
    "Wockhardt": {
        "Company Name": "Wockhardt",
        "Year": "1960-",
        "Description": ""
    },
    "W\u00f6rwag": {
        "Company Name": "W\u00f6rwag",
        "Year": "1971-",
        "Description": ""
    },
    "WuXi AppTec": {
        "Company Name": "WuXi AppTec",
        "Year": "2000-",
        "Description": "WuXi AppTec (WuXi  is pronounced as Wu-shee) is a global pharmaceutical, biopharmaceutical, and medical device company."
    },
    "Xiangxue": {
        "Company Name": "Xiangxue",
        "Year": "1986-",
        "Description": "Xiangxue Pharmaceutical Co., Ltd. also known as XPH, is a Chinese pharmaceutical company. It was headquartered in Guangzhou Economic and Technological Development Zone, Guangzhou, the capital of the Guangdong Province. The company started in a place that near to the tourist spot Luogang Xiangxue [zh] (now in the Luogang Subdistrict, Huangpu District), thus called itself Xiangxue (Chinese: Xiang Xue ; pinyin: Xiang xue; Jyutping: hoeng1 syut3; lit. 'Fragrant Snow')."
    },
    "Yangtze River": {
        "Company Name": "Yangtze River",
        "Year": "1971-",
        "Description": "Yangtze River Pharmaceutical Group (Chinese: Yang Zi Jiang Yao Ye Ji Tuan , YRPG) is a Chinese multinational pharmaceutical corporation headquartered in Taizhou, Jiangsu Province in the People's Republic of China, and with its research headquarters in Shanghai.[3] It is one of the Asia's largest pharmaceutical companies by revenues, and was listed in 2014 as being China's second largest pharmaceutical manufacturer, and leading company for technological and entrepreneurial innovation.[4]"
    },
    "Yuhan": {
        "Company Name": "Yuhan",
        "Year": "1926-",
        "Description": "Yuhan Corporation (Korean: jusighoesa yuhanyanghaeng; Hanja: Zhu Shi Hui She  Liu Han Yang Xing ; RR: Jusik Hoesa Yuhan Yanghaeng) is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962.[1][2] Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical.[3]"
    },
    "Yunnan Baiyao Group": {
        "Company Name": "Yunnan Baiyao Group",
        "Year": "2016-",
        "Description": "Yunnan Baiyao Group Co., Ltd is a Chinese pharmaceutical company that develops and manufactures pharmaceutical products (mainly traditional Chinese medicine) and the wholesale and retail of pharmaceutical products.[2]"
    },
    "Zambon": {
        "Company Name": "Zambon",
        "Year": "1906-",
        "Description": "Zambon is an Italian company that has been operating in the pharmaceutical and fine chemical industry since 1906. The company is currently run by Elena Zambon who is the daughter of the founder.[1]"
    },
    "Zandu Realty": {
        "Company Name": "Zandu Realty",
        "Year": "1910-",
        "Description": ""
    },
    "Zealand": {
        "Company Name": "Zealand",
        "Year": "1998-",
        "Description": "Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity.[1] The company's head office is situated in Soborg near Copenhagen, and it has close to 200 employees.[2] In 2018, they opened a subsidiary in the US.[3] Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley.[4]"
    },
    "Zentiva": {
        "Company Name": "Zentiva",
        "Year": "1998-",
        "Description": "Zentiva is a pharmaceutical company based in Prague, Czech Republic. The company is developing, manufacturing and marketing a wide range of generic and OTC products."
    },
    "Zeria": {
        "Company Name": "Zeria",
        "Year": "1955-",
        "Description": "Zeria Shinyaku Kogyo KK (zeriaXin Yao Gong Ye Zhu Shi Hui She , Zeria Shinyaku Kogyo Kabushiki-gaisha, Zeria Pharmaceutical Co., Ltd.) is a Japanese drug manufacturer that obtained Tillotts Pharma AG."
    },
    "Zoetis": {
        "Company Name": "Zoetis",
        "Year": "1952-",
        "Description": ""
    },
    "Zydus": {
        "Company Name": "Zydus",
        "Year": "1952-",
        "Description": ""
    },
    "Zymeworks": {
        "Company Name": "Zymeworks",
        "Year": "2003-",
        "Description": "Zymeworks Inc. is a publicly held biotechnology company based in Vancouver,\nBritish Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure.[1][2][3] In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year.[4]  In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million.  This was the largest Canadian biotech IPO in more than a decade.[5]  By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange."
    },
    "3M": {
        "Company Name": "3M",
        "Year": "",
        "Description": ""
    },
    "Abraxis BioScience": {
        "Company Name": "Abraxis BioScience",
        "Year": "2001-2010",
        "Description": "Abraxis BioScience was a global biopharmaceutical, and nano-medicine company that developed treatments for critically ill patients. It had over 2000 employees worldwide in 2007.[3]  Abraxis's portfolio included the world's first protein-based nanoparticle chemotherapeutic compound, called nab Technology.[4] From this the company developed Abraxane, a treatment for metastatic breast cancer.[5]"
    },
    "Actavis": {
        "Company Name": "Actavis",
        "Year": "1984-2015",
        "Description": "Actavis Generics[1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial presence across approximately 100 countries. The company has global headquarters in Dublin, Ireland and administrative headquarters in Parsippany-Troy Hills, New Jersey, United States."
    },
    "Actelion": {
        "Company Name": "Actelion",
        "Year": "1997-2017",
        "Description": ""
    },
    "Akorn": {
        "Company Name": "Akorn",
        "Year": "1971-2023",
        "Description": "Akorn Operating Company LLC (Akorn Inc. prior to its bankruptcy) was an American generic pharmaceuticals manufacturer based in Lake Forest, Illinois. The company dealt in developing, manufacturing and marketing of generic and prescription drugs as well as animal and consumer health products.[1] It was a component of the NASDAQ Biotechnology Index."
    },
    "Allen & Hanburys": {
        "Company Name": "Allen & Hanburys",
        "Year": "1715-1958",
        "Description": ""
    },
    "Allergan": {
        "Company Name": "Allergan",
        "Year": "2013-2019",
        "Description": "Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology.[1][2][3] The company is the maker of Botox.[1]"
    },
    "Allozyne": {
        "Company Name": "Allozyne",
        "Year": "2005-2014",
        "Description": "Allozyne was a clinical stage[clarification needed] biotechnology company headquartered in Seattle's biotech and high tech innovation corridor.[where?] Allozyne was founded in 2005 by California Institute of Technology researchers, and was incubated[clarification needed] by Accelerator Corporation.[1] Its lead product candidate, AZ01, is a long acting interferon beta for the treatment of the relapsing remitting form of multiple sclerosis, a chronic degenerative disease characterized by demyelination of nerve fibers leading to severe nerve damage and increasing disability. Multiple sclerosis is estimated to affect 400,000 individuals in the US alone and 2.5 million worldwide.[2] AZ01 is currently undergoing Phase I clinical trials in the US. Preclinical data indicates that AZ01 has the potential to be dosed once monthly compared to the current standard of care dosed anywhere from once daily to once per week.[3]"
    },
    "Alza": {
        "Company Name": "Alza",
        "Year": "1968-2001",
        "Description": ""
    },
    "Ambit": {
        "Company Name": "Ambit",
        "Year": "2010-2014",
        "Description": "Ambit was an American pharmaceutical company focused on development of kinase inhibitor therapeutics to treat a variety of human diseases.[1]: 3 [n 1] As of March 2014[update], the company was based in San Diego, California, and consisted of a single facility.[2]: 58   Ambit made an initial public offering in May 2013,[2] and was listed on the NASDAQ exchange under the symbol \"AMBI\".[3] Ambit was acquired by Daiichi Sankyo in 2014 and is no longer traded on the NASDAQ exchange.[4]"
    },
    "Amersham plc": {
        "Company Name": "Amersham plc",
        "Year": "1946-2003",
        "Description": ""
    },
    "Amylin": {
        "Company Name": "Amylin",
        "Year": "1987-2012",
        "Description": "Amylin Pharmaceuticals, Inc. is a biopharmaceutical founded in 1987 that was based in San Diego, California. The company was engaged in the discovery, development, and commercialization of drug candidates for the treatment of diabetes, obesity, and other diseases. Amylin produced three drugs: Symlin (pramlintide acetate), Byetta (exenatide) and Bydureon (exenatide extended release)."
    },
    "Anacor": {
        "Company Name": "Anacor",
        "Year": "2002-2016",
        "Description": "40deg45'01''N 73deg58'21''W / 40.75028degN 73.97250degW / 40.75028; -73.97250"
    },
    "Angiotech": {
        "Company Name": "Angiotech",
        "Year": "1992-2017",
        "Description": "Angiotech was a pharmaceutical company in Vancouver, British Columbia, Canada. Angiotech was founded in 1992 by William L. Hunter, Lindsay Machan, and Larry Arsenault. It sought to develop innovative technologies and medical products primarily for local diseases and complications associated with medical device implants, surgical interventions and acute injury."
    },
    "Antibe": {
        "Company Name": "Antibe",
        "Year": "2010-2024",
        "Description": "Antibe Therapeutics was a Toronto-based pharmaceutical company that develops pain and inflammation-reducing drugs based on gaseous mediator technology.[1]  Antibe was founded by John L. Wallace, also a co-founder of NicOx, the first company to develop drugs utilizing gaseous mediators. Founded in 2009, the company listed on the TSX Venture Exchange in 2013 and was moved to the Toronto Stock Exchange in November 2020. In 2015, Antibe acquired Citagenix, a distributor involved in regenerative medicine.[2]"
    },
    "Antikamnia": {
        "Company Name": "Antikamnia",
        "Year": "1890-1930",
        "Description": "Antikamnia Chemical Company (1890-1930), named after its patent medicine Antikamnia, was an American pharmaceutical company based in St. Louis that manufactured supposed cures for pains with the main ingredient being acetanilid, which was known to be toxic in high doses or in sensitive individuals. They produced a range of products with mixtures of therapeutic chemicals including both quinine and heroin. Unlike quack cures of the time, they contained potent chemicals but these were not carefully tested and were considered as nostrums by many physicians of the time. The company however made huge profits through clever advertising and marketing of the product targeting physicians, using physician testimonials and finding loopholes in the Pure Food and Drug Act of 1906."
    },
    "Apoth\u00e9Cure": {
        "Company Name": "Apoth\u00e9Cure",
        "Year": "1991-2013",
        "Description": "ApotheCure was a Dallas, Texas-based compounding pharmacy that specialized in custom compounded formulas and nutritional supplements for both patients and physicians. ApotheCure was a sister corporation of the Texas Institute of Functional Medicines. The company was the subject of multiple lawsuits starting in the mid-2000s."
    },
    "Aptalis": {
        "Company Name": "Aptalis",
        "Year": "2011-2014",
        "Description": "Aptalis was a company in the pharmaceutical industry. In January 2014, the company was acquired by Forest Laboratories (acquired by Allergan) for $675 million. Through a series of acquisitions, the company is now a contract development and manufacturing organization and rebranded as Adare Phama Solutions, headquartered in Lawrenceville, New Jersey.[1]"
    },
    "ARIAD": {
        "Company Name": "ARIAD",
        "Year": "1991-2017",
        "Description": "ARIAD Pharmaceuticals, Inc. was an American oncology company, now part of Takeda Oncology, which was founded in 1991 by Harvey J. Berger, M.D. and headquartered in Cambridge, Massachusetts. ARIAD engaged in the discovery, development, and commercialization of medicines for cancer patients."
    },
    "Astra": {
        "Company Name": "Astra",
        "Year": "1913-1999",
        "Description": "Astra AB was a former international pharmaceutical company headquartered in Sodertalje, Sweden. Astra was formed in 1913 and merged with the British Zeneca Group in 1999 to form AstraZeneca.[1] Product development was focused on therapeutics for gastrointestinal, cardiovascular and respiratory disorders and pain control. At the time of the merger, Astra was the largest Swedish pharmaceutical company. Astra also operated Astra Tech, a medical devices company, and marketed pharmaceuticals outside their primary development area, including anti-infective agents."
    },
    "Aurora": {
        "Company Name": "Aurora",
        "Year": "1995-2001",
        "Description": "Aurora Biosciences was a biotechnology company founded in 1995 in San Diego to commercialize fluorescence assays based on Roger Y. Tsien's discoveries concerning green fluorescent protein and its uses in basic research - work for which Tsien eventually won the 2008 Nobel Prize in chemistry along with two other chemists."
    },
    "Australian Pharmaceutical Industries": {
        "Company Name": "Australian Pharmaceutical Industries",
        "Year": "1910-2022",
        "Description": ""
    },
    "Ayrton": {
        "Company Name": "Ayrton",
        "Year": "1965-2020",
        "Description": "Ayrton Drug Manufacturing Limited was a Ghanaian pharmaceutical company. It was established on September 24, 1965. The business entity was listed on the stock index of the Ghana Stock Exchange, the GSE All-Share Index.\nThe factory it ran is based in Tesano, a suburb of Accra. The company's product portfolio included anti-hypertensives, hematinics, dermatological preparations, antibiotics, dewormers, pain killers and anti-inflammatory drugs. In February 2010 Adcock Ingram, a South African pharmaceutical company acquired 66% shares in the company.[1]"
    },
    "Barr": {
        "Company Name": "Barr",
        "Year": "1970-2008",
        "Description": "Barr Pharmaceuticals was a global specialty and generic drug manufacturer with operations in 30 countries."
    },
    "Baxalta": {
        "Company Name": "Baxalta",
        "Year": "2015-2016",
        "Description": "Baxalta (Bax from the name of its former parent company; alta a Latin adjective meaning 'high' or 'profound'[2]) is a biopharmaceutical company founded on 1 July 2015 after its parent company, Baxter International, spun off biopharmaceutical division.[1] The company began its operation with a revenue of $6 billion,[3] and is now a subsidiary of Takeda Pharmaceutical Company."
    },
    "Beecham Group": {
        "Company Name": "Beecham Group",
        "Year": "1859-1989",
        "Description": ""
    },
    "Biolex": {
        "Company Name": "Biolex",
        "Year": "1997-2012",
        "Description": "Biolex Therapeutics was a biotechnology firm in the Research Triangle of North Carolina which was founded in 1997 and raised $190 million from investors.  It filed for  Chapter 7 bankruptcy on July 5, 2012.[1]"
    },
    "Bionova": {
        "Company Name": "Bionova",
        "Year": "1996-2012",
        "Description": "Bionovo (NASDAQ: BNVI.OB) was an American biotechnology company focused on the discovery and development of botanically derived treatments for women's health and cancer based in Emeryville, California. The company had multiple drug candidates in U.S. Food and Drug Administration (FDA) clinical trials- Menerba (formerly known as MF101) a selective estrogen receptor beta agonist for hot flashes associated with menopause Seala (formerly VG101) a selective estrogen receptor beta agonist for menopausal vaginal dryness and Bezielle (formerly BZL101) for advanced breast cancer. The company has ceased activity after filing for Chapter 7 bankruptcy protection in California. Bionovo's stock is no longer listed."
    },
    "Biotie Therapies": {
        "Company Name": "Biotie Therapies",
        "Year": "1998-2016",
        "Description": "Biotie Therapies Oyj was a Finnish biotechnology and pharmaceutics company that was acquired by Acorda Therapeutics in January 2016. The company's research and development was focused on drugs for neurodegenerative and psychiatric disorders like Parkinson's disease, Alzheimer's disease and other cognitive disorders, alcohol and drug dependence and post traumatic stress disorder, and inflammatory and fibrotic liver disease. The company's headquarters is in Turku, Western Finland, and it is listed on NASDAQ OMX Helsinki."
    },
    "Biovail": {
        "Company Name": "Biovail",
        "Year": "1991-2010",
        "Description": "Biovail Corporation was a Canadian pharmaceutical company, operating internationally in all aspects of pharmaceutical products.  Its major production facility was located in Steinbach, Manitoba. It merged with Valeant Pharmaceuticals International in 2010."
    },
    "Biovest": {
        "Company Name": "Biovest",
        "Year": "-2017",
        "Description": "Biovest International, Inc (OTCQB: BVTI) was a Minneapolis-based biotechnology company. Their active immunotherapy, BiovaxID, is a cancer vaccine whose first indication was intended to be consolidation/adjuvant therapy of follicular Non-Hodgkin's Lymphoma.  Biovest filed to reorganize under chapter 11 bankruptcy in 2014,[1] BiovaxID was refused European marketing authorization in 2015,[2] and Biovest's stock listing was revoked in 2017.[3]"
    },
    "Block Drug": {
        "Company Name": "Block Drug",
        "Year": "1907-2001",
        "Description": "Block Drug Company was a pharmaceutical company based in Jersey City, New Jersey, United States, that specialized in dental care products. Its most popular products included Polident denture cleanser, Poli-Grip denture adhesive, Dentu-Creme denture toothpaste, Nytol sleeping pill, Tegrin medicated shampoo for psoriasis, Lava hand soaps (acquired from Procter & Gamble), Beano and Phazyme anti-gas products, Balmex diaper rash ointments, and Sensodyne desensitizing toothpaste.[1]"
    },
    "Boehringer Mannheim": {
        "Company Name": "Boehringer Mannheim",
        "Year": "1817--1997",
        "Description": ""
    },
    "Bradley": {
        "Company Name": "Bradley",
        "Year": "1985-2008",
        "Description": "Bradley Pharmaceuticals was a pharmaceutical company headquartered in Fairfield Township, Essex County, New Jersey.[1] The company was founded in 1985 by Daniel Glassman who was also its CEO."
    },
    "British Biotech": {
        "Company Name": "British Biotech",
        "Year": "1986-2003",
        "Description": ""
    },
    "Buckley's": {
        "Company Name": "Buckley's",
        "Year": "1919-2002",
        "Description": "W. K. Buckley Limited is a Canadian company which produces the Buckley's brand of cold medicines. It is known for its marketing that takes deprecating pride in the syrup's unpleasant taste. It also offers children's medicine, which is sold under the brand name Jack & Jill. The company is located in Mississauga, Ontario. It is a subsidiary of Novartis."
    },
    "Calcutta Chemical Company": {
        "Company Name": "Calcutta Chemical Company",
        "Year": "1916-????",
        "Description": "The Calcutta Chemical Company was a pharmaceutical company established in the city of Calcutta (now Kolkata) in 1916 by K.C. Das, B.N. Maitra, and R.N. Sen. Its founding was at the time of the Swadeshi Movement in Bengal, where the spirit of entrepreneurship was encouraged in opposition to British manufactured goods. Although it manufactured a variety of products, the company was best known for being the originators of Margo soap and Neem Toothpaste, as well as Lavender Dew Powder.[1] It was primarily run by the Dasgupta family (descendants of K.C. Das) until its acquisition by Shaw Wallace. It was then further sold to German consumer goods company Henkel, which incorporated Henkel India. More recently, the company once again changed hands and was acquired by VVF, a contract soap manufacturer, while Henkel retained the rights to the products and focused on their marketing.[2]"
    },
    "Cambridge Antibody Technology": {
        "Company Name": "Cambridge Antibody Technology",
        "Year": "1989-2007",
        "Description": ""
    },
    "CancerVax": {
        "Company Name": "CancerVax",
        "Year": "1998-2005",
        "Description": "CancerVax was an American pharmaceutical company founded in 1998 by Donald Morton. The company sought to develop a vaccine for cancer, and had candidates for melanoma reach phase III clinical trials. When those trials proved unsuccessful in 2005, the company soon underwent a reverse takeover with Micromet."
    },
    "Cangene": {
        "Company Name": "Cangene",
        "Year": "1984-2014",
        "Description": "Cangene Corporation was a biopharmaceutical company based in Winnipeg, Manitoba, Canada. It was founded in 1984 and specialized in hyperimmunes, contract manufacturing, biopharmaceuticals and biodefense.  Cangene was 61% owned by Canadian pharmaceutical giant Apotex and was publicly listed on the TSX under the symbol CNJ."
    },
    "CareFusion": {
        "Company Name": "CareFusion",
        "Year": "2009-2015",
        "Description": "CareFusion was a medical company specializing in two areas: reducing medication errors and prevention of health care-associated infections."
    },
    "Celltech": {
        "Company Name": "Celltech",
        "Year": "1980-2004",
        "Description": ""
    },
    "Cephalon": {
        "Company Name": "Cephalon",
        "Year": "1987-2011",
        "Description": ""
    },
    "Chiron Corporation": {
        "Company Name": "Chiron Corporation",
        "Year": "1981-2006",
        "Description": ""
    },
    "Chiroscience": {
        "Company Name": "Chiroscience",
        "Year": "1991-1999",
        "Description": ""
    },
    "Covidien": {
        "Company Name": "Covidien",
        "Year": "2007-2015",
        "Description": ""
    },
    "Crucell": {
        "Company Name": "Crucell",
        "Year": "2000-2010",
        "Description": "52deg09'56''N 4deg28'02''E / 52.1655degN 4.4673degE / 52.1655; 4.4673"
    },
    "Cubist": {
        "Company Name": "Cubist",
        "Year": "1992-2015",
        "Description": "Cubist Pharmaceuticals, Inc. was an American biopharmaceutical company that targeted pathogens like MRSA."
    },
    "Cutter": {
        "Company Name": "Cutter",
        "Year": "1897-1974",
        "Description": "Cutter Laboratories was a family-owned pharmaceutical company located in Berkeley, California, founded by Edward Ahern Cutter in 1897. Cutter's early products included anthrax vaccine, hog cholera (swine fever) virus, and anti-hog cholera serum--and eventually a hog cholera vaccine. The hog cholera vaccine was the first tissue culture vaccine, human or veterinary, ever produced. The company expanded considerably during World War II as a consequence of government contracts for blood plasma and penicillin. After Edward Cutter's death, his three sons--Robert K. Cutter (president), Edward \"Ted\" A. Cutter Jr. (vice-president), and Frederick A. Cutter--ran the company. In the next generation Robert's son David followed his father as president of the company. The Bayer pharmaceutical company bought Cutter Laboratories in 1974.[1]"
    },
    "Cynapsus": {
        "Company Name": "Cynapsus",
        "Year": "1984-2016",
        "Description": "Cynapsus Therapeutics Inc. is a specialty pharmaceutical company developing a drug to treat the motor symptoms of Parkinson's disease.  Based in Toronto, Ontario, Canada. Formerly named Cannasat Therapeutics they changed their name to Cynapsus Therapeutics in 2010.[1]"
    },
    "Dabur": {
        "Company Name": "Dabur",
        "Year": "1884-2008",
        "Description": ""
    },
    "Dawakhana Shifaul Amraz": {
        "Company Name": "Dawakhana Shifaul Amraz",
        "Year": "1894-2000",
        "Description": ""
    },
    "Distillers": {
        "Company Name": "Distillers",
        "Year": "1942-1963",
        "Description": ""
    },
    "Drug Houses of Australia": {
        "Company Name": "Drug Houses of Australia",
        "Year": "1936-2006",
        "Description": "Drug Houses of Australia (DHA) was originally established in 1936[1] as an amalgamation of seven Australian pharmaceutical companies, notably A. M. Bickford & Sons. In 1970, DHA was taken over by the British bank Slater Walker.[1]"
    },
    "\u00c9lan": {
        "Company Name": "\u00c9lan",
        "Year": "1969-2013",
        "Description": ""
    },
    "Empire": {
        "Company Name": "Empire",
        "Year": "1959-1967",
        "Description": "Empire Laboratories was a Canadian pharmaceutical company incorporated on August 21, 1959 as Empire Laboratories Limited by founder Louis Lloyd Winter in Toronto, Ontario, Canada.[1] It grew to become the largest pharmaceutical business in Canada during the 1960s, until the death of its founder on November 5, 1965."
    },
    "Epix": {
        "Company Name": "Epix",
        "Year": "20??-2009",
        "Description": "Epix Pharmaceuticals Inc. (formerly Predix Pharmaceuticals Inc.) was a pharmaceutical company based in Lexington, Massachusetts."
    },
    "Farmitalia": {
        "Company Name": "Farmitalia",
        "Year": "1935-1978",
        "Description": "Farmitalia was an Italian pharmaceutical company best known for its parallel discovery with Rhone-Poulenc of daunorubicin and subsequent discovery of doxorubicin.[1] \nFarmitalia had been founded in 1935 as a joint venture by Rhone-Poulenc and Montecatini.[2] Farmitalia occupied a position of choice in the world rankings of the profession, not only in Italy, but also at the world level with in particular the patent of Adriamycin, an anti-cancer drug qualified. From its creation, Farmaceutici Italia buys the Schiapparelli factory.[3]"
    },
    "F. H. Faulding & Co": {
        "Company Name": "F. H. Faulding & Co",
        "Year": "1845-2005",
        "Description": ""
    },
    "Fisons": {
        "Company Name": "Fisons",
        "Year": "1843-1995",
        "Description": ""
    },
    "Forest": {
        "Company Name": "Forest",
        "Year": "1956-2014",
        "Description": "Forest Laboratories was a company in the pharmaceutical industry incorporated in Delaware, with its principal office in New York City. It was known for licensing European pharmaceuticals for sale in the United States. On July 1, 2014, the company was acquired by Actavis (now Allergan)."
    },
    "Galena": {
        "Company Name": "Galena",
        "Year": "2006-2017",
        "Description": "Galena Biopharma, Inc. (originally RXi Pharmaceuticals) was a publicly traded pharmaceutical company based in San Ramon, California. The company was founded in Worcester, Massachusetts. In 2011, it moved to Oregon,[1][2] and in 2015 moved to San Ramon, California.[3] Mark Schwartz was the company's president and chief executive officer.[4][5][6][7] As of December 29, 2017, the company was acquired by Sellas Life Sciences Group Ltd. through a reverse merger transaction. Galena Biopharma was renamed to Sellas Life Sciences Group, Inc. (Nasdaq: SLS).[8]"
    },
    "Genetics Institute": {
        "Company Name": "Genetics Institute",
        "Year": "1980-1996",
        "Description": "Genetics Institute, Inc. was a biotechnology research and development company founded by Thomas Maniatis and Mark Ptashne, two Harvard molecular biologists, in 1980 in Massachusetts.  Originally operating out of Ptashne's house in Boston, the company found more spacious quarters first in Boston and then Cambridge before expanding further. Gabriel Schmergel joined soon afterwards as CEO.[1]"
    },
    "Genzyme": {
        "Company Name": "Genzyme",
        "Year": "1981-2011",
        "Description": ""
    },
    "G.F. Harvey Company": {
        "Company Name": "G.F. Harvey Company",
        "Year": "1880-1958",
        "Description": "The G.F. Harvey Company was a pharmaceutical manufacturer headquartered in Saratoga Springs, New York between 1890 and 1958."
    },
    "GPC Biotech": {
        "Company Name": "GPC Biotech",
        "Year": "1997-2009",
        "Description": "GPC Biotech (also referred to as GPCbiotech and GPC-Biotech) was a German biopharmaceutical company.  The company's mission statement reads \"... to discover, develop and commercialize new anticancer drugs.\"[1]"
    },
    "Graceway": {
        "Company Name": "Graceway",
        "Year": "????-2011",
        "Description": "Graceway Pharmaceuticals was a USA LLC based in Tennessee."
    },
    "H. K. Mulford": {
        "Company Name": "H. K. Mulford",
        "Year": "1880-1929",
        "Description": "The H. K. Mulford Company was a pharmaceutical company founded in Philadelphia, Pennsylvania. The company was founded in the late 1880s by Henry K. Mulford after his purchase of the Old Simes drugstore at 18th and Market Streets.[1] The company was purchased by Sharp & Dohme Corp in 1929."
    },
    "Hafslund Nycomed": {
        "Company Name": "Hafslund Nycomed",
        "Year": "1986-1996",
        "Description": "Hafslund Nycomed is a defunct company that existed between 1986 and 1996 after the power and industry company Hafslund had bought the pharmaceutical company Nycomed. The company was listed on the Oslo Stock Exchange. In 1996 it was demerged and Nycomed merged with the British pharmaceutical company Amersham, while Hafslund took the power division.[1][2][3]"
    },
    "Hoechst": {
        "Company Name": "Hoechst",
        "Year": "1863-1999",
        "Description": "Hoechst AG (German pronunciation: ['ho:cst]) was a German chemicals, later life sciences, company that became Aventis Deutschland after its merger with France's Rhone-Poulenc S.A. in 1999. With the new company's 2004 merger with Sanofi-Synthelabo, it became a subsidiary of the resulting Sanofi-Aventis pharmaceuticals group."
    },
    "Horizon": {
        "Company Name": "Horizon",
        "Year": "2005-2023",
        "Description": "Paul W. Hoelscher (CFO)\nAndy Pasternak (CBO)"
    },
    "Human Genome Sciences": {
        "Company Name": "Human Genome Sciences",
        "Year": "1992-2012",
        "Description": "Human Genome Sciences (HGS) was a biopharmaceutical corporation founded in 1992 by Craig Venter, Alan Walton and Wally Steinberg. It uses the human DNA sequence to develop protein and antibody drugs. It had drugs under development to treat such diseases as hepatitis C, systemic lupus erythmatosis, anthrax, and cancer.  It collaborated with other biotechnology and pharmaceutical companies for development partnerships and licensing.[1]"
    },
    "IL": {
        "Company Name": "IL",
        "Year": "????-2006",
        "Description": "IL Therapeutics Inc. was previously owned by Western Life Sciences Venture Fund LP\n(\"Western Life Sciences\") and in 2006 its shares were purchased by Pacgen Biopharmaceuticals Corporation (\"Pacgen\").[1][2]"
    },
    "ImmunoGen": {
        "Company Name": "ImmunoGen",
        "Year": "1981-2024",
        "Description": "ImmunoGen, Inc. was a biotechnology company focused on the development of antibody-drug conjugate (ADC) therapeutics for the treatment of cancer. ImmunoGen was founded in 1981 and was headquartered in Waltham, Massachusetts.[2]"
    },
    "Immunomedics": {
        "Company Name": "Immunomedics",
        "Year": "1982-2020",
        "Description": "Immunomedics was a biotechnology company focused on the development of antibody-drug conjugates for the treatment of cancer. In 2020, the company was acquired by Gilead Sciences.[1]"
    },
    "Immutep": {
        "Company Name": "Immutep",
        "Year": "2001-2014",
        "Description": ""
    },
    "Institute for OneWorld Health": {
        "Company Name": "Institute for OneWorld Health",
        "Year": "2000-2011",
        "Description": "PATH (formerly known as the Program for Appropriate Technology in Health) is an international, nonprofit global health organization.[2] PATH is based in Seattle with 1,600 employees in more than 70 countries around the world. Its president and CEO is Nikolaj Gilbert, who is also the Managing Director and CEO of Foundations for Appropriate Technologies in Health (FATH), PATH's Swiss subsidiary. PATH focuses on six platforms: vaccines, drugs, diagnostics, devices, system, and service innovations."
    },
    "Insys": {
        "Company Name": "Insys",
        "Year": "1990-2019",
        "Description": ""
    },
    "ISTA": {
        "Company Name": "ISTA",
        "Year": "1992-2012",
        "Description": "ISTA Pharmaceuticals, Inc., was a US-based pharmaceutical company that  specialized in ophthalmic pharmaceutical  products and discovers, develops, and markets therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye.[1] ISTA was acquired by Bausch & Lomb, an eye care company, on March 26, 2012.[2] Under the deal, Bausch & Lomb have agreed to pay $9.10 per share for ISTA, bringing the total value of the acquisition to $500 million.[3] In 2012, Valeant Pharmaceuticals withdrew its $360 million offer.[4]"
    },
    "James Woolley, Sons and Co.": {
        "Company Name": "James Woolley, Sons and Co.",
        "Year": "1833-1962",
        "Description": ""
    },
    "Jennerex": {
        "Company Name": "Jennerex",
        "Year": "2003-2014",
        "Description": "Jennerex Biotherapeutics, Inc. (now owned by SillaJen) was an American private biopharmaceutical company[1][3] that developed the oncolytic viruses JX-594[1][4] and JX-929[1] among others. By creating oncolytic viruses that can (1) kill tumor cells directly through lysis, (2) activate the immune system by delivering genes that encode immunostimulants and by overcoming tumor cell-induced immunological tolerance, and (3) reduce tumor nutrient supply through the destruction of blood vessels, Jennerex aimed to create a novel approach to treating and possibly curing cancer."
    },
    "Jerini": {
        "Company Name": "Jerini",
        "Year": "1994-2009",
        "Description": "Jerini AG was a pharmaceutical company based in Berlin, Germany, which focused on the discovery and development of novel peptide-based drugs. Using a proprietary technology platform, Peptides-to-Drugs (P2D), Jerini pursued disease indications for which limited, inadequate, or no treatment options exist. As a result, Jerini established a drug pipeline composed of its own programs as well as others in collaboration with partners. Jerini's commercialization strategy was to market new drugs in niche indications independently and in larger indications with partners. Jerini was acquired by Shire plc in 2008.[1]"
    },
    "Juno": {
        "Company Name": "Juno",
        "Year": "2013-2018",
        "Description": "Juno Therapeutics Inc. was an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute. The company was launched with an initial investment of $120 million, with a remit to develop a pipeline of cancer immunotherapy drugs.[1] The company raised $300 million through private funding and a further $265 million through their IPO."
    },
    "King": {
        "Company Name": "King",
        "Year": "1993-2010",
        "Description": "King Pharmaceuticals, Inc. is a pharmaceutical company, a wholly owned subsidiary of Pfizer based in Bristol, Tennessee. Before being acquired by Pfizer, it was the world's 39th largest pharmaceutical company.[1][2]  On October 12, 2010, King was acquired by Pfizer for $14.25 per share.[3] King produced a wide range of pharmaceuticals, including Altace for heart attack prevention, Levoxyl for hypothyroidism, Sonata, a sleeping aid,  and Skelaxin, a muscle relaxant.  King Pharmaceuticals operated manufacturing facilities in Bristol, Tennessee; Rochester, Michigan; St. Louis, Missouri; St. Petersburg, Florida; and Middleton, Wisconsin. They employed approximately 2,700 people including a sales force of over 1,000 individuals."
    },
    "Knoll": {
        "Company Name": "Knoll",
        "Year": "1886-1975",
        "Description": "Knoll Pharmaceuticals was a drug development company founded by Albert Knoll and Hans Knoll in Germany in 1886. The company was taken over by German BASF in 1975, which sold it to Abbott Laboratories on 30 June 2002 for $6.9 billion.[1][2]"
    },
    "KV": {
        "Company Name": "KV",
        "Year": "1942-2009",
        "Description": ""
    },
    "Leiner Health Products": {
        "Company Name": "Leiner Health Products",
        "Year": "1973-2008",
        "Description": "Leiner Health Products was a company based in Carson, California, and was one of America's largest manufacturers of vitamins, minerals, herbal nutritional supplements, and generic medications.  It was founded in 1973, and was owned by North Castle Partners, a private investment firm from Connecticut.[1]"
    },
    "Marathon": {
        "Company Name": "Marathon",
        "Year": "2015-2017",
        "Description": "Marathon Pharmaceuticals LLC was a privately held biopharmaceuticals company focused on drugs for people with rare diseases.[2] The Illinois-based company[3] developed and manufactured therapeutics and brought them to market. It employed 100 people in four global locations.[citation needed] In 2017, PTC Therapeutics acquired rights to Marathon Pharmaceuticals' drug Emflaza (deflazacort) for $140 million after criticism about their plan to sell the drug at a list price of $89,000 per year to sufferers despite the fact that the same drug was available in Canada and the UK for around $1,000 per year.[4][5]"
    },
    "Martek": {
        "Company Name": "Martek",
        "Year": "1985-2011",
        "Description": "Martek Biosciences Corporation was a pharmaceutical company based in Columbia, Maryland.[1]  It was acquired by Royal DSM NV in 2011,[2] and produces nutritional ingredients for the food, beverage, dietary supplement and early life nutrition industries.  By 2004, the company had a 70% market share in the United States for baby formula supplements, and about 30% globally.[3]"
    },
    "Massone (company)": {
        "Company Name": "Massone (company)",
        "Year": "????-",
        "Description": "Massone S.A., also Instituto Massone S.A., is a pharmaceutical company based in Buenos Aires, Argentina.[1]"
    },
    "Mayne": {
        "Company Name": "Mayne",
        "Year": "2005-2007",
        "Description": ""
    },
    "Maxygen": {
        "Company Name": "Maxygen",
        "Year": "1997-2013",
        "Description": "Maxygen Inc. was a biopharmaceutical company focused on developing improved versions of protein drugs using DNA shuffling and other protein modification technologies.[1] The company was headquartered in Redwood City, CA. It dissolved in 2013. The Maxygen legacy was revived in 2018 with a focus on Directed Evolution of Proteins using Molecular Breeding. Maxygen LLC is currently headquartered in Sunnyvale, CA."
    },
    "Medarex": {
        "Company Name": "Medarex",
        "Year": "1987-2009",
        "Description": "Medarex was an American biopharmaceutical company based in Princeton, New Jersey, with manufacturing facilities in Bloomsbury and Annandale, New Jersey, and research facilities in Milpitas and Sunnyvale, California.  In 2009, Medarex was purchased by Bristol Myers Squibb."
    },
    "Meda": {
        "Company Name": "Meda",
        "Year": "1995-2016",
        "Description": "Meda AB is a specialty pharmaceutical company, headquartered in Solna, Sweden. Meda imports and markets pharmaceuticals, nutritional, and health-care products, and offers services including clinical research, registration, and logistics. At the end of 2014, Meda had 5,202 employees. Meda's pharmaceuticals are currently sold in more than 150 countries.[1][self-published source]"
    },
    "MedImmune": {
        "Company Name": "MedImmune",
        "Year": "1988-2019",
        "Description": "MedImmune, LLC was a wholly owned subsidiary of AstraZeneca before February 14, 2019, when it was announced that the MedImmune name and branding would be discontinued in favor of AstraZeneca.[1][2]"
    },
    "Medivation": {
        "Company Name": "Medivation",
        "Year": "2004-2016",
        "Description": "Medivation, Inc. was an American biopharmaceutical company focused on development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation was headquartered in San Francisco, California, beginning operations in December 2004 with the acquisition of Medivation Neurology, Inc.[3] Its final CEO was David Hung.[4]"
    },
    "Meyer Brothers": {
        "Company Name": "Meyer Brothers",
        "Year": "1852-1981",
        "Description": "The Meyer Brothers Drug Company was a major wholesale drug house founded by Christian F. G. Meyer at Fort Wayne, Indiana, in 1852, beginning with Meyer as the owner and only salesman, working his trade on horseback.[1] Meyer had come to the United States from Hanover, Germany in 1847. In 1857, Meyer's brother John F. W. Meyer became a full partner in the business.[1]  By 1865, the business had grown and branched out to other cities; the firm abandoned retail sales for wholesale and moved its headquarters to St. Louis on the supposition that the city was destined to be one of the greatest distributing markets in America.[1] In 1865 Meyer purchased the M. Matthews and Sons drug firm, located on the corner of Second and Locust Streets (now part of the Gateway Arch grounds).  It was not until 1889 that the business was incorporated under the \"Meyer Brothers Drug Company\" name.[1]"
    },
    "Miles Laboratories": {
        "Company Name": "Miles Laboratories",
        "Year": "1884-1995",
        "Description": "Miles Laboratories was founded as the Dr. Miles Medical Company in Elkhart, Indiana, in 1884 by Dr. Franklin L. Miles, a specialist in the treatment of eye and ear disorders, with an interest in the connection of the nervous system to overall health. The company is known for inventing products such as Alka-Selzer and One-A-Day vitamins.[1]"
    },
    "Movetis": {
        "Company Name": "Movetis",
        "Year": "2006-2010",
        "Description": ""
    },
    "Mylan": {
        "Company Name": "Mylan",
        "Year": "1961-2019",
        "Description": ""
    },
    "Nederlandsche Coca\u00efnefabriek": {
        "Company Name": "Nederlandsche Coca\u00efnefabriek",
        "Year": "1900-1962",
        "Description": "The Nederlandsche Cocainefabriek (Dutch pronunciation: ['ne:d@rlants@ ko:ka:'(j)in@fa:,brik]; English: Dutch Cocaine Factory) or NCF was an Amsterdam-based company producing cocaine for medical purposes in the 20th century. It imported its raw materials mainly from the Dutch East Indies and sold its products across Europe, making good profits especially in the early years of World War I. The NCF produced morphine, heroin and ephedrine as well."
    },
    "Nereus": {
        "Company Name": "Nereus",
        "Year": "1988-2012",
        "Description": "Nereus Pharmaceuticals was a pharmaceutical company focused on the development of natural products from marine microbial and other natural sources into small molecule human therapeutics.[4]  The major disease area addressed by Nereus is cancer. Nereus was purchased by Triphase Research and Development in 2012.[5]"
    },
    "Nuvelo": {
        "Company Name": "Nuvelo",
        "Year": "1992-2009",
        "Description": "Nuvelo Inc. was  a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for acute cardiovascular disease, cancer and other debilitating medical conditions. On January 27, 2009, the company was acquired by ARCA Biopharma, Inc. in a reverse takeover transaction."
    },
    "Nycomed": {
        "Company Name": "Nycomed",
        "Year": "1874-2011",
        "Description": "Nycomed is a Swiss pharmaceutical company. Nycomed was acquired by Takeda Pharmaceuticals in September 2011. Production was located in Norway, Denmark, Poland, Austria, Belgium, Germany, Estonia, India, Mexico, Brazil and Argentina. Head office is located in Zurich, Switzerland. Total revenue was EUR3,400 million in 2006 and the group had 12,000 employees then. The company awarded an annual prize totaling 20,000 euros to four excellent junior scientists at the University of Konstanz. Also, the award promoted the concept of scientific exchange and networking of its winners."
    },
    "Omega": {
        "Company Name": "Omega",
        "Year": "1987-2015",
        "Description": "Omega Pharma was a Belgian-based pharmaceutical company which was acquired in 2014 by Perrigo Company plc, an Irish/United States-based global pharmaceutical public company.[1][3] The company was founded in 1987 and was based in the Industrial area 'de Prijkels' in Nazareth."
    },
    "Opsona": {
        "Company Name": "Opsona",
        "Year": "2004-2019",
        "Description": "Opsona Therapeutics was a drug development company specialising in the human immune system and new drugs and vaccines to prevent and treat autoimmune/inflammatory conditions, cancers and infectious diseases.[1][2][3]"
    },
    "Ortho": {
        "Company Name": "Ortho",
        "Year": "1931-1993",
        "Description": "Ortho Pharmaceutical was initially formed in the United States in 1931 as a subsidiary of Johnson & Johnson to market the first prescription spermicidal contraceptive jelly, Ortho-Gynol."
    },
    "OSI": {
        "Company Name": "OSI",
        "Year": "1983-2010",
        "Description": "OSI Pharmaceuticals, Inc. was an American pharmaceutical company formerly based in Long Island, New York with facilities in Colorado, New Jersey and the United Kingdom. On Sunday, May 16, 2010 OSI agreed to be acquired by Japan-based, TSE-listed Astellas Pharma for $4.0 billion.[4] The deal was closed on June 9, 2010. The company closed its last facilities in Long Island in May 2013.[5] OSI had specialized in the discovery and development of molecular targeted therapies.  Though oncology was the top priority for OSI, research and development targeting type 2 diabetes and obesity had been conducted through their U.K. subsidiary Prosidion Limited.[6][1]  OSI had also made a foray into the ophthalmology market through a marketing agreement with Pfizer over Macugen (Pegaptanib) for Age-related macular degeneration; however, acquisition of the firm Eyetech, meant to provide control over this product and diversify the company, was unsuccessful, ending in divestiture.[7][8]"
    },
    "Par": {
        "Company Name": "Par",
        "Year": "1978-2015",
        "Description": "Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations, and customers are almost exclusively U.S.-based, in 2013 Endo executed a corporate tax inversion to Ireland to avoid U.S. corporate taxes on their U.S. drug sales, and to avail of Ireland's corporate tax system.[2][3][4]"
    },
    "Parke-Davis": {
        "Company Name": "Parke-Davis",
        "Year": "1866-1970",
        "Description": "Parke-Davis is a subsidiary of the pharmaceutical company Pfizer. Although Parke, Davis & Co. is no longer an independent corporation, it was once America's oldest and largest drug maker, and played an important role in medical history. In 1970 Parke-Davis was acquired by Warner-Lambert, which in turn was acquired by Pfizer in 2000.[2]"
    },
    "Perseid": {
        "Company Name": "Perseid",
        "Year": "2009-2011",
        "Description": "Maxygen Inc. was a biopharmaceutical company focused on developing improved versions of protein drugs using DNA shuffling and other protein modification technologies.[1] The company was headquartered in Redwood City, CA. It dissolved in 2013. The Maxygen legacy was revived in 2018 with a focus on Directed Evolution of Proteins using Molecular Breeding. Maxygen LLC is currently headquartered in Sunnyvale, CA."
    },
    "Pharmacia": {
        "Company Name": "Pharmacia",
        "Year": "1911-1995",
        "Description": "Pharmacia was a pharmaceutical and biotechnological company in Sweden that merged with the American pharmaceutical company Upjohn in 1995."
    },
    "Pharmacia & Upjohn": {
        "Company Name": "Pharmacia & Upjohn",
        "Year": "1995-2002",
        "Description": "Pharmacia & Upjohn was a global pharmaceutical company formed by the merger of Sweden-based Pharmacia AB and the American company Upjohn in 1995.[1] Today the remainder of the company is owned by Pfizer. In 1997, Pharmacia & Upjohn sold several brands to Johnson & Johnson, including Motrin and Cortaid."
    },
    "Plexxikon": {
        "Company Name": "Plexxikon",
        "Year": "2001-2011",
        "Description": "Plexxikon is an American drug discovery company based in South San Francisco, California. It was co-founded in 2001 by Joseph Schlessinger of Yale University, and Sung-Hou Kim of the University of California, Berkeley."
    },
    "Pliva": {
        "Company Name": "Pliva",
        "Year": "1921-2006",
        "Description": "Pliva d.o.o. is a pharmaceutical company based in Zagreb, Croatia that primarily manufactures and sells generic drugs. It is a subsidiary of Teva Pharmaceuticals."
    },
    "Poulenc Fr\u00e8res": {
        "Company Name": "Poulenc Fr\u00e8res",
        "Year": "1827-1928",
        "Description": "Poulenc Freres (French: [pulek]; Poulenc Brothers) was a French chemical, pharmaceutical and photographic supplies company that had its origins in a Paris pharmacy founded in 1827.\nFrom 1852 it began to manufacture (or package) photographic chemicals.\nIt took the name Poulenc Freres in 1881, and by 1900 had a range of high-quality products. \nThat year it went public as the Etablissements Poulenc Freres.\nIt began production of synthetic medicines, and continued to grow during World War I (1914-18).\nIn 1928 it merged with the Societe des usines chimiques du Rhone to form Rhone-Poulenc."
    },
    "PowderJect": {
        "Company Name": "PowderJect",
        "Year": "1993-2003",
        "Description": ""
    },
    "Profound": {
        "Company Name": "Profound",
        "Year": "1999-2008",
        "Description": "Profound Pharma A/S was a Danish company that develops 2nd generation biopharmaceuticals.[1]"
    },
    "Proteolix": {
        "Company Name": "Proteolix",
        "Year": "2003-2009",
        "Description": "Proteolix, Inc., was a private biotechnology company with headquarters in South San Francisco, California. Proteolix was founded in 2003 based on technology developed by co-founders Craig M. Crews (Yale University) and Raymond J. Deshaies (California Institute of Technology). Susan Molineaux and Phil Whitcomeref>\"Paid Notice: Deaths WHITCOME, DR. PHILIP J.\" The New York Times. 2005-12-18. ISSN 0362-4331. Retrieved 2024-06-19.</ref> joined as co-founders."
    },
    "Purdue": {
        "Company Name": "Purdue",
        "Year": "1892-2019",
        "Description": "Purdue Pharma L.P., formerly the Purdue Frederick Company (1892-2019), was an American privately held pharmaceutical company founded by John Purdue Gray. It was sold to Arthur, Mortimer, and Raymond Sackler in 1952, and then owned principally by the Sackler family and their descendants.[1][2]"
    },
    "Ranbaxy Laboratories": {
        "Company Name": "Ranbaxy Laboratories",
        "Year": "1961-2014",
        "Description": ""
    },
    "Reliant": {
        "Company Name": "Reliant",
        "Year": "????-2007",
        "Description": "Reliant Pharmaceuticals was a company purchased by GlaxoSmithKline in December 2007 for $1.65B.[1] Co-founded by Joseph J. Krivulka."
    },
    "Renovo": {
        "Company Name": "Renovo",
        "Year": "1998-2011",
        "Description": ""
    },
    "Rh\u00f4ne-Poulenc": {
        "Company Name": "Rh\u00f4ne-Poulenc",
        "Year": "1928-1999",
        "Description": "Rhone-Poulenc (French pronunciation: [Ron pulek]) was a French chemical and pharmaceutical company founded in 1928.  In 1999, it merged with Hoechst AG to form Aventis.  As of 2015, the pharmaceutical operations of Rhone-Poulenc are part of Sanofi and the chemicals divisions are part of Solvay group and Bayer Crop Science."
    },
    "Roussel Uclaf": {
        "Company Name": "Roussel Uclaf",
        "Year": "1911-1997",
        "Description": "Roussel Uclaf S.A. was a French pharmaceutical company and one of several predecessor companies of today's Sanofi."
    },
    "S. E. Massengill": {
        "Company Name": "S. E. Massengill",
        "Year": "1898-2011",
        "Description": "S. E. Massengill Company was a pharmaceutical company founded in 1898 by Samuel Evans Massengill, who graduated from the University of Nashville Medical School but decided to manufacture drugs rather than practice medicine himself.[1] By 1937, it employed more than two hundred people in Bristol, Tennessee, including six graduate pharmaceutical chemists. In 2011, it was purchased by Prestige Brands, now known as Prestige Consumer Healthcare."
    },
    "Sanofi Pasteur": {
        "Company Name": "Sanofi Pasteur",
        "Year": "2004-2016",
        "Description": "45deg43'37''N 4deg50'37''E / 45.727degN 4.8437degE / 45.727; 4.8437"
    },
    "Santaris": {
        "Company Name": "Santaris",
        "Year": "2003-2023",
        "Description": "Santaris Pharma A/S was a biopharmaceutical company founded in 2003 in Copenhagen, Denmark.[1] The company also had a branch in San Diego, California that opened in 2009.[2] Created by a merger between Cureon and Pantheco, Santaris developed RNA-targeted medicines using a Locked Nucleic Acid (LNA) Drug Platform and Drug Development Engine.[3]"
    },
    "Schering AG": {
        "Company Name": "Schering AG",
        "Year": "1851-2006",
        "Description": "Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006, it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004."
    },
    "Schering-Plough": {
        "Company Name": "Schering-Plough",
        "Year": "1971-2009",
        "Description": "Schering-Plough Corporation was an American pharmaceutical company. It was originally the U.S. subsidiary of the German company Schering AG, which was founded in 1851 by Ernst Christian Friedrich Schering. As a result of nationalization, it became an independent company. In 1971, the Schering Corporation merged with Plough, Inc. (founded by Memphis-based entrepreneur Abe Plough in 1908[1]) to form Schering-Plough. On November 4, 2009 Merck & Co. merged with Schering-Plough with the new company taking the name of Merck & Co."
    },
    "Scioderm": {
        "Company Name": "Scioderm",
        "Year": "2013-2015",
        "Description": ""
    },
    "Serono": {
        "Company Name": "Serono",
        "Year": "1906-2006",
        "Description": "Serono was a biotechnology company headquartered in Geneva, Switzerland. It was acquired by the German pharmaceutical company Merck in 2006. The company was founded as the Serono Pharmacological Institute by Cesare Serono in 1906 in Rome, Italy.  \nA key step in its development was the discovery of a method of extracting urinary gonadotropins by Dr. Piero Donini. Serono was incorporated in 1987 and the holding company, Ares-Serono S.A., changed its name to Serono S.A. in May 2000."
    },
    "Shire": {
        "Company Name": "Shire",
        "Year": "1986-2019",
        "Description": ""
    },
    "Sigma Healthcare": {
        "Company Name": "Sigma Healthcare",
        "Year": "1912-2010",
        "Description": ""
    },
    "Smith, Kline & French": {
        "Company Name": "Smith, Kline & French",
        "Year": "1891-2000",
        "Description": "Smith, Kline & French (SKF) was an American pharmaceutical company."
    },
    "Starwin": {
        "Company Name": "Starwin",
        "Year": "1960-2020",
        "Description": "Starwin Products Ghana was a Ghanaian pharmaceutical manufacturer. It was the first pharmaceutical company to be listed on the Ghana Stock Exchange.  It was a component of the GSE All-Share Index. The company produced 8 brand name products."
    },
    "Sterling": {
        "Company Name": "Sterling",
        "Year": "1901-1994",
        "Description": ""
    },
    "Sucampo": {
        "Company Name": "Sucampo",
        "Year": "1996-2018",
        "Description": "Sucampo Pharmaceuticals, Inc. was a pharmaceutical company headquartered in Rockville, Maryland that focused on gastroenterology, ophthalmology, and oncology-related disorders.[1] In 2018, the company was acquired by Mallinckrodt."
    },
    "Sumitomo Chemical": {
        "Company Name": "Sumitomo Chemical",
        "Year": "1971-2005",
        "Description": "Sumitomo Chemical Co., Ltd. (Zhu You Hua Xue Zhu Shi Hui She , Sumitomo Kagaku Kabushiki-gaisha) is a major Japanese chemical company. The company is listed on the first section of the Tokyo Stock Exchange and is a constituent of the on the Nikkei 225[3] stock index. It's a member of the Sumitomo group and was founded in 1913 as a fertilizer manufacturing plant."
    },
    "Syntex": {
        "Company Name": "Syntex",
        "Year": "1944-1994",
        "Description": "Laboratorios Syntex SA (later Syntex Laboratories, Inc.) was a pharmaceutical company formed in Mexico City in January 1944 by Russell Marker, Emeric Somlo, and Federico Lehmann to manufacture therapeutic steroids from the Mexican yams called cabeza de negro (Dioscorea mexicana) and Barbasco (Dioscorea composita).[1]  The demand for barbasco by Syntex initiated the Mexican barbasco trade.[2]"
    },
    "Tanox": {
        "Company Name": "Tanox",
        "Year": "1986-2007",
        "Description": "Tanox was a biopharmaceutical company based in Houston, Texas. The company was founded by two biomedical research scientists, Nancy T. Chang and Tse Wen Chang in March 1986 with $250,000, which was a large part of their family savings at that time. Both Changs grew up and received college education in chemistry in National Tsing Hua University in Taiwan and obtained Ph.D. degrees from Harvard University. For postdoctoral training, Tse Wen shifted to immunology and did research with Herman N. Eisen at the Center for Cancer Research, M.I.T. The two Changs successively became research managers and worked with a range of monoclonal antibody projects in Centocor, Inc. based in Malvern, Pennsylvania, from 1981 to 1985.[1] The Changs were recruited by Baylor College of Medicine toward the end of 1985 and offered faculty positions in the Division of Molecular Virology. Soon after their arrival, they were encouraged by a high-ranking Baylor official and local business leaders to start a biotech venture in Houston. This was in a period of time when the economy of Houston was in slump as the result of the collapse of the oil industry.[1]"
    },
    "Telesta": {
        "Company Name": "Telesta",
        "Year": "1979-2016",
        "Description": "Telesta Therapeutics Inc. was a publicly traded, Canadian pharmaceutical company based in Montreal, Quebec.[1]  It was acquired by ProMetic Life Sciences in 2016.[2]"
    },
    "Tibotec": {
        "Company Name": "Tibotec",
        "Year": "1994-2002",
        "Description": "Tibotec was a pharmaceutical company with a focus on research and development of the treatment of infectious diseases such as HIV/AIDS and hepatitis C. The company was founded in 1994 and then acquired by Johnson & Johnson and merged into its Janssen Pharmaceuticals division in 2002."
    },
    "Trubion": {
        "Company Name": "Trubion",
        "Year": "1999-2010",
        "Description": "Trubion was a publicly held biopharmaceutical company that was focused on creating a pipeline of protein-based therapeutic product candidates to treat autoimmune and inflammatory diseases and cancer. Trubion was acquired by Emergent BioSolutions on October 28, 2010.[1] Trubion was established in 1999 in the State of Washington as an early stage development company, and was later reincorporated in October 2002 in the State of Delaware."
    },
    "Upjohn": {
        "Company Name": "Upjohn",
        "Year": "1886-1995",
        "Description": "The Upjohn Company was an American pharmaceutical manufacturing firm founded in 1886 in Hastings, Michigan, by Dr. William E. Upjohn who was an 1875 graduate of the University of Michigan medical school. The company was originally formed to make friable pills, which were specifically designed to be easily digested.[1] They could be \"reduced to a powder under the thumb\", a strong marketing argument at the time."
    },
    "Union de Pharmacologie Scientifique Appliqu\u00e9e": {
        "Company Name": "Union de Pharmacologie Scientifique Appliqu\u00e9e",
        "Year": "1935-1994",
        "Description": "The Union de pharmacologie scientifique appliquee (UPSA) is a French pharmaceutical group, independent from 1935 until acquisition by Bristol Myers Squibb in 1994. The company is now owned by Taisho Pharmaceutical.[1]"
    },
    "Vectura": {
        "Company Name": "Vectura",
        "Year": "1997-2021",
        "Description": ""
    },
    "Vernalis Group": {
        "Company Name": "Vernalis Group",
        "Year": "1991-2003",
        "Description": "Vernalis Group was a British-based pharmaceuticals business headquartered in Winnersh. The Vernalis name comes from the verb \"to vernalise\", meaning nurture or develop, and is derived from the Latin word vernus, meaning \"of the spring\"."
    },
    "Vernalis plc": {
        "Company Name": "Vernalis plc",
        "Year": "2003-2018",
        "Description": ""
    },
    "ViroPharma": {
        "Company Name": "ViroPharma",
        "Year": "1994-2014",
        "Description": ""
    },
    "Warner Chilcott": {
        "Company Name": "Warner Chilcott",
        "Year": "1968-2013",
        "Description": "Warner Chilcott (formerly Galen) was a company in the pharmaceutical industry based in Rockaway, New Jersey. It was primarily focused on women's healthcare and dermatology. On October 1, 2013, the company was acquired by Actavis (now Allergan)."
    },
    "Warner-Lambert": {
        "Company Name": "Warner-Lambert",
        "Year": "1955-2000",
        "Description": "Warner-Lambert was an American pharmaceutical company."
    },
    "Wyeth": {
        "Company Name": "Wyeth",
        "Year": "1860-2009",
        "Description": "Wyeth was a pharmaceutical company until it was purchased by Pfizer in 2009. The company was founded in Philadelphia, Pennsylvania, in 1860 as John Wyeth and Brother. Its headquarters moved to Collegeville, Pennsylvania, and Madison, New Jersey, before its headquarters were consolidated with Pfizer's in New York City after the 2009 merger."
    },
    "Zeneca": {
        "Company Name": "Zeneca",
        "Year": "1993-1999",
        "Description": ""
    },
    "Zonite": {
        "Company Name": "Zonite",
        "Year": "1922-1955",
        "Description": "Zonite Products Corporation was a New York City based company formed in 1922.[1] Headquartered in the Chrysler Building, it became a leader in the medical preparations' field starting in 1930. In February 1930, it purchased for $215,000 the New Brunswick manufacturing plant of Reichardt Cocoa & Chocolate Company. By April 1931, Zonite's subsidiaries became concentrated in a single production facility. These included Zonite, Forhan's toothpaste and antiseptic, Argyrol, and Larvex.[2] Annette's Perfect Cleanser Company was acquired in March 1932.[3]"
    },
    "ZymoGenetics": {
        "Company Name": "ZymoGenetics",
        "Year": "1981-2019",
        "Description": "ZymoGenetics, Inc was one of the oldest biotechnology/pharmaceutical companies in the USA,[1] based in Seattle, Washington. The company was involved in the development of therapeutic proteins. Located on Lake Union, the address of the ZymoGenetics headquarters was 1201 Eastlake Avenue East.[2] It was closed in 2019 after its acquisition by Bristol Myers Squibb.[3][4]"
    }
}